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Abstract: 
Cocaine and Amphetamine Regulated Transcript (CART) peptide is a putative 
neuropeptide, which has been implicated in a variety of physiological processes 
including feeding, reward and reinforcement and locomotion. However, CART 
peptide receptors have not yet been identified and CART peptide's mechanism of 
action still remains unclear. 
Using immunohistochemistry, I have confirmed the presence of CART peptide in 
fibres in the vestibular cerebellum (lobes IX and X and the paraflocculus) and have 
shown that the CART peptide has a banded distribution. Co-localisation with Vesicle 
Glutamate Transporter 2 (vGluT2) demonstrated CART peptide expression at 
climbing fibre-Purkinje cell synapses. Thus CART peptide may act as a 
neurotransmitter. 
Application of CART peptide (fragment amino acids 55-102), significantly increased 
the firing rate of vestibular Purkinje cells, an effect that persisted when synaptic 
inputs were blocked. CART peptide appeared to directly depolarise the membrane 
potential of Purkinje cells, and this may underlie the observed increase in firing rate. 
CART peptide did not modulate excitatory or inhibitory inputs onto Purkinje cells, 
and did not appear to have a role in synaptic plasticity. 
I have investigated what controls the firing rate and pattern of firing of Purkinje cells 
in vitro. The major factor is the activity of inhibitory interneurones whereas excitatory 
inputs have little effect. I have identified 7 different firing patterns and have shown 
that blocking synaptic inhibition not only changes the firing rate, but also the firing 
pattern. I have also demonstrated that the AMP A receptor antagonist, 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX) has a direct excitatory effect on Purkinje cells, 
increasing the firing rate and depolarising the membrane potential. 
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Chapter 1: Introduction 
1.1 - Neuropeptides 
Cocaine and amphetamine regulated transcript (CART) peptide is a putative 
neuropeptide. Neuropeptides can be defined as "peptides that have direct synaptic 
effects or indirect modulatory effects on the nervous system" (http://www.biology-
online.orgldictionary.asp, 17/09/07). Many neuropeptides were originally identified 
in non-neural tissue such as the gut and then later discovered in the brain. They vary 
in size from 2 amino acids up to around 50 (above 50 they are often classified as 
proteins). Neuropeptides represent the largest group of neurotransmitter molecules but 
differ in a number of significant ways from classical or fast neurotransmitters (Mains 
and Eipper, 2006). 
Neuropeptides can be classified either on the area of the brain where they are 
expressed (hypothalamic releasing factors: CRH (corticotropin releasing hormone), 
GHRH (growth hormone releasing hormone) and somatostatin) or on structural 
similarities (Opiate peptides: ~-endorphin, Leu-enkephalin, Met-enkephalin). 
However, structurally similar neuropeptides can have very different functions, for 
example the 9 amino acid peptides vasopressin and oxytocin are only different at 2 
positions, but their functions in the body are very different. For example, in the 
amygdala, both vasopressin and oxytocin have an excitatory effect on the neurones 
they innervate, however vasopressin increases the fear response whereas oxytocin 
reduces the fear response (Debiec, 2005). 
An important difference between classical neurotransmitters and neuropeptides is 
their synthesis and processing. For example, the neurotransmitter acetylcholine (ACh) 
1 
is synthesised at the nerve terminal by the enzyme choline acetyltransferance (ChAT) 
and after release the ACh is broken down to choline and acetic acid, the choline being 
transported back into the cell to be used again to synthesise more ACh (Bear et al., 
2007). In contrast, neuropeptides are initially synthesised as a large preprohormone 
(100-250 residues) by ribosomes in the cell body. This preprohormone contains a 
signal sequence which facilitates trafficking to the Golgi apparatus/endoplasmic 
reticulum (Figure 1.1). The preprohormone is then cleaved to form a smaller 
prohormone in the Golgi apparatus and the active neuropeptides are produced by the 
action of a prohormone convertase, packaged into vesicles and transported to the 
nerve terminals by axonal transport (Seidah and Chretien, 1999). 
A single prohormone can give raise to multiple copies of the same neuropeptide, as 
with FMRFamide precursors (Li et al., 1999) or multiple different neuropeptides, as 
with pro-opiomelancortin (POMC) (Zhou et al., 1999a). In cases where multiple 
neuropeptides can be generated from a single prohormone then it is the different 
prohormone convertases that give rise to the different neuropeptides. For example the 
action of prohormone convertase 1 on POMC gives adrenocorticotropic hormone 
(ACTH) and p-endorphin but further action of prohormone convertase 2 converts 
ACTH into the neuropeptide a-melanocyte-stimulating hormone (a-MSH). Diversity 
of members of a neuropeptide family can also be increased by gene splicing. 
Neuropeptides are packed into large dense core vesicles (LDCV). The concentration 
of neurotransmitter inside these vesicles is generally lower than found in the small 
synaptic vesicles containing classical neurotransmitters (3-10 mM compared to 100-
500 mM). In many neurones both LDCV and vesicles containing classical 
neurotransmitters are in the same terminals; however LDCV are usually at a lower 
density and located further from the synaptic cleft. Thus many neurones signal by the 
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Figure 1.1 - The intracellular pathway for synthesis, storage and secretion of neuropeptides. 
Neuropetide precursors are synthesised in ribosome on the endoplasmic reticulum , 
transported to the Golgi apparatus where they are processed before being packed into large 
dense core vesicle and transported to synapses. Taken from Siegal , G. J., R. W . Albers, S. T. 
Brady and D. L. Price (2006). Basic Neurochemistry: Molecular. Cellular and Medical Aspects, 
Elsevier Acemdemic Press. 
co-transmission of a fast classical neurotransmitter and a neuropeptide. The release of 
neuropeptides from LDCV is different from neurotransmitter release from small 
synaptic vesicles (SSV). Release from SSV is stimulated by a transient increase in 
calcium ion concentration in the pre-synaptic density; release is local and requires a 
high calcium ion concentration. Release from LDCV is also stimulated by an increase 
in cytosolic calcium ion concentration, but this can be from calcium ion influx or 
from the release of calcium ions from internal stores. In many cases, trains of stimuli 
are required to release neuropeptides compared to single stimuli for classical 
neurotransmitters. This may stem from the distal location of LDCV relative to the 
calcium ion entry sites. For example at sympathetic nerve terminals, NPY IS 
preferentially released at high stimulation frequencies whereas noradrenaline is 
released at low stimulation frequencies (Stjarne, 1989). Unlike classical 
neurotransmitters, there is no requirement for an uptake system as the neuropeptide 
can be readily synthesised from amino acids within the presynaptic neurone. 
The receptors for neuropeptides are often many orders of magnitude more sensitive 
than classical neurotransmitter receptors. This is probably because the concentration 
of peptide released is often much less than that for classical neurotransmitters. The 
receptors for neuropeptides are most commonly G-protein coupled receptors (Hille, 
2(01) with no evidence for neuropeptides directly activating ligand gated ion 
channels. G-protein coupled receptors (GPCR) can have a large number of post-
synaptic effects, and these are determined by the G-protein to which they are coupled. 
G-proteins can exert an effect by directly modulating ion channels, either by opening 
them directly, as with GIRK the potassium ion channel (Yi et ai., 2(01) or by 
changing the probability of opening, as with L-type calcium channels (Dolphin, 2(03). 
G-proteins also influence the levels of secondary messengers; this can then affect ion 
4 
channels directly, for example activation of Ih current by cAMP (DiFrancesco and 
Tortora, 1991) or activation of a signal cascade which can result in the 
phosphorylation/dephosphorylation of ion channels, altering their gating properties. 
In addition signal cascades, initiated by activation of G-proteins, can result in changes 
to receptor density either via phosphorylation or changes in gene expression. In 
general, the effects of neuropeptides are often much longer lasting than the action of 
classical neurotransmitters. 
1.2 - Cocaine and amphetamine regulated transcript 
Cocaine and amphetamine regulated transcript (CART) was first identified by 
Douglass et. al. (1995) as an mRNA upregulated in the striatum after application of 
the psychostimulants, amphetamine and cocaine. Using the method of PCR 
differential display (Liang and Pardee, 1992) a transcript was identified which was 
upregulated in the striatum, present but not regulated by psychostimulants in the 
hippocampus and absent from the cerebellum (Douglass et aI., 1995). Northern blots 
revealed that there were in fact two transcripts, approximately 700 and 900 base pairs 
long. The gene sequence was determined (ascension number Ul0071, Genebank); the 
CART gene contains 2 introns and 3 exons, and was predicted to code for an 116 or 
129 amino acid (aa) long peptide (Douglass et al., 1995). The peptide sequence 
shows no sequence similarity to any known peptides, however it did show sequence 
homology to an acid extract peptide fragment from ovine hypothalamus (Spiess et al., 
1981). Further to this work the human CART gene (ascension number U20325, 
Genebank) was identified (Douglass and Daoud, 1996) and showed to have 
5 
approximately 80 % sequence identity and 92 % sequence similarity in the protein 
coding region. The human CART gene maps to chromosome 5q13-14, a region 
which has been previously associated with obesity and energy homeostasis in humans 
(Dominguez, 2006). To date, CART type genes have been identified in at least 12 
different species (human, monkey, chimp, cow, pig, mouse, rat, chicken, frog, puffer 
fish, zebra fish and goldfish) and the protein coding region of these genes appears 
tightly conserved. Interestingly no homologous genes have been identified in 
invertebrates. 
Analysis of the upstream region of the CART gene in mouse identified a number of 
binding motifs (Dominguez et aI., 2002), including TAT A box, STAT, cAMP 
responsive element (CRE), AP I, SP I, AP2, E-box and Pit-l sites. Of these sites two 
have received attention. CART peptide levels show diurnal variation in blood and in 
brain (hypothalamus, nucleus accumbens, amygdala and midbrain) and this maybe via 
the E-box and a circadian transcription factor (Vicentic, 2006). It has also been 
shown that p-CREB binds to the CRE binding site upstream of the CART gene 
(Lakatos et aI., 2002) and increases CART peptide levels in GH3 and CATH cells 
(Domingez and Kuhar, 2004). It has been shown in vivo that CART expression in the 
nucleus accumbens is regulated by the cAMP/PKAlCREB pathway (Jones and Kuhar, 
2005). 
The CART gene codes for a 129 or 116 aa long peptide (rat long below): 
MESSRLRLLPVLGAALLLLLPLLGAGAQEDAELQPRALDIYSA VDDASHEKE 
LPRRQLRAPGA VLQIEALQEVLKKLKSKRIPIYEKKYGQVPMCDAGEQCAVR 
KGARIGKLCDCPRGTSCNSFLLKCL 
6 
The first 27 aa (in red) are a signal sequence that aids trafficking and peptide secretion 
and are removed to give the proCART peptide. In rat, both the long (including the aa 
shown in g.rL'l.:n) and short form are expressed, however in human only the short form 
is found. There are 6 cysteine resides and these form 3 disulphide bridges: CysI(55)-
CysIII(73), CysII(61)-CysV(81) and CysIV(75)-CysVI(88). There are a number of 
pairs of basic residues (putative sites for the action of pro hormone convertases) on the 
CART peptide, however only 3 of these lie before the first cysteine residue: 
Lys(48)Lys(49), Lys(53)Arg(54) and Lys(60)Lys(61). The peptide fragments that 
have been observed will be addressed in the next section. 
1.3 - CART peptides 
1.3.1 - What CART peptide fragments are present in the brain and where are they 
expressed? 
In situ hybridisation studies revealed that CART mRNA is expressed all over the 
mammalian central nervous system (CNS) (Couceyro et aI., 1997) and peripheral 
nervous system (PNS) (Ekblad, 2006; Wierup and Sundler, 2006), including: the 
hypothalamus, striatum, retina, spinal cord, pituitary, medulla, adrenal gland, gut and 
pancreas. Although CART mRNA is widely expressed, it is not ubiquitous. 
There are very few studies that look at the ontogeny of CART. As early as prenatal 
day 11 (Ell) CART positive cells have been observed from the mesencephalon to the 
ventral brainstem and by E 13 cells in the diencephalon are observed (Risold et aI., 
2006). CART positive cells are not observed in the telencephalon until the late stages 
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of gestation (EI8) and continues after birth reaching a maximum between 5 and 8 
days postnatal (P5-8) and decrease after that reaching the low adult expression level 
by P22 (Dun et aI., 2001). The only PNS area where developmental changes in 
CART peptide have been explored is the pancreas. It would seem plausible that 
CART peptide fragments may have roles in neurogenesis or synaptagenesis but as of 
yet there is no experimental evidence to support this. 
In the hypothalamus, CART mRNA expression is regulated by leptin (a feeding factor 
which inhibits feeding) and injection of a recombinant CART peptide fragment 
(corresponding to the amino acids residues 55-102 of the long CART peptide) into rat 
brain results in a decrease in feeding (Kristensen et al., 1998). In addition, an 
antibody against the CART peptide 55-lO2 fragment, when injected into the rat brain, 
increases feeding. These three observations led to the proposition that CART peptide 
is anorectic and provided the first test of CART peptide function: the inhibition of 
feeding. The CART peptide fragment 55-lO2 was isolated from yeast expression 
(Thim et al., 1998) and the presence of 3 disulphide bridges confirmed. Disruption of 
the disulphide bridges results in the loss of peptide function (it no longer inhibits 
feeding). The N-terminus fragments (from amino acid 1-53) are inactive (having no 
effect on feeding). The fragment aa 55-102 is considered by most investigators to be 
the longest physiologically active CART peptide fragment. Because the yeast 
expression system includes intrinsic prohormone convertases it was not possible to 
isolate the full length proCART peptide. However expression in Escherichia coli 
resulted in the isolation of a full length peptide, which also inhibited feeding upon 
central administration (Couceryro and Fitz, 2003). The other major CART peptide 
fragment which has received attention is the fragment 62-lO2 which also inhibits 
feeding (Dylag et al., 2006). 
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A full immunohistochemical study of the distribution of CART peptide showed that it 
has a wide distribution of expression in the rat brain (Koylu et al., 1998). CART 
peptide is found either in neuronal cell bodies or in fibres (axons) systems in many 
areas of the CNS and PNS. To my knowledge there is no evidence of CART peptide 
in glia. In the monkey hypothalamus CART peptide has been shown by electron 
microscopy to be present in LDCV (Smith et aI., 1997). 
The CART peptide fragments are generated in vivo by prohormone convertase 113 
(PC1I3) and 2 (PC2) (Dey et aI., 2003). The longer fragment (55-102) can be 
generated by either PC 113 or PC2, but the shorter fragment (62-102) is only generated 
by PC2. This gives a mechanism to differentially produce these two CART peptides: 
convertase expression. 
Because modulation of CART mRNA levels is associated with stimulant drugs, areas 
of the brain associated with reward and reinforcement (ventral tegmental area, 
substania nigra, nucleus accumbens, lateral hypothalamus and prefrontal cortex) have 
been intensively studied. The identification of CART peptide as anorectic has also 
led to intensive study of the distribution and role of CART peptides in the area of the 
brain which controls feeding: the hypothalamus. CART peptide is also found in areas 
of the brain associated with stress (hypothalarnic-pituitary-adrenal axis and 
sympathetic division of the autonomic nervous system). Finally the presence of 
CART peptide in the areas of the brain associated with emotional states (amygdala 
and hippocampus) has led to research into a possible role for CART peptides in fear 
and anxiety. 
There are currently two CART gene knockout mice strains (Asnicar et aI., 2(01) 
(Wierup et aI., 2005). Both of these mice strain strains show a mild obese phenotype 
and have altered responses to psychostimulants compared to wild-type mice (Moffett 
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et al., 2006). In addition these mice have altered pancreatic function, have slightly 
reduced bone mass and show high levels of anxiety. 
1.3.2 - CART peptides and reward/reinforcement. 
As previously mentioned, CART was identified after administration of the 
psychostimulants cocaine and amphetamine (Douglass et al., 1995). However these 
results proved to be controversial as other groups were unable to repeat this 
observation (Vrang et ai., 2002; Marie-Claire et al., 2(03). It appears that to get a 
reliable increase in CART mRNA and CART peptide expression levels requires a 
binge-dosing regime rather than acute administration (Hunter et aI., 2(05). The 
increase in CART mRNA in the nucleus accumbens is due to an increase in 
intracellular levels of cAMP (Jones and Kuhar, 2(05). Elevated levels of cAMP have 
also been found in this area of the brain in human cocaine overdose victims (Tang et 
al.,2(03). 
Although the neurochemistry of drug abuse is highly complex, one of the key 
pathways that is activated during drug use and facilities drug addiction is the 
mesolimbic dopamine system (Figure 1.2). The mesolimbic dopamine system can 
simply be thought of as 4 interconnected areas of the brain: the striatum (dorsal 
striatum (DS) and nucleus accumbens (NA», substantia nigra (- pars compacta (SNc) 
and - pars recticula (SNr», lateral hypothalamus (perifomical area (PefILH» and 
ventral tegmental area (VT A). All of these areas contain CART peptide positive 
fibres and the NA and PeflLH contain CART positive cell bodies. 
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Figure 1.2 - The mesolimbic dopamine system . Four interconnected brain areas with the final 
output being from the nucleus accumbens . CART, cocaine-and-amphetamine regulated 
transcript; DA, dopamine; MCH, melanin-concentrating hormone; NA, nucleus accumbens; 
Pef/LH, perifornical area of the lateral hypothalamus; SNc, substantia nigra pars compacta; 
SNr, substantia nigra pars reticulata; SP, SUbstance P; VTA, ventral tegmental area .. Taken 
from Philpot, K. B. and Y. Smith (2006). "CART peptide and the mesolimbic dopamine 
system." Peptide 27(8): 1987-1992. 
Direct injection of CART peptide (unless otherwise stated CART peptide refers to the 
fragment 55-102) into the VT A results in an increase in locomotive activity and 
induces conditional placement preference (the animal spends more time in the area 
associated with injection of CART peptide) (Kimmel et al., 2000). This effect is 
similar to direct cocaine administration, although somewhat smaller. When low doses 
of cocaine and CART peptide are co-injected they are additive, but at higher doses 
they become sub-additive, suggesting they may mediate effects via different 
mechanisms (Kuhar et al., 2005). Immunohistochemistry and tracer studies show that 
the CART peptide positive terminals in the VTA corne from the PeflLHA and co-
express the inhibitory neuropeptide a-MSH (Philpot and Smith, 2006) suggesting that 
they are inhibitory in nature. The CART positive terminals in the VTA primarily 
innervate GABAergic neurones with only 30 % of CART positive fibres contacting 
dopamine containing neurones. The GABAergic neurones of the VT A contact 
dopaminergic neurones which project out to the NA. It appears that CART peptide in 
the VT A has its effect by dis-inhibiting the excitatory doparninergic neurones. 
In contrast, injection of CART peptide into the NA does not have any effect on 
locomotion, in fact CART peptide attenuate the locomotive effect of cocaine 
(Jaworski et al., 2003). The CART positive cells in the NA receive dopaminergic 
inputs from the VTA and the PeflLH and project out of the NA into various brain 
regions associated with reward behaviour. Inside the NA there are local intemeurons 
which are positive for CART peptide and GABA, and also for other neuropeptides 
such as substance P (Hubert and Kuhar, 2005) and dynorphin (Dallvechia-Adarns et 
al., 2002). In addition there is a CART peptidergic output from the NA to SNr and 
SNc areas. 
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The substantia nigra is the final part of the reward and reinforcement CART puzzle. 
The synaptic terminals of CART peptide containing fibres from the NA in the SN 
also contain GABA and are almost exclusively found in the substantia nigra pars 
reticula (SNr) (Dallvechia-Adams et aI., 2001). These neurones are inhibitory in 
nature and project to the dopaminergic neurones of the substantia nigra pars compacta 
(SNc), which in turn project out of the SN back to the NA and the DS. 
Finally CART knockout mice still show typical behaviour when given 
psychostimulant drugs but different labs give conflicting results on how much the 
knockout effects locomotor activity and conditioned place preference (Moffett et al., 
2006). What is clear is that CART knockout mice self administers less cocaine than 
wild type mice (Couceyro et al., 2005). It appears that CART peptide mediates the 
reward and reinforcement mechanisms in the brain by dis-inhibition of the 
dopaminergic neurones of the mesolimbic system. This suggests that the CART 
peptide receptor(s) are inhibitory, at least in the VTA, NA and SN. As of yet there 
has been no direct electrophysiological evidences of effect of CART peptide on 
neurones in mesolimbic dopamine system. 
1.3.3 - CART peptides and feeding/energy homeostasis 
The initial suggestion that CART peptide was involved in feeding and energy 
homeostasis came from the observation that injection of CART peptide into the fourth 
or lateral ventricles resulted in reduction of food intake, primarily by reduction of 
meal size rather than meal number (Aja et al., 2002). This reduction in food intake 
translated into a reduction in body fat and was seen in both lean and obese rats 
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(Larsen et al., 2000). It was expected that the CART knockout mice would have a 
strong obese phenotype, but this was not observed. The mild obesity phenotype seen 
in the CART knockout mice may in fact be due to a pancreatic dysfunction rather than 
central effects (CART knockout mice are hypoinsulinemic). It is clear that the 
involvement of CART peptides in feeding and energy homeostasis is not simple, and 
this may reflect the complexity of the neuronal circuits involved. 
When thinking about food intake and energy expenditure it has become clear that the 
accurate nucleus (Arc) is central. The Arc is located in the hypothalamus adjacent to 
the third ventricle. Neurones of the Arc respond to circulating leptin. Leptin is 
produced by adipose tissue, crosses the blood brain barrier at the median eminence, 
and inhibits feeding. Neurones of the Arc can (in simple terms) be classified as either 
anabolic or catabolic; the anabolic neurones of the Arc contain CART peptide and 
POMC, are stimulated by leptin, increase energy expenditure and reduce feeding. 
The catabolic neurones contain neuropeptide Y (NPY) and agouti-related peptide 
(AGRP), are inhibited by leptin, decrease energy expenditure and increase feeding. 
Thus it appears that in the Arc, CART peptides partially mediate the anabolic 
homeostatic signal, and this explains the decrease in feeding observed when CART 
peptide is injected in the rat brain. In humans a point mutation in the CART gene 
(resulting in a change from Leu to Phe at position 34) leads to an obese phenotype 
(Yanik et al., 2(06). This mutation interferes with the processing of proCART into 
the active CART peptide fragments, therefore reducing the available active CART 
peptide. This would seem to add more weight to the argument that CART's role in 
the hypothalamus is anabolic. However more recent immunohistochemical studies 
have demonstrated that in humans, CART peptide is not co-localised with POMC, but 
is expressed in a subset of NPY containing neurones (Menyhert et aI., 2007) which 
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are usually considered catabolic. These conflicting results demonstrate that the role 
of CART peptide in energy homeostasis is still not clear. 
1.3.4 - CART peptides and stress. 
Stress can be defined as something perceived, real or imagined, which threatens 
homeostasis. It is a very general term, as many things, especially in higher mammals, 
can be thought of as stressors. What is clearer is how the body responds to stress. 
There is a three phase response to stress; firstly signals are send out to prepare muscle 
for activity. Secondly the sympathetic division of the ANS become activated; this 
increases heart rate, relaxes airways, inhibits digestion and increases available energy. 
Finally stress hormones are released, these are chemical such as adrenaline and 
noradrenaline and glucocorticoids. 
The stress response is mediated by the hypothalamic-pituitary-adrenal (HPA) axis. 
Under stressful situation the hypothalamus releases the neuropeptide/horomone 
corticotrophin releasing hormone (CRF) which then stimulates the release of ACTH 
from the pituitary gland into the blood stream. ACTH travels to the adrenal gland 
where it stimulates the release of corticosterone (in rodents, or cortisol in humans) 
which in turn stimulates the release of energy from energy stores. Corticosterone also 
inhibits the CRF producing neurones in the hypothalamus, creating a negative 
feedback loop. CART peptide is found at all level of the HPA axis as well as in the 
sympathetic division of the ANS (Dun et al., 2006). 
Intracerebroventricular injection of CART peptide increases expression of CRF in the 
hypothalamus (Stanley et al., 200 1) which in term leads to an increase in circulating 
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ACTH and corticosterone. In turn, levels of CART peptide in the hypothalamus 
appear to be regulated by CRF and corticosterone (Stanley et al., 2004). CART 
peptide is found in the blood and passes freely across the blood brain barrier (Kastin 
and Akerstrom, 1999), the source of CART peptide in the blood is unknown but its 
levels are under the control of corticosterone (Vicentic et al., 2004). What role CART 
peptide plays in the blood is unknown, but its link to corticosterone suggests a role in 
energy release. 
Intracerebroventricular injection of CART peptide into conscious rabbits results in an 
increase in heart rate, arterial blood flow, renal sympathetic nerve activity and 
increases the plasma concentration of epinephrine and norepinephrine (Matsumura et 
al., 2001). This is most likely due to activation of the sympathetic division of the 
ANS. In the spinal cord, sympathetic preganglionic neurones (SPNs) contain CART 
peptide, with SPN terminals onto postganglionic neurones also positive for CART 
peptide (Dun et al., 2000). The SPNs are one of only a few sites were there is data on 
the electrophysiological effects of CART peptide. Application of 100-300 nM CART 
peptide increased the amplitude of NMDA receptor mediated currents without directly 
depolarising the SPNs suggesting a possible increase in the number of functional 
NMDA receptors. The frequency of miniature postsynaptic excitatory currents was 
also increased which suggests an action on the presynaptic neurone (Dun et aI., 2006). 
1.3.5 - CART peptides and fear/anxiety 
There is increasing evidence that appetite regulating peptides have a role in the 
regulation of anxiety and in most cases anorectic peptides act as anxiogenic factors 
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(Stanek, 2006). This appears true for CART peptide as application of CART peptide 
(55-102) increases anxiety in mice. Interestingly, application of CART peptide (63-
102) has no such effect on anxiety, even at doses which inhibit feeding (Chaki et al., 
2003). This suggests that the mechanism (or receptor) by which CART peptide 
modulates anxiety is different from that modulating energy homeostasis. It has also 
been demonstrated that humans with a point mutation in the CART gene (Leu 
changed to Phe at position 34) have increased anxiety as compared to weight matched 
controls (Miraglia del Giudice et aI., 2006). 
The amygdala is the centre of emotion in the brain, and as previously mentioned 
CART is expressed in the amygdala, but mRNA levels of CART are not altered by 
chronic stress (Hunter et al., 2007). This suggests that CART peptide has a different 
mechanism in anxiety than in responding to stress. 
1.3.6 - Other putative roles of CART peptide 
CART peptide has been implicated in the regulation of lactation as the levels of 
CART peptide are increased in the hypothalamus and pituitary during lactation (Smith 
et aI., 2006). CART peptide also modulates the hypothalamic-pituitary-gonadaI axis, 
as CART peptide decreases gonadotrophin-releasing hormone interpulse interval via a 
leptin-dependant mechanism (Lebrethon et aI., 2000). CART peptide is implicated in 
pain transmission in the spinal cord; intrathecal injection of CART peptide produces 
hyperalgesia in mice (Ohsawa et al., 2000) and enhances the analgesic effect of 
morphine (Damaj et aI., 2004). Female odours stimulate neurones in the 
premamillary nucleus which express CART peptide (Cava1cante et aI., 2006), 
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suggesting a possible role in mating behaviour.!n the pancreas CART peptide is 
expressed in c)-cells and also during development in a-cells, p-ce1ls and PP-cells 
(Wierup et al., 2004). CART peptide levels in p-cells are upregulated in several type 
of type-2 diabetes (Wierup and Sundler, 2006). 
Of the other areas of the CNS where CART peptide is expressed, the one of most 
interest to me is the cerebellum. Although no CART mRNA is found in the 
cerebellum, CART positive fibres have been observed in the vestibular cerebellum 
presumably from climbing fibres (Koylu et al., 1998). Climbing fibres originate in 
inferior olive, and this structure is positive for both CART mRNA and CART peptide. 
There are no reports in the literature of CART peptides in any other areas of the 
vestibular system, but this may reflect that no-one has studied CART peptide 
CART peptide's diverse distribution in the CNS is reflected in the diversity of 
physiological effects which CART peptide has been implicated in. Much of the 
research into CART peptide has been focused on feeding/homeostasis, and this 
probably reflects the growing medical importance of obesity. However CART 
research has been hindered because of the lack of antagonists and the lack of an 
identified CART receptors. It seems that wherever you look in the brain you find 
CART peptide, but the roles of CART peptide in different areas appears to be very 
different. I'm certain that interest in CART peptide will continue, as if could reveal 
more about how some of the key pathways in the brain work, and CART receptor 
agonist/antagonist are interesting targets of medical pharmacology, for the treatment 
of obesity, stress related disorders and drug addiction. 
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1.4 - CART peptide receptor 
Although the CART peptide receptor has yet to be identified, we do know that CART 
peptide shows no appreciable binding affinity to 60 different receptors including 
classical neurotransmitters receptors (for example GABAA receptor) and neuropeptide 
neurotransmitters receptors (such as NPY receptor) (Vicentic et al., 2006). It has been 
demonstrated that CART peptide can bind specifically to neuronal type cells. Using 
radiolabelled CART peptide AtT20 cells (mouse LAFl, pituitary tumour cells; 
http://www.biotech.ist.unige.itlcldb/cl296.html) were shown to bind CART peptide 
with a I«J value of 49.5 pM (Vicentic et aI., 2005). It has also been demonstrated that 
CART peptide can bind to dissociated hypothalamic neurones and also HepG2 cells 
(human, hepatocellular carcinoma cells; http://en.wikipedia.org/wikilHep G2, 
17/09/07) suggesting that a specific receptor for CART peptide does exist (Keller et 
al., 2005). It has also been found that CART peptide increases ERKlMAPK 
(extracellular signal-regulated kinase/mitogen-activated protein kinase) activity in 
AtT20 cells in a dose-dependent manner, and this effect is blocked by both MEK 
(MAPKIERK kinase) inhibitor and pertussis toxin (selective inhibitor of Gi/o). This 
suggests that CART peptide can bind to a receptor coupled to Gi/o protein leading to 
the activation of the ERKlMAPK signalling cascade (Lakatos et aI., 2005) . 
. More recently, a binding study identified the first protein to show a direct binding 
affinity for CART peptide, however this protein was not a GPCR, or even a protein 
expressed in the outer cell membrane, but a mitochondrial protein (Mao et aI., 2007). 
The protein which interacts with CART peptide is subunit B of the mitochondrial 
succinate dehydrogenase (SDHB). At a concentration between 0.2-4.0 nM, CART 
peptide significantly increased SDHB activity resulting in increased ATP generation. 
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This increase in ATP generation may underlie the apparent neuroprotective role of 
CART peptide during cerebral ischemia (Xu et al., 2006). If CART peptide is a 
modulator of mitochondrial activity then it may have a primary role in setting the 
basal metabolic rate of cells or could be associated with the flight or fight mechanism. 
There have been few studies investigating whether CART peptides have 
electrophysiological actions on neurones. Studies have shown that injection of CART 
into the brain can result in c-fos expression, which is a marker for increased neuronal 
activity (Vrang et al., 1999; Vrang et al., 2(00).The first direct evidence for an action 
of CART peptide on neuronal electrophysiology comes from Yermolaieva et al 
(2001), who showed that CART peptide inhibits L-type voltage gated calcium 
channels in cultured hippocampal neurones. They showed using fura-2 AM (a 
calcium dependant fluorophore) filled neurones that 1 IlM CART peptide reduced the 
cytosolic calcium increase elicited by potassium induced depolarisation by 48 ± 14 %. 
This reduction is similar to that seen with the L-type calcium channel antagonist, 
nifedipine (55 %). Furthermore the application of CART peptide and nifedipine was 
not significantly different from applying nifedipine alone. The calculated ECso for 
CART peptide was 600 nM and the inhibitory effects of CART peptide were blocked 
by the Gi/o inhibitor pertussis toxin and were not affected by other G-protein inhibitors. 
Using the patch-clamp method (barium ions as the charge carrier) they were able to 
show that CART peptide reduces the L-type calcium channel current by 80-90 % 
(Yermolaieva et al., 2001). 
Wall and Spanswick (2004) showed that application of CART peptide (100-200 nM) 
either hyperpolarised or depolarised the membrane potential of rat sympathetic 
preganglionic neurones (SPNs) in spinal cord slices (Wall and Spanswick, 2004). The 
hyperpolarisation was abolished by bicuculline suggesting that the CART peptide was 
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via GABAA receptor activation. In contrast, Dun et al (2006) showed that CART 
peptide did not affect the resting membrane potential of SPNs, but their experiments 
were done in the presence of the sodium channel blocker, TTX. It would seem 
plausible that CART peptide could be modulating the activity of local (inhibitory) 
intemeurones contacting SPN as well as directly affecting the SPNs via a GPCR. 
The major problem with investigating CART peptide, using electrophysiology, is the 
lack of any CART receptor antagonists thus it is difficult to exclude any non-specific 
actions. This is further complicated by the diverse actions of CART peptide in 
different areas of the CNS. In addition it appears that CART peptide seems to have 
multiple effects on the same cellular target (for example SPNs). The identification of 
a single mechanism of CART peptide action in a discrete area of the brain could help 
narrow the possible targets of CART peptide and aid the identification of a CART 
peptide receptor. This is one of the main reasons I chose to investigate the role of 
CART peptide in the cerebellum, as it appears that CART peptide is expressed in a 
distinct region (vestibular cerebellum) and appears to be in a distinct subset of 
neurones (climbing fibres). 
1.5 - Overview of cerebellum anatomy and function 
The cerebellum is an area of the hindbrain located dorsal to the brainstem. It is 
connected to the brainstem via the three pairs of fibre bundles (peduncles) and the 
space between the brainstem and cerebellum forms the 4th ventricle (Figure 1.3). It is 
unique within the brain as being the only area which is continuous across the midline 
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Figure 1.3 - Position of the cerebellum relative to other major brain structures. Taken from 
http://www.sfn.orq/, 19/09/07. 
of the brain. In humans, the cerebellum makes up approximately 10 % of the total 
brain volume and contains more than 50 % of the total neurons of the brain (Bear et 
al.,2oo7). 
The main functions of the cerebellum are reasonably well understood, its primary 
function being in the coordination of complex movements, maintenance of 
eqUilibrium (balance), influences posture, muscle tone and motor learning (Robinson, 
1995). In addition the cerebellum is implicated in higher brain functions such as 
reasoning, speech, spatial awareness, and memory (Fiez, 1996; Wiser et al., 1998). 
The cerebellum operates at an unconscious level. 
Systemic or acute damage to the cerebellum results in a number of different 
conditions such as: hypotonia (reduced muscle tone), ataxia (incoordination of 
movement), dysarthria (inability to articulate properly) and nystagmus (rapid jerky 
eye movements) (Barker and Barasi, 2003). The symptoms produced by damage to 
the cerebellum, depends on the location of the lesion as different areas of the 
cerebellum control the movement of different parts of the body. Damage to the 
anterior lobes of the cerebellum cause gait ataxias; these are often observed in 
alcoholics and give a characteristic drunken walk, even when sober. Whereas damage 
to the midline of the cerebellum can cause a truncal ataxia (incoordination of muscles 
used to maintain upright posture) and nystagmus (FitzGerald and Folan-Curran, 2002). 
Ataxias can also result from genetically inherited diseases, such as Friedreich's ataxia 
(Pearce, 2004). Friedreich's ataxia is an autosomal recessive disease caused by a 
GAA triplet repeat expansion in the intron of the gene coding for a 210 amino acid 
protein, frataxin (Campuzano et al., 1996) and is characterised by a gait ataxia, 
dysarthria, variable nystagmus and eventually heart failure (due to cardiac 
hypertrophy). 
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1.5.1 - Anatomy 
The outer surface of the cerebellum consists of a thin sheet of cortex which is 
repeatedly folded to give the cerebellum its characteristic appearance. When cut 
saggitally there are a number of deep fissures which divide the cerebellum into ten 
lobes (labelled I to X) (Figure 1.4). In the medial-lateral axis, the cerebellum can be 
divided into three regions; in the centre is the vermis (Latin worm) and on the outside 
are two hemispheres (Figure 1.5). There are two pairs of small additional structures 
on the edge of the hemispheres called the flocculus and paraflocculus. Between the 
brainstem and the cerebella cortex are the peduncles which carryall the fibres 
entering and leaving the cerebellum. Underneath the cerebellar cortex lies a layer of 
subcortical white matter composed of all afferent and efferent fibres and the deep 
cerebellar nuclei (DeN), which receive the output of the cerebellar cortex. The cortex 
of the cerebellum has three distinct layers; the outermost layer is the molecular layer, 
then there is the Purkinje cell layer, and the innermost layer is the granule cell layer. 
As the name suggests, the granule cell layer mainly contains the granule cells and also 
contains the mossy fibres and Golgi cells (inhibitory interneurones). Traversing the 
granule cell layer are the climbing fibres (on the way to the molecular layer) and 
Purkinje cell axons leaving the cortex. The Purkinje cell layer contains the cell bodies 
of the Purkinje cells and the cell bodies of Bergmann glia (cerebellar astrocytes). The 
molecular layer contains the axons of the granule cells (parallel fibres), the dendrites 
of the Purkinje cells, Golgi cell dendrites and the stellate cells and basket cells 
(inhibitory interneurones) (Figure 1.6). The processes of Bergmann glia extend into 
the molecular layer, terminating with bulbous endfeet at the pial surface. 
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Figure 1.4 - Parasaggital slice showing relative positions of the 10 lobes. Taken 
from http://health.ucsd.edu/news/2002/11 07 Nikon2.html, 10105/05. 
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Figure 1.5 - Rodents brain showing position of vermis, hemispheres, flocullus and parafloculus 
(under the floccullus) . Taken from http://www.nervenet.org/papers/cerebellum2000.html. 
19/09/07. 
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Figure 1.6 - Illustration of three layer of the cerebellar cotrex showing 
the relative positions and morphology of neurones. Taken from 
http://www.tnb.uaac.be/models/index.shtml. 10105/05. 
There are two major inputs into the cerebellum; the mossy fibres, which originate 
from many nuclei throughout the brainstem (such as the pontine nucleus) and from 
spinal cord, and the climbing fibres, which originate from the inferior olive (also in 
the brain stem). Both of these inputs are glutamatergic and also innervate neurones in 
the DeN via collaterals. There is only one output from the cerebella cortex, the 
Purkinje cell axon and these connect to the neurones of the DeN, which in tum 
project to other areas of the eNS. 
1.5.2 - The cells of the cerebellum 
The granule cells of the cerebellum are the most prolific neurone in the entire eNS, 
and the granule cell layer has one of the highest densities of neurones of any part of 
the brain. The granule cells are small glutamatergic neurones with oval or circular 
soma of 5-8 ~m in diameter. Granule cell dendrites form complex synapses with 
glutamatergic mossy fibres and the axons of GABAergic intemeurones (Golgi cells). 
These synapses are wrapped with glial processes to form structures called cerebellar 
glomeruli. The axons of the granule cells project upward into the molecular layer, 
making en passante synapses (ascending synapses) with Purkinje cells and Goigi cells 
before their axons bifurcate and become parallel fibres. Parallel fibres can run for 
several mm making multiple excitatory synaptic contacts onto Purkinje cells and 
Golgi cells. 
The GABAergic intemeurones, Golgi cells, have somas located in the granule cell 
layer and their axons form part of the granule cell glomeruli. Their dendrites are 
located in the molecular layer and also in the granule cell layer. They receive 
excitatory (glutamatergic) inputs from parallel fibres in the molecular layer, and also 
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from mossy fibres and climbing fibres. They are inhibited by axon collaterals from 
Purkinje cells (GABAergic). The Golgi cells provide feed-back inhibition to granule 
cells. 
GABAergic Purkinje cells are the sole output of the cerebellar cortex and are located 
in a layer between the granule cell layer and molecular layer. They have a large soma 
(20-40 ILm), a long axon which projects out of the cerebellar cortex and a single large 
and extensively arborised dendrite. The dendrites of Purkinje cells are planner in the 
dorsal-ventral axis (maintained in saggital slices) and neighbouring Purkinje cells' 
dendrites significantly overlap. Purkinje cells receive excitatory (glutmatergic) inputs 
from parallel fibres and from climbing fibres and inhibitory (GABAergic) inputs from 
stellate and basket cells. 
Basket cells have their soma and dendrites in the molecular layer, but their axons 
project onto the Purkinje cell bodies. The basket cell dendrites contact parallel fibres, 
but also receive inputs from climbing fibres and Purkinje cell axon collaterals. The 
axons from a single basket cell can contact up to 150 Purkinje cells and a single 
Purkinje cell can receive inputs from as many as 50 different basket cells, this gives 
the basket cell-Purkinje cell synapse a dense mesh like appearance somewhat 
reminiscent of basket work, hence the name, basket cell. 
Stellate cells are located in the outermost 1/3 of the molecular layer and are small 
cells with radial dendrites contacting parallel fibres. Their axons form inhibitory 
(GABAergic) synapses with Purkinje cell dendrites. Together the basket cells and 
stellate cells are thought to provide feed-forward inhibition of Purkinje cells. 
29 
1.5.3 - The neural circuits of the cerebellum 
The cerebellum has two intrinsic circuits, both converging on the Purkinje cell (Figure 
1.7): 
• mossy fibres -7 granule cell / parallel fibres -7 Purkinje cells 
• climbing fibres -7 Purkinje cell 
A single glutamatergic mossy fibre forms synapses with 20-30 granule cells. The 
axons of the granules cells bifurcate to become the parallel fibres which make 
glutamatergic synaptic contacts on the most terminal dendrites of Purkinje cells, the 
so called spiny branchlets. The parallel fibres pass through the cerebella cortex 
orthogonal to the plane of the Purkinje cell dendrites (thus are cut in saggital sections), 
and a single parallel fibre will make a synaptic contact onto one in every 3-5 Purkinje 
cell it passes. Because of the very large number of parallel fibres, a Purkinje cell can 
receive up to 200,000 synaptic contacts from parallel fibres, each synapse being very 
weak, activation of approximately 50 parallel fibres are required to generate an action 
potential in a Purkinje cell (Barbour, 1993). 
The climbing fibre-Purkinje cell synapse is a unique synapse in the CNS; each 
Purkinje cell is innervated by only one climbing fibre (although this is not the case in 
immature animals). The glutamatergic climbing fibre makes hundreds of individual 
synaptic contacts onto the stubby spines of the main dendrites and on the soma of the 
Purkinje cell. The shear number of synaptic contacts makes this the strongest single 
synapse in the whole nervous system. The activation of the climbing fibre produces a 
very large depolarisation of the Purkinje cell (called a complex spike). 
There is also an extrinsic circuit which the cerebellum is part of; the mossy fibres and 
climbing fibres make excitatory (glutamatergic) inputs onto neurones of the DCN 
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Figure 1.7 - Two intrinsic circu its of the cerebellum , with the interneurones shown . 
before they pass into the cerebella cortex, the Purkinje cells make inhibitory 
(GABAergic) synapses onto neurones of the DCN. The DCN contains at least 3 
different types of neurones, and little is know about how neurones of the DCN 
integrate their synaptic inputs. The smallest neurones of the DCN are GABAergic and 
project to the inferior olive, the source of the climbing fibres, and this may provide 
feed-back inhibition. 
1.5.4 - Purkinje cells 
The firing patterns of Purkinje cells in slices 
Purkinje cells are the sole output of the cerebellar cortex and have cell bodies which 
are located in a single row between the granule cell layer and molecular layer. 
Recordings from Purkinje cells in vivo show two different types of action potential 
termed simple and complex spikes (Armstrong and Rawson, 1979; Udo et aI., 1981; 
Jaeger and Bower, 1994). The simple spikes are observed at frequencies between 10-
100 Hz and are thought to be generated by the activity of parallel fibres as well as the 
intrinsic membrane properties of Purkinje cells. Complex spikes are generated by 
climbing fibre activity and occur at a frequency between 1-10 Hz, which is in 
agreement with the observed firing rate of neurones in the inferior olive, the source of 
climbing fibres (Bal and McCormick, 1997). 
In parasagittal cerebellar slices, the climbing fibre inputs are usually inactive (as their 
soma are in the inferior olive and thus their axons are cut) and therefore very few 
spontaneous complex spikes are observed. The majority of the parallel fibres are also 
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cut, with only a small number still intact and active. Despite this, Purkinje cells in 
slices are still constituently active, exhibiting a wide range of reported firing 
frequencies (1-150 Hz) (Llinas and Sugimori, 1980a; Hausser and Clark, 1997; 
Womack and Khodakhah, 2002; Smith and Otis, 2003; Cerminara and Rawson, 2004; 
Loewenstein et al., 2005). The firing frequency of Purkinje cells in vitro appears to 
be modulated by the activity of inhibitory interneurones (stellate and basket cells), 
since blocking these inputs significantly increases the firing frequency of Purkinje 
cells (Hausser and Clark, 1997). The firing frequency is also modulated by nitric 
oxide which is released by parallel fibres (Smith and Otis, 2003). Purkinje cells (in-
vitro) exhibit a variety of firing patterns including tonic (continuous) and bursting 
(episodes of firing interspersed with periods of quiescence). An interesting firing 
pattern is the 'trimodal' firing pattern, first observed when the GABAergic synapse 
were blocked (Womack and Khodakhah, 2002). This pattern of firing consists of a 
fast tonic burst of action potentials, followed by a group of short fast bursts of firing, 
in which the interval between progressive spikes inside the bursts gets shorter and 
shorter, and finally a period of quiescence. This whole pattern lasts from tens of 
second to a few minutes (at 32°C) and then repeats. This trimodal firing has also been 
observed in slices without pharmacological modification (McKay et aI., 2007) but as 
far as I know not in vivo. 
The membrane properties of Purkinje cells are complex since they express a large 
number of different voltage and ligand gated ion channels and have a complex planar 
arborised dendrite. The tonic firing of Purkinje cells is thought to result from a 
complex interplay of the somatic resurgent sodium current, voltage gated calcium 
current and calcium-dependant potassium current, which are all active around the 
resting membrane potential of the active Purkinje cell (Raman and Bean, 1997; Jaeger 
33 
and Bower, 1999; Raman and Bean, 1999; Swensen and Bean, 2003). As well as 
firing tonically, Purkinje cells are sometimes observed to firing in long bursts of tonic 
activity interspersed with periods of quiescence. It is thought that activation of the 
hyperpolarisation-activated mixed cation current, (Ih), is required to produce this 
pattern (Williams et aI., 2002). The firing pattern of Purkinje cells is also modulated 
by the dendrites. As early as 1980 it had been demonstrated that calcium spikes in the 
dendrites filtered down into the soma to give mixed sodium/calcium action potentials 
(Llinas and Sugimori, 1980b) and more recently it has been shown that it is the 
dendrites that control tonic and trimodal firing (Womack and Khodakhah, 2002) and 
also bursting behaviour (Womack and Khodakhah, 2004). 
Purkinje cell inputs 
Upon activation of a climbing fibre there is a very strong post synaptic Purkinje cell 
response (the complex spike). The complex spike consists of a sodium-dependent 
action potential followed by 2 or 3 calcium spikes and a long afterhyperpolarisation 
(AHP) in which the Purkinje cell is unable to generate simple spikes. The climbing 
fibres release glutamate to activate Purkinje cell alpha-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPARs) and also release CRF onto CRF 
receptor type 1 (Primus et al., 1997; Chen et aI., 2000). When recordings are made 
from Purkinje cells in voltage clamp, the stimulation of climbing fibres produces a 
large fast excitatory postsynaptic current (EPSC) which shows paired pulse 
depression (Llano et al., 1991 b). The kinetics of the EPSC are determined by the 
glutamate transporters in the membranes of glia that surround the climbing fibre-
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Purkinje synapse (Takayasu et ai., 2004). CRF modulates the AHP of complex spikes 
(Fox and Gruol, 1993). 
Parallel fibres also release glutamate, which activate Purkinje cell AMPA receptors 
and metabotropic glutamate receptors (mGluRs) and they also release nitric oxide 
(Kimura et al., 1998). However the activation of parallel fibres is different from 
climbing fibre activation as upwards of 50 parallel fibres need to be activated to push 
the Purkinje cell to threshold and fire an action potential (Barbour, 1993). When 
parallel fibre EPSCs are recorded in voltage clamp, paired stimulation results in 
facilitation, this is thought to be due to the residual pre-synaptic cytosolic calcium 
from the previous stimulation increasing the number of vesicles released (Atluri and 
Regehr, 1996). Parallel fibres influence Purkinje cells directly and indirectly via the 
activation of GABAergic intemeurones. 
The GABAergic stellate and basket cells (inhibitory intemeurones) exert a strong 
influence on the properties of Purkinje cells. The Purkinje cell expresses GABAA 
receptors on it dendrites and on its soma, and in addition GABA released from 
inhibitory intemeurones can act on GABAB auto receptors (Kulik et al., 2002). The 
GABA receptors of Purkinje cells are all of the form 0.1 ~ 11212 and thus are sensitive 
to benzodiazepine modulation (Laurie et al., 1992; Macdonald and Olsen, 1994). The 
classical model of the cerebellum suggests that the role of the inhibitory intemeurones 
is to increase the temporal resolution of information through-put by inhibiting the 
Purkinje cells surrounding the Purkinje cells directly excited by parallel fibres (centre 
surround antagonism) (Dunbar et al., 2004). However, it is now becoming clear that 
the activation of the inhibitory intemeurones by parallel fibres affect the integration of 
parallel fibre activity (Mittmann et ai., 2005). 
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Plasticity 
The cerebellum is thought to be one of the areas of the brain involved in the 
acquirement of motor learning: the increased efficiency of performing a motor task 
(such as walking or throwing a ball) produced through repeated trials. It has been 
suggested that plasticity of Purkinje cell synapses is the site of motor learning in the 
cerebellum (Ito, 2000) and that long term depression (LTD) of the parallel fibre-
Purkinje cell synapse is key. LTD is produce by the repeated co-stimulation of 
parallel fibres and climbing fibres (for example 5 minutes at 1 Hz). The depression of 
the parallel fibre synapse requires calcium influx, activation of AMPAR and mGluRs 
(which are located outside of the synaptic cleft and are activated by glutamate 
spillover) (Hartell, 2(02). The calcium influx is produced by the activation of 
climbing fibres which depolarise the Purkinje cell dendrites resulting in influx of 
calcium ions through voltage gated calcium channels. The activation of mGluRs 
activates protein kinase C, phospholipase C and phospholipase A2, these combined 
with the increased cytolsolic calcium produce intemalisation of AMP ARs (Daniel et 
al., 1998). In addition to this mechanism, nitric oxide (NO) has also been implicated 
in the induction of LTD via protein kinase G (Hartell, 2002). The parallel fibre-
Purkinje cell synapse has also been shown to undergo long term potentation (LTP), 
however this effects appear to be completely presynaptic, requiring only high 
frequency stimulation of parallel fibres, and interestingly is mediated by NO. It has 
been suggested that the LTP may reverse LTD, which is required if the system is not 
to become saturated. Another hypothesis is that LTD is not involved in motor 
learning, but is rather a form of neuroprotection (Kimura et al., 2(05). High levels of 
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glutamatergic activity can lead to excititoxic cell death of Purkinje cells (O'Hearn and 
Molliver, 1993). 
Another form of plasticity, which is observed at Purkinje cell synapses is the 
depolarization-induced suppression of inhibition (DSI) and depolarization-induced 
suppression of excitation (DSE) (Llano et al., 1991a; Kreitzer and Regehr, 2001). 
This is the short-term (several tens of seconds) inhibition of either inhibitory 
interneurones (in DSI) or paralleVclimbing fibres (in DSE) after depolarisation of 
Purkinje cells. DSI/DSE is produced by the release of endocannabinoids from 
Purkinje cell dendrites, which then activate CB) receptors on interneurone axon, 
parallel fibre and climbing fibre terminals (Maejima et aI., 2001; Yoshida et aI., 2002; 
Brown et aI., 2003; Diana and Marty, 2004). Endocannabinoid release from Purkinje 
cells is triggered by either calcium influx from a strong depolarisation (such as 
climbing fibre activity) (Brenowitz and Regehr, 2003), activation of mGluRs 
(produced by a train of parallel fibre EPSPs) (Maejima et al., 2001) or a combination 
of weak activation of mGluRs and mild depolarisation (Maejima et al., 2005). 
Although DSI/DSE is only a form of short-term plasticity, CB) knockout mice, where 
DSI/DSE is blocked (Wilson and Nicoll, 2002), show impaired motor learning 
(Kishimoto and Kano, 2006). This suggests that DSI/DSE and the endocannabioniods 
are involved in longer term plasticity in the cerebellum. It has recently demon stated 
another form of retrograde plasticity at the Purkinje cell. After termination of DSI 
(from stimulation of climbing fibres) a depolarization-induced potentiation of 
inhibition (DPI) can occur (Duguid and Smart, 2004). This increase in interneurone 
activity islonger lasting that DSE and is mediated my retrograde release of glutamate 
acting on NMDA receptors on interneurones. 
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1.6. - The vestibular cerebellum 
As previously mentioned, CART peptide expression has been reported in the 
vestibular cerebellum (Koylu et al., 1998). The vestibular cerebellum is part of the 
vestibular system which is concerned with maintaining balance; it includes the otolith 
organs, the semicircular canals, cranial nerve VIn and the vestibular nuclei. The 
vestibular cerebellum is thought to be concerned primarily with maintaining balance. 
The vestibular cerebellum is made up to neurones in lobe IX and X as well as the 
paraflocculus (Bear et ai., 2007). Neurones of the vestibular nucleus project to a 
subset of neurones on the inferior olive which project only into the vestibular 
cerebellum. Vestibular neurones also project directly to the cerebellar cortex in the 
form of mossy fibres (Fushiki and Barmack, 1997; Xiong and Matsushita, 2000). 
The granule cells of the vestibular cerebellum also receive inputs from other areas of 
the brainstem including brain stem nuclei relaying information from the visual system 
of the CNS as well as postural muscles via the spinal cord (Barmack et ai., 1992b). 
The current model is that the vestibular cerebellum integrates information about the 
position of the head with information about the state of the postural muscles of the 
body to maintain balance. 
The vestibular cerebellum is different in a number of ways from the rest of the 
cerebellum. All mossy fibres are glutamatergic, but in the vestibular cerebellum 
many of the fibres also contain acetylcholine and both granule cells and the deep 
cerebellar nuclei express both nicotinic and muscarinic acetylcholine receptors 
(Barmack et al., 1992a; Jaarsma et aI., 1997; Takayasu et al., 2003). The firing 
frequency of Purkinje cells in the vestibular cerebellum appears lower than in other 
areas of the cerebellum (personal observation). Because of the position of the 
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vestibular cerebellum (lobe IX and X are located on the dorsal edge of the cerebellum, 
directly above the brainstem and the paraflocucllus in the rat is located in a small 
pocket of the temporal bone of the skull) if it very difficult to make in vivo recordings. 
However field recordings have shown that Purkinje cell activity (both simple and 
complex spike) is linked to head motion (Kano et aI., 1991; Barmack and Shojaku, 
1992). 
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Chapter 2: Materials and Methods. 
2.1 - Immunohistochemistry 
2.1.1 - Solutions for immunohistochemistry. 
TST - Tris 1.21 gil, NaCl 5.84 gIl and Tween 0.5 mIll; adjusted to pH 7.5 with 1M 
HCl. 
TST + Marvel - As TST but with 5 % Marvel milk powder. 
Dissection aCSF - NaCl 124 mM, MgS04 1.3 mM, KCI 5 mM, CaCh 2.4 mM, 
KH2P04 1.2 mM, o-glucose 10 mM and NaHC03 26 mM. 
PBS - NaCl 8 gil, KCl 0.2 gIl, Na2HP02 1.15 and KH2P04 0.2 gil (made up by media 
prep, University of Warwick) 
PF A - PBS with 4% paraformaldehyde (The paraformaldehyde was dissolved by 
heating the mixture to reflux whilst stirring). 
Immuno PBS - PBS with 0.4% Triton 100 and 1 % BSA 
2.1.2 - Antibodies for immunohistochemistry 
Rabbit anti·CART (55·102) (rat) serum - came as lyophilized powder (Phoenix 
Pharmaceuticals, Inc). Made up to 50!!1 with distilled water and then frozen (-20°C) 
as 1!!1 and 5!!1 aliquots until required. 
40 
Monoclonal anti-calbindin D-28K (mouse IgGl isotype) - came as a solution in 
PBS with 15 mM sodium azide (Sigma). Stored frozen as 1 III and 5 III aliquots until 
required. 
Rabbit anti-CRF(H-I04) IgG - came as solution in PBS with <0.1 % sodium azide 
and 0.1 % gelatine (Santa Cruz Biotechnology, Inc). Stored frozen as 1 III and 5 III 
aliquots until required. 
Sheep anti-CRF(N-20) IgG - came as solution in PBS with <0.1 % sodium azide and 
0.1 % gelatine (Santa Cruz Biotechnology, Inc). Stored frozen as 1 III and 5 III 
aliquots until required. 
Guinea-pig anti-VGluT2 (rat) IgG - (Chemicon). Stored frozen as 1 III and 5 III 
aliquots until required. 
Goat anti-rabbit IgG, HRP conjugated - Stored frozen as 1 III aliquots (Sigma 
Aldrich) 
Donkey anti-goat IgG, HRP conjugated - Stored frozen as 1 III aliquots (Sigma 
Aldrich) 
Alexa Fluor® antibodies (Invitrogen) - The probes used were raised in goat and 
donkey. Probes used against CART peptide antibody were raised against rabbit. 
Probes used against Calbindin-D-28K antibody were raised against mouse. Probes 
used against CRF antibodies were raised against rabbit or goat (goat and sheep 
antibody are 100 % cross-reactive). Probes used against VGluT2 antibody were raised 
against guinea-pig. The wavelengths used were 405 nm, 488 nm, 594 nm and 633 nm. 
These secondary antibodies were stored frozen as 2-5 J.ll aliquots. 
CART peptide - (Pheonix Pharmaceuticals), rat long CART peptide fragment 55-102, 
rl CART (55-102). Stored frozen as 10 III vials (100 IlM). 
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2.1.3 - CART peptide dot blot. 
A strip of Polyvinylidene fluoride (PVDF) membrane was wetted with methanol, then 
distilled water and then allowed to dry. Four concentrations (100 !!M, 10 !!M, 1 !!M 
and 100 nM) of CART peptide solution were dotted (2 J.lI drops) onto the membrane 
and allowed to completely dry. The PVDF membrane was placed in a tube with 
sufficient TST + Marvel to cover it and then agitated for 1 hour at room temperature. 
The solution in the tube was replaced with one containing the CART peptide antibody 
(1:5000 in TST + Marvel) and then the tube was agitated over night at room 
temperature. The membrane was washed 5 times with TST. The solution in the tube 
was then replaced with one containing the secondary antibody (Goat anti-rabbit IgG-
HRP conjugated 1:2500 in TST + Marvel) and the tube was then agitated for 1 hour at 
room temperature. The membrane was washed 5 times with TST. The membrane was 
incubated in a 1: 1 mixture of luminol and hydrogen peroxide from an enhanced 
chemiluminescence kit (EZ-ECL Chemiluminescence Detection Kit; Biological 
Industries Ltd.). The membrane was then dried, wrapped in cling film and under dark 
conditions, fixed to a photographic film (Kodak BioMax XAR) and exposed for 10 
seconds, moved and exposed for 30 seconds. Finally, the photographic film was then 
developed. 
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2.1.4 - CRF dot blot. 
A similar protocol was used for the CRF dot blots as for the CART peptide dot blots 
(section 2.1.3). Four squares of membrane were used, and onto each were dotted 4 
drops (S Ill) of 100 IlM CRF (Sigma Aldrich) onto the same spot. Two of the pieces 
of membrane were incubated in a solution of rabbit anti-CRF(H-104)(human) serum 
(1 :SOO) and the other 2 pieces were incubated in a solution of goat anti-CRF(N-
20)(human) serum (1 :500). The secondary antibodies used were goat anti-rabbit IgG, 
HRP conjugated and donkey anti-goat IgG, HRP conjugated (1:2500). The 
membranes were treated in the same way with the EZ-ECL kit but exposed to the 
photographic film for 30 and 90 seconds 
2.1.S - Preparation of tissue for fluorescence immunohistochemistry. 
In accordance with the Animals (Scientific Procedures) Act (1986) male Wistar rats 
were killed by cervical dislocation and decapitated. Either the whole brain or just the 
vermis of the cerebellum was rapidly dissected out while washing with ice-cold aCSF 
(bubbled with 95 % O2/ S % CO2). The block of brain was placed directly into ice 
cold PFA and fixed at SoC over night. On the following day, the tissue was washed 3 
times in PBS, and in the case of young animal brains (or when coronal sections were 
required), the block of tissue was mounted in 2 % agar (Sigma). The tissue or agar 
block (containing tissue) was trimmed and glued to a cutting chamber filled with ice 
cold dissection aCSF. Slices (100-125 J..1m) were cut using a vibratome (HM 650V; 
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Microm). Individual slices were placed into wells of a 24 well plate with 
approximately 1 ml of PBS in each well. 
2.1.6 - Single antibody stain. 
In some experiments, the tissue was only stained with one antibody: either CART 
peptide or calbindin D-28K. In this case, the PBS was removed from each well and 
replaced with 450fll of a 10 % solution of normal goat serum in immuno- PBS. This 
was incubated (with agitation) for one hour at room temperature. The solution was 
removed and the slices washed 3 times with PBS. Primary antibody (1:1000) in 
immuno-PBS (200 Ill) was added to each well, agitated at room temperature for 1 
hour, then incubated at 5°C overnight. The primary antibody solution was removed 
and kept at 5°C for a maximum of 14 days. The solution of primary antibody was 
used a maximum of 3 times with no loss of activity, although before use the solution 
was filtered to remove any particulate matter. The slices were washed 5 times with 
PBS. Secondary antibody solution (300 Ill, 1 :300 in immuno-PBS) was added to each 
well and agitated at room temperature for 4 hours. The secondary antibody solution 
was removed and discarded. The slices were washed 5 times with PBS. The slices 
were mounted on glass slides with glass covers lips in VectaShield mounting median 
(Vector laboratories) and then viewed. 
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2.1.7 - Double antibody stain. 
Double stain experiments where carried out for: CART peptide and calbindin D-28K, 
CRF peptide and calbindin D-28K, and VGluT2 and calbindin D-28K. All primary 
antibodies were used at 1: 1000 except the CRF antibody which was used at 1: 100. In 
all experiments, calbindin D-28K staining was used as a positive control. 
A similar protocol was followed as for the single stain experiments except that the 
solutions of primary antibodies contained two antibodies and the solutions of 
secondary antibodies contained two different secondary antibodies, raised against the 
animals used for the primary antibodies with different wavelength responses (488 nm 
and 594 nm). In the case of the experiment using the antibody against CRF, horse 
serum was used instead of normal goat serum. 
2.1.8 - Triple antibody stain. 
The triple stain protocol was only used for CART peptide, calbindin D-28K and 
VGluT2. A similar protocol to that of the single and double staining experiments was 
used, only all three antibodies were applied together. The wavelengths of the 
secondary antibodies used were 405 nm against the mouse (for calbindin D-28K), 488 
nm against guinea-pig (for VGluT2) and 633 nm against rabbit (for CART peptide). 
For these experiments, the slices were mounted within 24 hours. 
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2.1.9 - Immunohistochemistry controls. 
During the antibody staining experiments outlined above, one or two slices were 
always used as negative controls: the primary antibodies were omitted and replaced 
with immuno-PBS. I also carried out some additional controls: to eliminate the 
possibility of cross reaction between antibodies in multiple staining experiments and; 
tested the specificity of the CART peptide antibody, by preabsorbing it with CART 
peptide. Eighteen slices were taken, and placed in 6 columns of 3 wells. The same 
procedure was carried out for all the wells in each column, thus giving 3 repeats of 
each experiment. As a positive control, the triple stain protocol (CART peptide, 
calbindin and VGluT2) was applied to the slices in the first and sixth columns. The 
triple stain protocol was also carried out on the slices in the second column but 1 ~M 
CART peptide was present. The triple stain protocol was carried out on slices in the 
third, fourth and fifth columns but a single primary antibody was missing from each 
column, CART peptide (column 3), calbindin D-28K (column 4) and VGluT2 
(column 5). The same secondary antibody solution was applied to all wells (as section 
2.2.5). An additional control experiment was carried out to check that the 
fluorescence observed originated from the binding of secondary antibodies: primary 
antibodies were applied to six slices and the secondary antibody step was omitted. 
2.1.10 - Fluorescence and Confocal microscopy 
Lower magnification images showing distribution of staining were acquired with a 
Lecia MZ FIll upright microscope. Confocal images were acquired using the Lecia 
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SP2 confocal system linked to a Lecia DM RE7 upright microscope. For multiple 
stainings the response of the photodiodes was set to minimise cross contamination 
between signals. Most images were made from stacks for confocal sections; these 
were made by performing maximal averages of thin slices. The number of sections 
taken for a stack varied based on thickness of stack, but was chosen to be as close as 
possible to the maximum effective number (calculated as stack thickness divided by 
optical slice thickness). For very thick stacks were fine details was not necessarily 
required the number of sections in the stack was significantly lower than the 
maximum to reduce the time taken to acquire them. Figure were prepared using 
Adobe Photoshop CS. 
2.2 - Electrophysiology 
2.2.1 - Solutions for cell electrophysiology. 
Dissection aCSF - NaCI 124 mM, MgS04 1.3 mM, KCI 5 mM, CaCh 2.4 mM, 
KH2P04 1.2 mM, D-glucose 10 mM and NaHC03 26 mM. 
aCSF - NaCl 124 mM, KCI 1.9 mM, KH2P04 1.2 mM CaCh 2.4 mM, MgCh 1.3 
mM, D-glucose 10 mM and NaHC03 26 mM. Osmolarity of 310-320 mOsm. 
esCI internal - CsCl 130 mM, MgCb 2 mM, CaCh 1 mM, Cs EGT A 10 mM, Cs 
HEPES 10 mM and Na2 ATP; adjusted to pH 7.2 with 1M CsOH and the osmolarity 
was adjusted to 300 mOsm with sucrose. 
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KGluc internal - K o-gluconate 135 mM, NaCI 7 mM, HEPES 10 mM, EGTA 0.5 
mM, Na2ATP 2 mM, Na2GTP 0.3 mM and 10 mM Na phosphocreatine; adjusted to 
pH 7.2 with KOH and the osmolarity was adjusted to 300 mOsm is sucrose. 
KGlucJCl internal - KCI 70 mM, K o-gluconate 60 mM, MgCh4 mM, Na2 ATP 4 
mM, Na2 GTP 0.4 mM, and HEPES 10 mM; adjusted to pH 7.2 with KOH and the 
osmolarity was adjusted to 300 mOsm is sucrose. 
2.2.2 - Slice preparation for electrophysiological recording 
In accordance with the Animals (Scientific Procedures) Act (1986) male Wistar rats 
(postnatal days 20-35) were killed by cervical dislocation and then decapitated. The 
vermis of the cerebellum was rapidly removed into ice cold dissection aCSF (bubbled 
with 95 % 02/ 5 % CO2). The tissue was glued onto the cutting stage of a microtome 
(HM 650 V; Microm) and covered with ice cold dissection aCSF (bubbled with 95 % 
02/ 5 % C02). Typically 6-8 slices (250 J.lm) were cut from each adult rat. Slices 
were stored in recording aCSF (continually bubbled with 95 % 02/5 % CO2) at room 
temperature for a minimum of one hour before recording. 
2.2.3 - Set up for recording of electrical properties of Purkinje cells. 
Individual slices were viewed on a Zeiss FS Axioskop microscope with a 40X water 
immersion objective and Normaski differential interference optics at a total 
magnification of 640X. Slices were held down with a platinum harp, maintained at 
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either 22-24°C (room temperature) or 30-32°C and continually perfused with 
recording aCSF (bubbled with 95 % 02/ 5 % CO2). The perfusion system consisted of 
a heating element (controlled by a temperature regulator via a thermocouple in the 
bath), a dripper, flow regulator and a multi-tap array fitted with multiple syringe 
barrels. The aCSF entered the bath by gravity and was sucked out of the bath by a 
peristaltic pump (Watson Marlow) via a capillary tube. The perfusion rate was set to 
one drop every two seconds, which was approximately 1 ml/min. The bath volume 
was between I to 2 mi. Experiments using a dye (Fast Green) showed that the time 
taken for the aCSF to reach the bath from the multi-tap array was 2-3 minutes, and the 
aCSF in the bath was completely exchanged after 4 minutes. The bath temperature 
was recorded during experiments to ensure it stayed constant. 
Recordings were made using either a Patch Clamp EPC8 (HEKA) or Axopatch 200A 
(Axon Instruments) amplifier. The signal from the amplifier was digitised on-line by 
a Digidata 1322A (Axon Instrument) controlled by Clampex 8.0 software (Axon 
Laboratories). Synaptic currents were evoked by a DS2A MKll stimulator (Digitimer 
Ltd.) controlled by a Master 8 stimulator (Intracel) via a thin walled patch-pipette 
filled with aCSF positioned on the surface of the slice. 
2.2.4 - General procedures for patch clamp recordings. 
Cell attached and whole cell patch clamp recordings were made from the soma of 
superficially located Purkinje cells (identified by position in the slice and 
characteristic morphology) in the vestibular cerebellum (lobes IX and X). Recording 
pipettes were pulled from thick-walled borosilicate glass capillaries (GC150F; 
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Harvard Apparatus) on a horizontal puller (P-97; Shutter Instruments) and then fire-
polished. For stimulating synaptic currents, stimulating pipettes were pulled from 
thin-walled borosilicate glass capillaries (GCI50TF; Harvard Apparatus), the tips 
broken and fire polished to remove sharp edges. 
2.2.5 - Cell attached recording. 
Patch pipettes were filled with aCSF and had resistances of 2-10 MO. After 
establishing a cell attached recording, if the seal resistance was less than 50 MO or 
greater than IGn then the recording was discarded. Recordings with a seal resistance 
outside this range tended to be either unstable or the recorded action potentials had a 
low amplitude making analysis difficult. The data was filtered at 5 kHz and sampled 
at 5 kHz. Age of the rats used was 20-35 days postnatal (P20-35). 
2.2.6 - Climbing fibre excitatory post synaptic currents (EPSCs) 
Climbing fibre EPSCs were recorded with CsCI filled patch-pipettes which had 
resistances of 4-8 MO. The series resistance (5.7 ± 0.4 Mn) and capacitance (35.8 ± 
4.2 pF) were compensated by 70 %. The stimulation pipette was placed in the granule 
cell layer near to the Purkinje cell being recorded from. EPSCs were evoked with 
alternate and single pairs of square voltage pulses of 200 J.ls duration and 10-50 V 
amplitude. EPSCs were recorded using Clampex 8.0., with the stimulus artefact used 
to trigger acquisition. EPSCs were filtered at 5 kHz and sampled at 20 kHz. To isolate 
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climbing fibre EPSCs, recordings were made in the presence of 10 /lM bicuculline. 
Age of the rats used was P15-21. 
2.2.7 - Parallel fibre excitatory post synaptic currents (EPSCs) 
Parallel fibre EPSCs were recorded with CsCI filled patch pipettes which had a 
resistance of between 4-8 MO. Resistance (4.7 ± 0.2 MO) and capacitance (9.7 ± 1.5 
pF) were compensated by 70 %. The stimulation pipette was placed in the molecular 
layer near to the Purkinje cell being recorded from. EPSCs were evoked with 
alternate and single pairs of square voltage pulses of 200 /ls duration and 10-50 V 
amplitude. EPSCs were filtered at 5 kHz and sampled at 20 Khz. EPSCs were 
recorded using Clampex 8.0., with the stimulus artefact used to trigger acquisition. To 
isolate parallel fibre EPSCs, recordings were made in the presence of 10 /lM 
bicuculline. Age of the rats used was P15-21. 
2.2.8 - GABAergic miniature inhibitory postsynaptic currents (mIPSCs). 
GABAergic mIPSCs were recorded with patch pipettes filled with CsCI internal 
solution with resistances of 4-8 MO. Resistance (19.8 ± 2.6 MO) and capacitance (8.0 
± 0.9 pF) were compensated by 70 %. Miniature IPSCs were filtered at 5 kHz and 
sampled at 20 kHz and were continuously recorded using a roll mode protocol 
(Clampex 8.0). Miniature IPSCs were recorded in 0.5 /lM tetrodotoxin and in the 
presence of the glutamate receptor antagonist kynurenic acid. Under these recording 
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conditions (symmetrical chloride, at a holding potential of -70 m V), mIPSCs were 
inward. Age of the rats used was P20-24. 
2.2.9 - Current clamp roll mode. 
Current clamp recordings from Purkinje cells were made using KGluc filled patch-
pipettes with resistances of 4-8 MO. Data was sampled at 20 kHz using a roll mode 
protocol (Clampex 8.0). Routinely, 7 minute sessions of roll mode recording were 
interspersed with the periodic recording of current-voltage relationships. Age of the 
rats used was P20-26. 
2.2.10 - Current clamp current-voltage relationships. 
There were two different protocols for acquiring current voltage relationships. The 
method used for sections 4.6.1-2 was 10 current steps starting at -450 pA and 
increasing by 50 pA each successive step. The step length was 1 second and the 
interval between steps was 5 seconds. The current voltage relationship protocol used 
in section 4.6.3 was different because the 10 currents steps started at -300 pA and 
increased by 100 pA each time. Age of the rats used was P20-26. 
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2.2.11 - LTD protocol. 
The same protocol was used as to acquire parallel fibre EPSCs with the modification 
that KGluc/CI internal solution (Kimura et al., 2005) was used in the patch pipette. 
Resistance (14.4 ± 1.5 Mn) and capacitance (15.1 ± 2.0 pF) were compensated by 70 
%. Age ofthe rats used was PI5-20. 
2.2.12 - Drugs used in recordings 
CART peptide - (Pheonix Pharmaceuticals), rat long CART peptide fragment 55-102, 
rl CART (55-102). 
Bicucuclline - (Trocris), bicuculline methyiodide. 
CNQX - (Trocris), 6-cyano-7 -nitroquinoxaline-2,3-dione. 
Kynurenic acid - (Sigma Aldrich) 
Zolpidem - (Sigma Aldrich) 
TTX - (Alomone), tetrodotoxin. 
2.3 - Data Analysis 
2.3.1 - Analysis of cell attached firing rate. 
The initial analysis of Purkinje cell firing rates was carried out using Mini Analysis 
software (v 6. Synaptasoft Inc). Action potentials were recorded by the crossing of a 
manually set threshold. Analysis was semi-automatic with any detection of noise or 
missed action potentials corrected by the operator. The output of Mini Analysis 
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consisted of the time of occurrence of each action potential. This was converted to an 
Excel (Microsoft) file and imported into Excel. The data was first sorted so all the 
events were sequential (any missed events are added to the end of the Mini Analysis 
file and so are out of order). Then the time interval between successive action 
potentials and the instantaneous frequency (inverse of the event interval) were 
calculated. Events per second were calculated using the histogram function in Origin 
(v 6.1 Microcal). Once the instantaneous frequencies had been calculated they were 
sorted numerically and events with an instantaneous frequency of zero (double 
detection of the same event) or above 500 Hz (these events are too fast to be real) 
were deleted from the data. Histogram plots and cumulative frequency plots were all 
produced using Origin. The mean, standard deviation, number of events, standard 
error of the mean, coefficient of variance, 5 % value, 25 % value, median, 75 % value 
and 95 % value were all calculated with Excel. Statistical Significance, unless 
otherwise stated, was calculated with the student t-test (Excel). 
2.3.2 - Analysis of EPSCs. 
Both parallel fibre and climbing fibre EPSCs were analysed with Clampfit (v 8.0 
Axon Laboratories). Amplitudes and 10-90 % rise times were measured from 
individual EPSCs and then averaged. Decay kinetics where calculated by fitting the 
decay of averaged EPSCs (aligned on stimulus artefact) with single or multiple 
exponentials. Minimising standard deviation (Clampfit) was used to determine 
whether the decay was best fitted by a single exponential or by the sum of two 
exponentials. The zero time point of the fitted exponentials was defined as the time at 
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the peak of the current. Weighted decays were calculated using the formula: tau(w) = 
(taulxAI+tau2xA2)/(AI+A2), where taul and tau2 were decays constants and Al 
and A2 were relative amplitudes. For paired EPSCs, the amplitude of the second 
EPSC was determined by subtracting the averaged and scaled single EPSC from each 
pair of EPSCs. The paired pulse ratio was then calculated as the ratio of the mean 
second and first EPSC amplitudes. 
2.3.2 - Analysis of mIPSCs 
Miniature IPSCs were semi-automatically detected (with a threshold of -20 pA) using 
Mini Analysis software. Events were identified as mIPSCs by a slower decay than 
rise. There was considerable heterogeneity in the time course of mIPSCs, with some 
having very slow rises (presumably because they arise from synapses on distal 
dendrites and undergo heavy filtering). Thus to simplify analysis, currents with a 10-
90 % rise time longer than 3 ms were excluded from analysis (Wall, 2005).The time 
of mIPSC occurrence, mIPSC amplitude and 10-90 % rise time were measured for 
each individual mIPSc. Instantaneous frequency was calculated in the same way as 
for Purkinje cell firing. 
2.3.3 - Analysis of current clamp current-voltage data. 
The current voltage relationships (IVs) were analysed using Clampfit 8.0. Current 
voltage relationships for Purkinje cells have a characteristic shape: injection of 
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negative current produces a rapid hyperpolarisation followed by a slow "sag" back up 
towards the baseline (for example see figure 4.22C in chapter 4). This sag results 
from the slow activation of the hyperpolarisation activated current, Ih. Thus to fully 
describe this IV relationship, the membrane potential change in response to negative 
current injection has to be measured at two points: firstly, at the beginning of the 
current step (initial, before activation of Ih) and secondly at the end of the step (steady 
state, after Ih activation). It was necessary to adjust both these values to compensate 
for the voltage drop across the seal resistance. This was done by measuring the 
instantaneous jump in membrane potential at the end of the current step and deleting 
this value from the membrane potentials. The initial membrane potential was plotted 
against current injected to calculate the resting membrane potential and membrane 
resistance (intersect and gradient respectively). The steady state membrane potential 
was subtracted from the initial membrane potential to give the potential produced by 
activation of the hyperpolarisation activated current, Ih. Changes in the initial, steady 
state and Ih potential were used to investigate possible effects of CART peptide on 
Purkinje cell electrical properties. By plotting the Ih potential against injected current 
then the Ih conductance was calculated as the inverse of the gradient; the intersect 
with the y-axis gives the size of the Ih current at rest. 
Injection of positive current steps causes the Purkinje cell to fire action potentials. By 
plotting the number of action potentials fired during each current step against the 
amount of current injected, the excitability of the Purkinje cell can be calculated. The 
gradient of this line gives the excitability: frequency of action potentials (Hz)/current 
injected (pA). By normalising this value to the membrane resistance it is possible to 
remove any effects of differences in membrane resistance between Purkinje cells. 
The X-intersect of this line gives the firing threshold (in pA), and this can be 
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converted to firing threshold in mY by multiplying by the membrane resistance and 
adding the resting membrane potential. 
2.4 - Statistical methods. 
Most of the statistical methods used were standards and were calculated in either 
excel, origin or graphpad ins tat. However the product moment correlation was 
calculated was calculated by hand using the equation: 
r= 
L(X-X)(Y- Y) 
The degrees of freedom were equal to n-2 and significance tested using statistical 
tables (Campbell, 1989). 
Were median values were used (firing rate) then significance was calculated either 
using Wilcoxen t-test, for paired data, or Krustal-Wallis test, for unpaired data. For a 
worked example of Wilcoxen t-test on firing rate data see appendix 1. The upper and 
lower quartiles were used to indicate the confidence interval for the median and were 
tabulated after the median in the format (lower quartile, upper quartile). 
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Chapter 3: Distribution of CART peptide in the Cerebellum. 
3.1 - Introduction. 
The extensive study of CART peptide distribution by Koylu et. al in 1997 identified 
that a CART peptide fragment is present in the adult rat cerebellum. Their staining 
study showed that CART peptide was only present in fibres in the parafloccus and 
nodulus, areas of the vestibular cerebellum, no staining was observed in cell bodies 
and no CART mRNA was detectable in the cerebellum. 
I have used an antibody against CART peptide to fully characterise the distribution 
and development of CART peptide expression in the cerebellum. By combining 
CART peptide antibody staining with other antibodies, I have investigated the specific 
cellular localisation of CART peptide. This has helped me to localise the regions of 
the cerebellum where CART peptide is most likely to have a signalling role and thus 
aided my physiological experiments. 
3.2 - Reactivity of CART peptide antibody to CART peptide. 
To check the effectiveness of the antibody against CART peptide, I performed a dot 
blot experiment using an antibody raised against rat long CART peptide fragment 55-
102 (Phoenix Pharmaceuticals) together with the rat long CART peptide fragment 
55-102 (Serotec) (fig 3.1). Four different concentrations of CART peptide where 
dotted onto a PVDF membrane and reacted with the CART peptide antibody (1 :5(00). 
Using Enhanced Chemo Luminescence the antigen was still detectable with a dot of 2 
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Figure 3.1 Dot blot illustrating sensitivity of CART peptide antibody. 
PVDF membrane dotted with 2f..ll ofrlCART(55-102) peptide solution A-100f..lM, 
B-lOf..lM, C-lf..lM and D-100nM. Treated with 1:5000 rabbit anti-rlCART(55-
102). Membrane developed using ECL and exposed on photographic film for 
lOs. Figure twice actual size. 
JlI of 100 nM CART peptide. The dots were less than 2 mm across giving a lower 
detection limit of 64 nmol/m2• 
The membrane only required a 10 second exposure to visualise the CART peptide 
dots, longer exposures resulted in the development of the area outside the dot. This 
was probably due to a low level of non-specific antibody (primary or secondary) 
binding directly to the PVDF membrane. 
3.3 - Localisation of CART peptide in parasaggital section of the cerebellum. 
Having established that the CART peptide antibody is effective at detecting CART 
peptide, parasagittal vermal sections from 6 adult rats' (postnatal days 28-42) 
cerebella were stained for CART peptide (fig 3.2). As previously reported (Koylu et 
al., 1998) CART peptide had a distinct expression pattern being localised to distinct 
vermallobes. By convention vermal lobes are numbered from 1 to 10 (I to X, see 
figure 3.2a). Slices showed densities of CART peptide positive staining only in lobe 
X and in the ventral region of lobe IX adjacent to lobe X. The CART peptide staining 
was in the molecular layer, in fibre like structures and not in cell bodies. Little or no 
staining was detected in the granule cell or Purkinje cell layers, or in any structures in 
the white matter of the cerebellum. Not all the parasagittal slices were positive for 
CART peptide (in some slices there was no CART peptide expression). The positive 
slices were grouped together in the lateral or medial regions of the vermis. 
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Figure 3.2 CART peptide taining in cerebellar parasaggital slice. 
Parasaggital section (125J.!m) from adult rat cerebella (A-D P32, E P48, and F P28) 
stained for CART peptide (red). A-D images aquired on Ziess upright fluorescence 
microscope E-F on Lieca confocal microscope. A- Low magnification image of a slice 
from the centre of the vermis. There was only staining in the molecular layer oflobe X 
(nodulus). B,C - Higher magnification of lobe X shows that the CART peptide positive 
structures were a dense matting of fibres and no cell bodies. 0 - Outside oflobe X, 
lobe VII, there were no CART peptide positive structures. E - Stack of confocal images 
(20J.!m) shows CART peptide was only present in fibres in the molecular layer. F-
Stack of confocal images (10J.!m) shows the fibres containing CART peptide (white 
triangle) originate outside of the molecular layer (ML) and pass through the granule cell 
layer (OC). Scale bar A 400J,!m, B-F 40J.!m 
3.4 - Banded distribution of CART peptide in coronal sections of the cerebellum. 
In the cerebellum some peptides are found in parasagittal bands (Leclerc et al., 1992); 
the observation that CART peptide is not present in all the parasagittal sections could 
be the result of such a banded distribution. To investigate this, coronal sections from 
4 adult rats (postnatal day 30-42) cerebella were stained for CART peptide (fig 3.3). 
CART peptide positive structures were only found in the centre of the vermis or at the 
lateral edges, forming 3 distinct bands of CART peptide positive fibres within lobes 
IX and X. This banding of CART peptide is consistent with my previous observation 
that CART peptide is only expressed in either the medial of the lateral regions of the 
vermis. There was no CART peptide staining observed in the cerebellar hemispheres. 
Lobes IX and X of the cerebellum, together with the paraflocculus (two small lobes 
on the posterior border of the cerebellum) make up the vestibular cerebellum. To 
investigate whether CART peptide is expressed in the paraflocculus coronal sections 
of the paraflocculus from 2 adult rats (postnatal day 30-42) cerebella were stained for 
CART peptide (fig 3.4). CART peptide containing fibres were observed in the 
molecular layer of the paraflocculus, suggesting that CART peptide is expressed in all 
regions of the vestibular cerebellum. 
3.5 - CART peptide is not expressed in Purkinje cell dendrites. 
Since the majority of the CART peptide staining was observed in the molecular layer, 
the cellular element expressing CART peptide must be within this layer. There are a 
number of different cellular components in the molecular layer: the dendrites of the 
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igure 3.3 CART peptide taining in cerebellar coronal 
oronal ections (1251..1m) from adult rat cerebella -D P52, , and P2) 
tained for ART peptide (red). A-O image aquir d n Zi upright flu r 
micr cope, -0 on Lieca confocal micro op. A - At I w magnifi ati n AR 
peptide positive tructures were only ob erved in I b I and . -D - AR 
peptide po itive fibre are only found in the centre and th lat ral edge 
vermi . E- - Stack of confocal ection (201..1m how imilar n ntrati n f 
ART peptide containi ng fiber in lobe IX and X in the center and edge f 
ermi. ca le bar A 2001..1m, B-O 401..1m 
igure 3.4 CART peptide staining on paraflocculu . 
Coronal sections (125J..lm) from P42 rat paraflocculus tain d fi r ART p ptid 
(red). Paraflocculus showed dense CART peptide po iti e taining f fi r In 
the molecular layer. Scale bar 40Jlm 
Purkinje cells, the climbing and parallel fibres, stellate cells and glia. To begin 
investigating which structures contain CART peptide, I used an antibody against a 
protein expressed exclusively in Purkinje cells, calbindin D-28K (calbindin). 
Calbindin is a calcium binding protein, in the cerebellum it is only found in Purkinje 
cells and is therefore a useful marker of Purkinje cell soma, dendrites and axon. Thus 
if CART peptide is expressed in Purkinje cell dendrites there should be co-localisation 
with calbindin. 
Parasagittal vermal sections from 7 adult rats (postnatal day 28-42) cerebella were 
stained for calbindin. Purkinje cells in all the lobes of the cerebellum were stained 
(fig 3.5). Calbindin stained Purkinje cell dendrites (in the molecular layer), cell 
bodies and axons (in the granule cell layer). Using confocal microscopy, thin optical 
sections (21Am) revealed the complex structure of the Purkinje cell dendrites. Small 
unstained circular spaces in the molecular layer were observed. These are presumably 
the cell bodies of stellate cells, GABAergic intemeurones, which do not express 
calbindin. 
To investigate whether CART peptide and calbindin co-localise, parasagittal vermal 
sections from 6 adult rats (postnatal day 28-42) cerebella were stained for both CART 
peptide and calbindin (fig 3.6). Superficial examination suggested that CART peptide 
positive fibres did co-localise with the calbindin staining in Purkinje cells dendrites in 
lobes IX and X. However when viewed at a higher magnification (using confocal 
microscopy), thin optical sections of the molecular layer (2IAm) revealed that the 
CART peptide positive structures were not Purkinje cell dendrites, but instead were 
structures associated with the surface of Purkinje cell dendrites. These structures 
could be synaptic boutons making contacts onto Purkinje cell dendrites suggesting a 
possible signalling role for CART peptide in the cerebellum. 
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Figure 3.5 Calbindio taining in cerebellar parasaggital sections. 
Parasaggital ection (l25Ilm) fr m adult rat cerebella (A-B P37, C P30) stained 
for calbindin (green). A-B image aquired on Ziess upright fluorescence 
microscope acquir don Lieca c nfocal microscope. A - At low magnification 
all of the lobe were tained for calbindin. B - The molecular layer (containing 
the Purkinje cell dendrite ) wa densely tained for calbindin and the Purkinje cell 
bodies were al 0 vi ibl. - tack of confocal images (4Ilm) shows the fine 
structure of the Purkinje cell and al 0 mall holes where presumably the cell 
bodies of the interneuron are I cated. cale bar A 400llm, B-C 40llm 
CART peptide Calbindin merge 
Figure 3.6 Double staining for CART peptide and calbindin. 
Parasaggital sections (125flm) from adult rat cerebella (A-C P32, D-E P28) 
stained for CART peptide (red) and calbindin(green). Where both were present in 
the same structure they appear as yellow in merged images (C,F). A-C images 
aquired on Ziess upright fluorescence microscope D-F on Lieca confocal 
microscope. A-C - The molecular layer containing the Purkinje cell dendrites 
(green) also contain the CART peptide positive structures (red), and at low 
magnification these appear to colocalise (C - yellow). D-F - Stack of confocal 
sections (I flm) shows that CART peptide positive structure are not Purkinje cell 
dendrites, but are located in what appear to be pre-synaptic structures contacting 
the Purkinje cell dendrites. The bright structures in images A and C are non-
specific binding of the antibody, possibly to dust particles. Scale bar A-C 40flm, 
D-F 16flm 
3.6 - CART peptide iri expressed in the inferior olive, source of the climbing fibres. 
There are 3 different synapses onto Purkinje cell dendrites in the molecular layer: 
climbing fibres, parallel fibres and stellate cells. As neuropeptides are manufactured 
in the soma of neurones and transported down the axons, the soma should also contain 
CART peptide. However since no staining of either stellate cell or granule cell 
(parallel fibres are granule cell axons) bodies were observed, these are unlikely to be 
the sources of the CART peptide positive fibres. Climbing fibres are more likely to 
be the CART peptide positive fibres as their cell bodies lie outside the cerebellum, in 
the inferior olive, a nucleus in the medulla. Thus if CART peptide is expressed in 
climbing fibres, cell bodies in the inferior olive should be positive for CART peptide. 
To investigate the possibility that the CART peptide containing fibres in the 
cerebellum were climbing fibres, coronal sections from 3 adult rats (postnatal days 
28-42) medullas were stained for CART peptide (fig 3.7). At low magnification the 
medulla showed dense CART peptide staining on its dorsal side, near the fourth 
ventricle, and also near the centre line on the ventral side, this is where the inferior 
olive is located. At higher magnification fibres and cell bodies containing CART 
peptide were observed. The inferior olive has several subdivisions and the area 
positive for CART peptide is most likely part of the medial accessory olive (MAO). 
The MAO projects fibres into the entire vermis and part of the paraflocculus, this 
includes the areas making up the vestibular cerebellum (Paxinos, 2004). 
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Figure 3.7 CART peptide staining of inferior olive. 
Coronal sections (125~m) from P42 rat medulla stained for CART peptide 
(red). All images aquired on Ziess upright fluorescence microscope. A - Low 
magnification shows various densities of CART peptide in the medulla, 
however the area of interest in the inferior olive, a nucleus located medially 
and ventrally (white triangles). B - Only the medial accessory inferior olive 
(10M) is positive for CART peptide. C - Both cell bodies and fibres in the 
10M contain CART peptide. Scale bar A 500~m B 200~m C 20~m 
3.7 -CART peptide expression mirrors climbing fibre development. 
From the previous experiments it is reasonable to suggest that CART peptide is 
expressed in climbing fibres. Climbing fibres do not arrive in the cerebellum until the 
first postnatal week (Mariani and Changeux, 1981); therefore if CART peptide is only 
expressed in climbing fibres then none should be detectable in the cerebella of new 
born rats. 
ParasagiUal vermal sections from 2 new born rats (postnatal days 0-1) cerebella and 
medullas were stained for CART peptide and calbindin (fig 3.8). Because the layer 
structure of the cerebellum is not well defined at this young age, it is difficult to 
identify. with certainty, either the molecular layer or lobes IX and X. However no 
CART peptide was detected in any area of the cerebellum. However CART peptide 
containing cells were still observed in the inferior olive suggesting that although the 
climbing fibres have not yet innervated the cerebellum, CART peptide is still being 
produced. 
If CART peptide is present in climbing fibres then CART peptide positive structure 
should be detected after the first postnatal week when climbing fibres have innervated 
Purkinje cells. To investigate, this parasagittal vermal sections from a postnatal day 
10 rat cerebellum were stained for CART peptide and calbindin (fig 3.9). In these 
slices CART peptide containing fibres were present, consistent with CART peptide 
being expressed by climbing fibres. 
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CART peptide Calbindin merge 
Figure 3.8 Double staining for CART peptide and calbindin in neonatal cerebellum. 
Parasaggital sections (125J..Lm) from PI rat cerebella stained for CART (red) and calbindin 
(green). All images aquired on a Lieca confocal microscope. A-C - Stack of concofocal 
sections (20J..Lm) contained no CART peptide positive structure. The lobular structure of 
the cerebellum is not present in the neonatal cerebellum, how the ventral and 
ventral/rostral area contains the Purkinje cells which will become lobes IX and X. The 
bright structures in image A and C are non-specific binding of the antibody, possibly to 
dust particles. Scale bar 40J..Lm 
CART peptide Calbindin D-28K merge 
Figure 3.9 Double staining for CART peptide and calbindin in PIO cerebellum. 
Parasaggital sections (125Jlm) from PIO rat cerebella stained for CART (red) and 
calbindin (green). Where both were present in the same structure they appear as yellow in 
merged images (C,F). All images aquired on a Leica confocal micrcoscope. A-C - Stack 
of confocal sections (125 Jlm ), CART peptide positive structures are observed in the 
Purkinje cell layer of lobe X. D-F - At higher magnification (211m thick stack of confocal 
sections) CART peptide positive structures appear to synapse onto the soma and proximal 
dendrites ofPurkinje cells. Scale bar A-C 200Jlm, D-F I6Jlm 
3.8 - CRF/CRH could not be used to localise CART peptide expression. 
The presence of CART peptide in the inferior olive and the appearance of CART 
peptide containing fibres at the correct developmental stage is good evidence that 
CART peptide is present in climbing fibres. To confirm this, I used an antibody as a 
marker for climbing fibres and looked for co-localisation with CART peptide. 
Corticotropin-releasing factor (CRF, sometime called corticotropin-releasing hormone) 
is a widely distributed neuropeptide with roles in energy homeostasis and feeding, but 
it is also found in the inferior olive and in climbing fibres (van den Dungen et al., 
1988). If CART peptide is in climbing fibres, then CRF staining should co-localise 
with CART peptide staining. 
Two commercial antibodies against the neuropeptide CRF were obtained, one raised 
in rabbit and one in guinea-pig. These antibodies were tested for their effectiveness to 
detect CRF using the dot blot technique (fig 3.10). Using the rabbit antibody, it was 
not possible to detect a 10 IJ.I dot of 1 mM CRF peptide (n = 2) thus this antibody is 
either in-active or has a very low affinity. In contrast, the same dot of CRF was 
detected by the guinea-pig antibody (n = 2). However a large concentration of 
antibody together with a long exposure time was required to visualise the CRF dot, 
suggesting that the antibody was not very effective at detecting CRF. 
Parasagittal vermal sections from 2 adult rats (postnatal day 32-40) cerebella were 
stained for calbindin and CRF, using the guinea pig antibody (fig 3.11). Although 
clear calbindin staining was observed, no CRF positive structures were detected in 
any of the slices. This probably reflects the poor effectiveness of the antibody as 
previous studies have observed CRF staining in the cerebellum (Olschowka et al., 
1982). Thus we were unable to use CRF as a marker for climbing fibres 
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Figure 3.10 Dot blot test sensitivity of CRF antibody. 
PVDF membrane dotted with 20lll of lOOIlM CRF solution (inside red 
circles). A was treated with 1:500 rabbit anti-CRF and B with 1:500 sheep 
anti-CRF. Membrane was developed using ECL and exposed on 
photographic film for 90s. A - High background staining is probably due 
to none specific binding on antibody to the membrane and not to the dot 
ofCRF' B - Only area dotted with CRF has significant binding ofCRF 
antibody, however long exposure time and high antibody concentration 
was required, suggests that the antibody has a low affinity for CRF. 
Figure twice actual size. 
CRF Calbindin merge 
Figure 3.11 Double staining for CRF and calbindin. 
Parasaggital sections from P41 rat cerebella stained for CRF (red) and calbindin 
(green). All images were acquired on a Lieca confocal microscope. A-C - Stack of 
concofocal sections (5~m) contain no CRF positive fibres. Scale bars 40~m 
3.9 - CART peptide is co-localised with VGluT2, a climbing fibre-Purkinje cell 
synapse marker. 
Climbing fibres release the neurotransmitter glutamate, which is packaged into 
vesicles by the vesicular glutamate transporter 2 (VGluT2). VGluT2 is only 
expressed in climbing fibres in the cerebellar molecular layer and thus can be used as 
a marker for climbing fibres (Hioki et aI., 2003). Furthennore, because VGluT2 is 
localised in climbing fibre-Purkinje cell synapses, VGLUT2 is also a pre-synaptic 
marker for climbing fibre-Purkinje cell synapses. Thus if CART peptide is expressed 
in climbing fibre-Purkinje cell synapses there should be co-localisation with VGluT2. 
VGluT2 is also expressed in mossy fibre terminals, but as these are in the granule cell 
layer they will not obscure climbing fibre observation. 
Parasaggital vennal sections from 3 adult rats (postnatal days 28-35) cerebella where 
stained for VGluT2 and calbindin (fig 3.12). In all of the lobes, VGluT2 positive 
fibres associated with Purkinje cell dendrites were observed in the molecular layer. In 
addition, mossy fibres also showed clear VGluT2 staining. The climbing fibres are 
also reported to make synaptic connections with basket cells (Llimis et al., 2004), 
however I was unable to observe any structures consistent with climbing fibre-basket 
cells synapses. There are no reports in literature of VGluT2 being present at the 
basket cell synapse, however this may be due to the high density of climbing fibre-
Purkinje cell synapses masking them, or another glutamate transporter maybe be 
present at these synapses. When viewed using confocal microscopy, the pre-synaptic 
climbing fibre terminals were stained for VGluT2. 
Parasagittal sections from 2 adult rats (post natal days 31-35) cerebella where stained 
for VGluT2, CART peptide and calbindin (fig 3.13-14). The fibres in lobes IX and X 
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Figure 3.12 Double staining for VGluT2and calbiodio. 
Parasaggital sections (125Jlm) from P28 rat cerebella stained for VGluT2 (blue) and 
calbindin (green). When both were present in the same structure they appear as cyan in 
merged images (C,F,I). All images acquired on a Lieca confocal microscope. 
A-C - As previously reported the VGluT2 antibody stained the climbing fibres in the 
molecular layer (ML) and the mossy fibre terminals in the granule cell layer (GL). 
D-F - There was no staining of the Purkinje cell bodies. G-I - At high magnification 
the glutamatergic synaptic boutons were positive for VGluT2 which contact Purkinje 
cell dendrites. Scale bar A-C 200Jlm, D-F 40Jlm, G-I 8Jlm 
! 
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Figure 3.13 Tripi t inin for ART peptide, calbindin and VGluT2. 
id 
Figure 3.14 Tripi 
Para aggital li n 
V luT2 blu and 
that expressed CART peptide also expressed VGluT2. Thus VGluT2 is co-localised 
with CART peptide, confirming that CART peptide is present at climbing fibre-
Purkinje cell synapses, and thus may act as a neurotransmitter being co-released with 
glutamate. 
Figure 3.14 shows a section of molecular layer containing one or two large Purkinje 
cell dendrites. In panel D there are no structures containing only CART peptide (red 
in figure), but there maybe some structures only containing VGluT2 (blue in figure), 
this suggests that not all climbing fibre synapses in the vestibular cerebellum contain 
CART peptide. However looking at panel G (the triple overlay), it is clear that on a 
single section of dendrite all the pre-synaptic densities which contain VGluT2 also 
contain CART (magenta or white in figure) and that none of them are only positive 
for VGluT2 only (blue or green in figure). This was also observed for several other 
dendrites. As a Purkinje cell is only innervated by a single climbing fibre, this 
suggests that if a climbing fibre expresses CART peptide then all of its synaptic 
contacts onto a single Purkinje cell contain CART peptide. 
3.10 - The observed patterns of CART peptide expression are not explained by non-
specific antibody binding. 
To eliminate the possibility that the observed staining is due to non-specific binding 
of the antibodies, I performed a series of control experiments. Parasagittal vermal 
sections from a postnatal day 30 rat cerebellum were treated as previously but either 
the primary antibodies (fig 3.15A-C) or secondary (fig 3.15D-F) antibodies were 
omitted. When the primary antibody was omitted (n = 3), only a weak background 
staining was observed for all three secondary antibodies. This demonstrates that the 
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Figure 3.15 Controls. 
Parasaggital sections (125~m) from P35 rat cerebella stained for CART (red), VGluT2 
(blue) and calbindin (green). Where both CART peptide and calbindin were present in the 
same structure they appear as yellow in merged images All images acquired on a Lieca 
confocal microscope. A,B,C - When the primary antibody was omitted, but the secondary 
antibody was still applied, no specific binding was observed. D,E,F - When the secondary 
antibody was omitted, but the primary antibody still applied, then no fluorescence was 
observed. G-I - When the CART antibody was pre-absorbed with l~m rlCART(55-102) 
peptide solution, no CART peptide positive structures were observed. 
Scale bar 200~m 
secondary antibodies do not bind non-specifically to the slices. When the secondary 
antibodies were omitted (n = 3) no fluorescence was detected from any of the primary 
antibodies (CART peptide, calbindin or VGluT2), thus the fluorescence detected was 
not the result of any non-specific background fluorescence. Additional slices (n = 3) 
were treated with the CART peptide antibody which had been previously incubated 
with 10 ~M CART (55-102) peptide. Only a low level of background staining was 
observed in these slices (fig 3.150-1) with no fibre like structures observed. Thus the 
CART peptide antibody is specific for CART peptide in the slices, as binding can be 
blocked by prior adsorption of the antibody to freely dissolved CART peptide. 
3.11 - Summary 
I have confirmed the earlier observation that CART peptide is present in the 
cerebellum. By using multiple antibodies I have shown that the CART peptide is 
expressed in a subset climbing fibres in the vestibular cerebellum and that the fibres 
containing CART peptide make synaptic contact onto Purkinje cells and also contain 
glutamate. The changing distribution of CART peptide during development provides 
further confirmation of the presence of CART peptide in climbing fibres. The 
distribution of CART peptide suggests it may acts as a neurotransmitter or 
neuromodulator, and this was the next focus of my work. 
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Chapter 4: Electrophysiological Measurement of CART peptide 
actions in the vestibular cerebellum. 
4.1 - Introduction. 
Having established that CART peptide is present at climbing fibre-Purkinje cell 
synapses, I hypothesise that CART peptide is released (presumably by exocytosis) in 
response to climbing fibre activity to have actions on the Purkinje cells and/or their 
synaptic inputs in the vestibular cerebellum. If CART peptide does act as a signalling 
molecule at this synapse then there are a number of Purkinje cell properties which 
could be modulated (table 4.1). Because, in most cases, the net effect of these 
modulations is to change the Purkinje cell firing rate, I initially investigated whether 
CART peptide changes the firing rate of vestibular Purkinje cells. I then investigated 
whether CART peptide modulated the various forms of synaptic input to Purkinje 
cells and also examined whether CART peptide directly affects the membrane 
properties of Purkinje cells. Finally I investigated whether CART peptide had an 
affect on synaptic plasticity, by measuring its effects on long term depression (LTD) 
of the parallel fibre-Purkinje cell synapse. 
4.2 - Cell attached recording from Purkinje cells in parasaggital cerebellar slices 
To investigate the effects CART peptide has on the spike firing properties of 
vestibular Purkinje cells, I made cell attached recordings from Purkinje cells in lobes 
IX and X of parasaggital slices from the vermis of the cerebellum. Purkinje cells in 
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Target Possible physiological effect on Purkinje cell 
Ion channel on Purkinje cell Increasing simple spike firing rate. 
( excitatory). Increasing resting membrane potential. 
Decrease membrane resistance. 
Ion channel on Purkinje cell Decrease simple spike firing rate. 
(inhibitory). Decrease resting membrane potential. 
Decrease membrane resistance. 
Modulation of response to glutamate. Modulation of size or kinetics of excitatory post synaptic 
potentials (EPSP). 
Change in simple spike firing rate without large change in 
membrane properties. 
Modulation of response to GABA. Modulation of size or kinetics of inhibitory post synaptic 
potentials (IPSP). 
Change in simple spike firing rate without large change in 
membrane properties. 
Pre-synaptic modulation of 1 )Modulation of size or duration of EPSP. 
glutamatergic synaptic transmission. OR 2)Modulation of probability/frequency of release. 
Both lead to change in simple spike or complex firing rate 
without large change in membrane properties. 
Pre-synaptic modulation of GABAergic 1 )Modulation of size or duration of IPSP. 
synaptic transmission. OR 2)Modulation of probability/frequency of release. 
Both lead to change in simple spike firing rate without large 
change in membrane properties. 
Secondary messengers in Purkinje Many possible effects including: change in receptor density/type 
cells. at synapses, morphological changes in Purkinje cells, changes 
in mRNA expression, changes to intrinsic membrane properties. 
Physiological effects could be seen as: slow change in 
membrane potential, slow and irreversible change in simple 
spike firing rate and/or membrane properties, change in synaptic 
plasticity. 
Table 4.1 - Overview of different possible effects of CART peptide on Purkinje cells 
vivo fire a combination of simple spikes and complex spikes; the simple spikes are 
high frequency sodium-dependent events driven by a combination of parallel fibre 
input and the intrinsic electrical properties of Purkinje cells (Llinas et al., 2004). The 
complex spikes (produced by climbing fibre activity) are a lower frequency event 
which can be distinguished from simple spikes because they are a compound large 
sodium event followed by 2-3 smaller calcium events and an extended 
afterhyperpolarization (AHP). Although in parasaggital slices both the climbing 
fibres and parallel fibres are cut (and thus the excitatory transmission to Purkinje cells 
is weak), Purkinje cells still spontaneously fire action potentials (Loewenstein et al., 
2005). Furthermore, in parasaggital slices the cell bodies of the Purkinje cells are 
easily visually identified (by their characteristic morphology and position in the slice) 
and the Purkinje cell planar dendritic tree of is not damaged during slicing. 
Because Purkinje cells are spontaneously active, it is possible to use the cell attached 
recording method to measure any effects of CART peptide on the firing pattern. 
Other possible recording methods include extracellular (field) recordings or visually 
guided whole cell patch clamp recordings. Field recordings were not used as it is 
difficult to record from single cells. Whole cell patch clamp was not initially used, as 
cell attached recording is a much less invasive technique (there is no cell cytoplasm 
dialysis which could potentially change the membrane potential) and thus the firing 
pattern is more stable over prolonged periods (see later). 
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4.2.1 - Firing pattern of Purkinje cells at room temperature. 
There are many different ways to analyse the firing of Purkinje cells. To determine 
the best methods, the firing pattern of 10 Purkinje cells was recorded at room 
temperature. The data was recorded using Clampex 8 (Axon Laboratories) and 
visually assessed in Clampfit 8 (Axon Laboratories) (Figure 4.1A). Further analysis 
(detection of each spike for measuring intervals and frequencies) was carried out 
using Minianalysis (Synaptosoft, see chapter 2 for more detail Figure 4.1B). 
In all 10 recordings spike like events were clearly observed and these were confirmed 
as action potentials by application of TTX (l ~M) to block Na+ channels. Figure 4.2 
shows the analysis of a ten second section of Purkinje cell firing data. Calculating the 
number of events per second is the simplest way to analyse the firing (Figure 4.2B). 
For example the mean number of events per second over the 10 second period was 5.5 
(because this is the number of spikes in a one second period it is equivalent to the 
frequency in Hz) which is the same as dividing the total number of spikes (55) by the 
time (10 s). However this method gives the least information about the firing pattern, 
if there are periods of high frequency firing interspersed with silent periods this could 
give the same value of events per second as for a cell that fired tonically at a lower 
frequency. 
Another way of analysing the firing is to calculate the time interval between each 
event and either plot this against time or construct a cumulative histogram (figure 
4.2C,D). This gives more information, however the mean event interval is the same 
as the inverse of the mean number of events per second. In this case, the mean event 
interval was 182 ms, the inverse of 5.5 Hz. The advantages of using event interval 
over events per second are that breaks in firing can be clearly identified and measured, 
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Figure 4.1 - Screen captures of analysis of cell attached raw data. A - Raw data in Clampfit 8 
(Axon Laboratories), each simple spike is an up-down deflection. The variability in peak high is 
due to a low sampling rate (2 kHz) cutting of the top and bottom of some peaks. B - The same raw 
data displayed in MiniAnalysis. Green crosses mark baseline before peaks, red crosses mark the 
peak maximums, yellow circles mark the peak minimums and pink circles mark the peak decays 
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Figure 4.2 - Analysis of 10 seconds of cell attached firing data from a single Purkinje cell . A - Cell 
attached trace (each up and down deflection is an action potential). B - The number of events per 
second was counted and plotted against time. C - The event interval was calculated and plotted against 
time. D - The histogram of event intervals was plotted from data in panel C. E - The instantaneous 
frequency was calculated by inversing the event interval and plotted against time. F - The histogram of 
instantaneous frequency plotted from data in panel E. 
in addition statistics can be used to calculate parameters such as the standard 
deviation and median. There are however some problems with using event interval; 
because of the way it is calculated it is biased towards the longer intervals. 
The final way of analysing that data is to calculate the instantaneous firing frequency, 
this is simply the inverse of the event interval (figure 4.2E,F). The advantage of using 
the instantaneous frequency over event interval is that the average instantaneous firing 
frequency provides a more realistic representation of the firing pattern. In addition, as 
there are more high frequency events than low frequency events during Purkinje cell 
firing, the instantaneous firing frequency, which is biased toward higher frequency 
events, is a more appropriate measure than event interval. The statistics on the data 
shown in figure 4.2 are in table 4.2. Therefore, to analyse the firing of Purkinje cells I 
decided to use the instantaneous firing frequency. When the instantaneous firing 
frequency was plotted against time, the breaks between bursts of firing produce points 
very close to zero (and thus difficult to quantify). To overcome this problem, the 
instantaneous firing frequency was plotted on a log scale, allowing identification of 
any changes in the period between bursts. 
I chose to use 5 minute samples to calculate instantaneous firing frequency because 
the CART peptide solutions were made up in 10 ml volumes (larger volumes would 
have been financially prohibitive) for each experiment and in the bath perfusion 
system this volume takes 5-6 minutes to pass through the bath. To check that a 5 
minute sample of firing is representative of the Purkinje cell firing, I have compared 
the statistics for 5 minute samples to longer 20 minute samples from 3 recordings 
(figure 4.3). There was no significant difference between the instantaneous firing 
frequency measured from the 5 minute samples and 20 minutes sample using a 
student t-test (n = 3). 
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10 second 5 minute 20 minute 
sample sample sample 
Mean 1Hz 6.23 7.40 7.35 
Standard deviation I Hz 1.92 2.30 2.20 
Number 55 1038 4038 
Standard error of mean I Hz 0.26 0.07 0.04 
Coefficient of variance I percentage 31 31 30 
5 percentile I Hz 3.04 3.52 3.62 
Lower quartile I Hz 5.27 6.02 6.02 
Median 6.43 7.44 7.49 
Upper quartile / Hz 7.68 8.89 8.70 
95 percentile I Hz 9.02 11.00 10.53 
Table 4.2 - Statistics on firing frequency from a single Purkinje cell 
with different sample lengths. 
A .8 0 B ,-~~,~ tj 0 :I! 10 18 0 0 9 :m N 0 00 ~ :r: " 0 
~ 12 o 0 " 0 ~ o 0 0 0 ~Ii~~"!" o 0 '" 0 ::> i 1 flO g> 8 ·c .): "" .& ~ 8 ~ . "" ~ 01 0 C 0 0 '" o J> 0 0 0 ~ 0 0 0 0 1J5 2 S 0 0 £: c 
0 0 o 0 0 0 0 0 '" 1J5 £: 
1 min 1 min 
c 
:I! 10 
00 0 
o 0 00 0 0 0 °00°000 000 000 
o 0 00 000 0 0 0 
2 min 
Figure 4.3 - The analysis of 5 and 20 minutes of cell attached firing data from a single Purkinje cell . A -
Plot of instantaneous firing frequency against time for a 5 minute sample. B - The same data as panel 
A but using a log scale. This allows both the high frequency events (inside bursts) and low frequency 
events (periods between bursts) to be visualised on the same plot. C - Plot of instantaneous firing 
frequency (log scale) against time for the same Purkinje cell as panel A and B, but for a 20 minute 
sample. 
Mean Standard Deviation 
Mean I Hz 9.93 8.86 
Standard deviation I Hz 6.79 5.33 
Number in 5 minutes 1659 1238 
Standard error of mean I Hz 0.28 0.45 
Coefficient of variance I percentage 88.80 72.53 
Median LowerQ UpperQ 
5 percentile I Hz 2.65 1.24 6.16 
Lower quartile I Hz 4.59 2.48 10.44 
Median 5.85 3.61 12.03 
Upper quartile I Hz 7.60 4.98 12.89 
95 percentile I Hz 13.69 10.76 16.82 
Table 4.3 - Average instantaneous firing frequency statistics from 10 
Purkinje cells. Lower a - Lower quartile (25%) Upper a - Upper Quartile 
(75%) 
The instantaneous firing frequency of 10 Purkinje cells was measured and then the 
statistics for 5 minute samples were calculated (table 4.3). The mean instantaneous 
firing frequency was 9.93 ± 2.80 Hz. and the mean standard deviation was 6.79 ± 1.76 
Hz. Thus within each cell there is a large variation in firing frequency. There was 
also a large variation in firing frequency between cells (standard deviation of 8.86 Hz). 
I believe that using a mean value is not the best measure of the firing frequency. In 
order to correctly use the mean, the sample data should come from a normally 
distributed population, and for a population to be normal each event in that population 
should be independent of each other. However during spike firing, each event is not 
independent and therefore the mean is not an appropriate measurement. The median 
instantaneous firing frequency is a better statistic to compare the firing properties of 
cells as it does not rely on a normal distribution and is less skewed by extremes than 
the mean (Campbell, 1989). Although most other investigators use mean events per 
second to measure Purkinje cell firing rate (Hausser and Clark, 1997; Womack and 
Khodakhah, 2002; Smith and Otis, 2003), I believe that the median instantaneous 
firing frequency is a more sensitive measure of changes in firing frequency. The 
median instantaneous firing frequency often cells analysed was 5.85 (3.61,12.03) Hz, 
this is more than one SEMs of the mean firing frequency (9.93 ± 2.80 Hz). Also 
using the Kolmogorov-Srnirnov test to compare the data to an ideal shows the data not 
to be normally distributed. 
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4.2.2 - Positive controls for the investigating changes in firing frequency. 
To check that the cell attached recording method and my analysis method can detect 
changes in firing frequency, I have used 3 positive controls: raising the extracellular 
potassium ion concentration; applying bicuculline to block synaptic inhibition; and 
applying zolpidem to increase synaptic inhibition. 
By increasing the extracellular concentration of potassium from 3.1 to 6.2 mM, the 
Purkinje cells will become depolarized and the firing rate will increase. Application 
of aCSF containing 6.2 mM potassium resulted in a doubling of the median 
instantaneous firing frequency from 2.11 Hz to 4.15 Hz (n = 4) (figure 4.4A and table 
4.4). Thus an increase in the firing rate can be detected. 
Bicuculline was also used as a positive control. As expected block of GABAergic 
synaptic transmission to Purkinje cells, by applying lO11M bicuculline, resulted in an 
increase in the median instantaneous firing frequency from 3.50 Hz to 6.59 Hz (n = 13) 
(figure 4.4B and table 4.4). Thus the median instantaneous firing frequency can be 
used to measure changes in the firing rate produced by changes in the synaptic 
transmission to Purkinje cells. I have also measured changes in the firing rate in 
response to application of neurotransmitters such as 5-HT and ATP (not illustrated). 
Finally it is possible that CART peptide may decrease the firing rate of Purkinje cells, 
to test whether I could detect this, I applied zolpidem to Purkinje cells. Zoplidem 
increases the GABAA receptor affinity for GABA, therefore increasing inhibitory 
postsynaptic current amplitude and prolonging decay (Wall 2006). This will have the 
net effect of maintaining the hyperpolarisation and preventing the membrane potential 
reaching threshold. Bath application of 500 nM zolpidem resulted in a decrease in 
median instantaneous firing frequency from 7.06 Hz to 4.52 Hz (n = 7) (figure 4.4C 
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6.2mM 10 11M 500 nM 
control K+ control bicuculline control Zolidem 
Mean I Hz 1.71 5.15 3.48 6.50 7.06 4.52 
Standard deviation I Hz 0.97 4.72 1.18 1.51 2.85 4.95 
Number in 5 minutes 310 1010 410 1832 1517 133 
Standard error of mean I Hz 0.05 0.15 0.06 0.04 0.07 0.43 
Coefficient of variance I percentage 57 92 34 23 40 110 
5 percentile I Hz 0.36 1.66 1.60 3.97 3.15 0.11 
Lower quartile I Hz 0.97 2.99 2.78 5.41 5.29 0.68 
Median 2.11 4.15 3.50 6.59 6.74 2.47 
Upper quartile I Hz 2.27 5.36 4.26 7.62 8.43 7.37 
95 percentile I Hz 3.47 19.05 5.23 8.86 12.08 13.80 
Table 4.4 - Effect on the Purkinje cell-firing frequency of 3 different known modulators. 
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Figure 4.4 - Modulation of firing frequency can be detected using my method of analysis. A - Application 
of 6.2 mM potassium markedly increased the firing rate. B - Application of 10 ~M bicuculline markedly 
increased the firing rate. C - Application of 500 nM zolpidem markedly decreased the firing rate. 
control CART wash 
Time interval of data I min 7·12 13·18 29·34 
Mean I Hz 3.36 3.55 3.67 
Standard deviation I Hz 2.93 1.20 1.21 
Number in 5 minutes 374 374 420 
Standard error of mean I Hz 0.15 0.06 0.06 
Coefficient of variance I percentage 87 34 33 
5 percentile I Hz 1.21 1.58 1.71 
Lower quartile I Hz 2.46 2.92 2.95 
Median 3.43 3.75 3.80 
Upper quartile I Hz 3.84 4.30 4.41 
95 percentile I Hz 4.89 5.35 5.75 
Table 4.5 - Effect of 100 nM CART peptide on a single Purkinje 
cell at room temperature. 
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Figure 4.5 - An example of the effects of 100 nM CART peptide on the firing frequency of a single 
Purkinje cell at room temperature. A - Application of CART peptide increased instantaneous firing 
frequency. B - Histogram of instantaneous frequency in control , median instantaneous firing frequency 
was 3.43 Hz. C - Histogram of instantaneous frequency following CART peptide application, the 
median instantaneous firing was 3.75 Hz. 0 - Histogram of instantaneous frequency following washout, 
the median instantaneous firing frequency was 3.80 Hz. E - Normalised cumulative frequency count 
plotted against instantaneous firing frequency. Although the changes in frequency are not obvious from 
the histograms, there is a clear increase in frequency in the cumulative frequency plot. 
and table 4.4). This implies that median instantaneous firing frequency can detect the 
decreases in firing rate produced by hyperpolarisation of Purkinje cells. 
4.2.3 - CART peptide increases Purkinje cell firing rate at room temperature. 
The firing of 10 Purkinje cells in lobe X were recorded using cell attached method at 
room temperature, after a minimum of 10 minutes of control, 100 nM rlCART(55-102) 
was applied to the slice for 5 minutes with continuous recording. This represents the 
application of -10 ml of CART peptide solution which will exchange the bath volume 
at least 4 times. Longer applications were not routinely used because of the 
prohibitive cost of CART peptide. Concentrations of the order of 100 nM are similar 
to concentration of CART peptide which have been shown to be effective in other 
areas of the CNS (Dun et aI., 2(06). Figure 4.5 shows a typical recording (the raw 
data is similar to figure 4.1) and the statistics are shown is table 4.5. CART peptide in 
this case increased the median instantaneous firing rate from 3.43 Hz to 3.75 Hz (109 
% of control). This effect was not reversed with washing. For 10 Purkinje cells, 
application of CART peptide significantly (p<0.05) increased the median firing rate 
from 5.85 (3.61, 12.03) Hz to 6.07 (3.99, 13.59) Hz (figure 4.6A). There was little 
recovery during wash 5.94 (3.99, 12.34) Hz. Because of the large variation in median 
instantaneous firing frequency between cells it is more convenient to express the 
change in instantaneous firing frequency as a percentage of control. Thus in CART 
peptide the firing rate was 110.8 (108.7, 116.7) % of control and 105.5 (95.1, 110.4) 
% of control after wash (figure 4.6B). The median firing frequency after wash was 
not significantly different from control. 
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Figure 4.6 - CART peptide (100 nM) significantly increases the median instantaneous firing frequency 
of Purkinje cells at room temperature (n = 10; panels A and B) and at 32°C (n = 9; panels C and D). 
Control (red), CART peptide (green) and washout (blue). Error bars are one SEM. * - p<0.05, **-
p<0.01 . Panels A and C show the absolute firing frequencies and panels Band 0 show frequencies 
normalised to control. 
4.2.4 - CART peptide increases Purkinje cell firing rate at 32°C 
The CART peptide-mediated increase in median Purkinje cell firing frequency 
suggests CART peptide may have a signalling role in the cerebellum. However for an 
in vitro effect to be relevant it should occur at more physiological temperatures. 
Therefore the experiments were repeated at 32°C. The firing of 9 Purkinje cells in 
lobe X were recorded using cell attached method, after a minimum of 10 minutes of 
control 100 nM CART peptide was bath applied for 5 minutes. There was no 
observable difference between the quality of the raw traces, thus the analysis was 
performed in the same way as for the room temperature recordings. The median 
instantaneous firing frequency in control was 8.8 (6.6, 14.7) Hz, in CART peptide the 
frequency was 10.2 (7.6, 15.4) Hz and after wash the frequency was 7.7 (6.4, 9.5) Hz 
(figure 4.6C). Expressed as a percentage of control the firing frequency in CART 
peptide was 107.9 (104.6, 119.6) % and after wash the frequency was 107.7 (103.0, 
117.6) % of control (figure 4.6D). Both the firing frequency measured in the presence 
of CART peptide and in wash were significantly different from control (p<O.Ol and 
p<0.05 respectively). There was no significant difference between the firing 
frequency measured in the presence of CART peptide and in wash. 
Surprisingly, there was no significant difference between the median instantaneous 
firing frequencies at room temperature and at 32°C, neither was there a significant 
difference between the firing frequencies during CART peptide application or a 
significant difference between the percentage instantaneous firing frequencies during 
CART peptide application, implying that CART peptide, has an identical effect at 
both room temperature and 32°C. By plotting the median instantaneous firing 
frequencies in control against the median instantaneous firing frequency measured in 
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the presence of CART peptide at both room temperature and 32°C it is clear the data 
is not split into different groups (figure 4.7 A). Combining all the data together, the 
median control firing rate was 7.5 (4.5, 13.7) Hz, in CART peptide the median firing 
rate was 7.6 (5.2, 15.3) Hz and in wash the median firing rate was 7.2 (4.4, 10.9) Hz 
(figure 4.7C). As a percentage of control, the firing rate in CART peptide was 109.4 
(105.6, 118.6) % and in wash was 106.4 (101.2, 113.0) % (figure 4.7D). The median 
instantaneous firing frequency in CART peptide and the median instantaneous firing 
frequency in wash are both significantly different from control (p<O.OOI and p<O.OI 
respectively). To investigate whether there is a relationship between the action of 
CART peptide and the firing frequency in control, the median instantaneous firing 
frequency in control was plotted against the instantaneous firing frequency in CART 
peptide (percentage of control, Figure 4.7B). Upon visual investigation there appears 
to be a negative correlation, suggesting that CART peptide has a larger effect on the 
firing frequency if the cell is firing at a lower frequency to begin with. However a 
product-moment correlation was performed and gave an r value of -0.195 with 17 
degrees of freedom, which was not significant (Campbell, 1989). Therefore the 
actions of CART peptide do not depend on the firing frequency in control. 
4.2.5 - CART peptide still increases Purkinje cell firing rate in the presence of 
synaptic blockers. 
CART peptide could increase the firing rate directly (by a postsynaptic action on the 
Purkinje cell) or indirectly (by modulating synaptic inputs to the Purkinje cell). 
Therefore, to determine the mechanism of CART peptide action, I have recorded the 
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Figure 4.7 - The effects of appl ication of 100 nM CART peptide are not significantly different at room 
temperature or at 32°C. A - Plot of firing frequency in control against firing frequency in the presence 
of CART peptide shows that the experiments done at room temperature cannot be visually 
differentiated from those done at 32°C. Solid squares are room temperature experiments, open circles 
are 32°C experiments. B - Plot of firing frequency in control against firing frequency in the presence of 
CART peptide normalised to control. There is no significant correlation . Panel C shows absolute firing 
frequency for all temperatures and panel 0 show frequencies normalised to control for all 
temperatures . Control (red), CART peptide (green) and washout (blue). Error bars are one SEM . .... -
p<0.01 , ...... - p<0.001 . 
effect of CART peptide on the median instantaneous firing frequency in the presence 
of drugs which block excitatory and inhibitory synaptic transmission to Purkinje cells. 
If the CART peptide-mediated effects on firing rate is via the modulation of synaptic 
inputs then blocking these synaptic inputs should prevent any CART peptide effect on 
firing frequency. 
The firing of 9 Purkinje cells in lobe X were recorded using the cell attached method 
at 32°C, 10 IlM bicuculline, to block GABAA receptors and 10 IlM CNQX, to block 
glutamate receptors, were added to the aCSF and after a minimum of 10 minutes 200 
nM CART peptide was bath applied for 5 minutes. The median instantaneous firing 
frequency in the presence of bicuculline and CNQX was 23.8 (20.4, 27.8) Hz, this 
was significantly (p<O.OOI) greater than the firing frequency in the absence of 
synaptic blockers (23.8 Hz vs 8.8 Hz). The median instantaneous firing frequency 
after CART peptide application was 26.3 (23.1, 27.8) Hz and in the wash was 26.3 
(21.7, 29.4) Hz (figure 4.8A). Expressed as a percentage of control, the firing 
frequency was 106.2 (104.2, 117.6) % in the presence of CART peptide and 107.0 
(106.2, 114.1) % in wash; these are both significantly different from control (p<0.05) 
(figure 4.8B). There was no significant difference between the percentage median 
instantaneous firing frequency during CART peptide application with and without the 
synaptic blockers. 
I observed that when CNQX was applied on its own it produced an unexpected 
increase in the firing frequency of Purkinje cells. This did not reflect a loss of 
excitatory drive to inhibitory neurones as CNQX still increased the firing rate when 
applied in the presence of bicuculline (see chapter 5). This paradoxical effect of 
CNQX could reflect a direct effect on the Purkinje cell, as there is evidence that 
CNQX directly increases the firing rate of GABAergic neurons 
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Figure 4.8 - Synaptic blockers did not alter the actions of CART peptide. In the presence of synaptic 
blockers (panel A and B, 1 0 ~M bicuculline and 1 0 ~M CNQX; panels C and D, 1 0 ~M bicuculline and S 
mM kynurenic acid) 200 nM CART peptide significantly increased the median instantaneous firing 
frequency of Purkinje cells at 32°C. Control (red), CART peptide (green) and washout (blue). Error bars 
are one SEM. • - p<O.OS. Panels A and C show the absolute firing frequencies and panels Band D 
show frequencies normalised to control. 
(McBain et aI., 1992; Brickley et aI., 200 1; Maccaferri and Dingledine, 2002; 
Hashimoto et al., 2004).1 therefore decided to repeat the experiment investigating the 
effects of CART peptide in the presence of bicuculline combined with kynurenic acid 
(a non specific glutamate receptor antagonist). The firing of 9 Purkinje cells in lobe X 
were recorded using cell attached method at 32°C, 10 J..LM bicuculline and 5 mM 
kynurenic acid were added to the aCSF and after a minimum of 10 minutes of control 
200 nM CART peptide was bath applied for 5 minutes with continuous recording. 
The median instantaneous firing frequency in the presence of bicuculline and 
kynurenic acid was 17.0 (13.8, 20.5) Hz, this was not quite significantly different than 
the control median instantaneous firing frequency in the absence of synaptic blockers 
(p::O.0535), but is significantly lower then the median instantaneous firing frequency 
in the presence of bicuculline and CNQX (p<O.Ol), providing further confirmation 
that CNQX does have a direct effect on the firing rate of Purkinje cells. The median 
instantaneous firing frequency after CART peptide application was 17.0 (15.0, 24.8) 
Hz and following wash was 15.6 (15.4, 21.5) Hz (figure 4.8C). Expressed as a 
percentage the firing frequency measured in the presence of CART peptide was 111.3 
(101.1,117,8) %. Following wash, the firing rate was 106.0 (95.9,113.3) % (figure 
4.8D). CART peptide still significantly increased the firing rate in the presence of 
bicuculline and kynerunic acid (p<0.05). 
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4.2.6 - The CART peptide-mediated increases in firing rate are concentration 
dependent. 
CART peptide was initially used at a concentration of 100-200 nM because CART 
peptide have been shown to be active at similar concentrations in brain slice 
physiology experiments (Dun et aI., 2006) and the cost of CART peptide would make 
the routine use of high concentrations difficult. However having shown that CART 
peptide does have an affect on the firing of Purkinje cells, I was interested in how the 
effects of CART peptide depended on concentration. I therefore examined the actions 
of CART peptide at concentrations ranging from 20 to 1000 nM. 
The firing pattern of 6 Purkinje cells in lobe X were recorded using the cell attached 
method, after a minimum of 10 minutes of control, 1000 nM CART peptide was bath 
applied for 5 minutes with continuous recording. The median instantaneous firing 
frequency in control was 9.8 (9.1, 10.6) Hz, this increased to 13.9 (12.4, 14.8) Hz in 
the presence of 1000 nM CART peptide, and was 10.8 (10.1,17.9) Hz following wash 
(figure 4.9A). As a percentage of control, in the presence of CART peptide the firing 
rate was 125.7 (115.5, 141.4) % and in wash the firing rate was 105.5 (104.6, 128.2) 
% (figure 4.9B). Although the median instantaneous firing frequency was 
significantly increased in 1000 nM CART peptide compared to control (p<0.05), it 
was not significantly different from the increases observed with 100-200 nM CART 
peptide. 
The firing of 9 Purkinje cells in lobe X were recorded using cell attached method at 
32°C, after a minimum of 10 minutes of control 20 nM CART peptide was bath 
applied for 5 minutes with continuous recording. The median instantaneous firing 
frequency in control was 16.8 (11.8, 21.1) Hz, in the presence of 20 nM CART 
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Figure 4.9 - Concentration dependence of CART peptide actions on firing frequency. Application of 1000 
nM CART peptide (n = 6, panel A and B), but not 20 nM CART peptide (n = 9, panels C and D) 
increased the median instantaneous firing frequency of Purkinje cell at 32°C. Control (red), CART 
peptide (green) and washout (blue). Error bars are one SEM. * - p<0.05. Panels A and C show the 
absolute firing frequencies and panels Band 0 show frequencies normalised to control. 
peptide the median instantaneous firing frequency was 17.5 (12.0, 23.8) Hz and 
following wash the frequency was 17.2 (15.6, 19.3) Hz (figure 4.9C). As a 
percentage of control, in the presence of CART peptide the firing rate was 107.4 
(103.9, 123.7) % and following wash was 97.3 (93.8, 105.2) % (figure 4.9D). The 
median instantaneous firing frequency was significantly increased in 20 nM CART 
peptide compared to control (p<0.05), it was not significantly different from the 
increases observed with 100-200 nM CART peptide. 
The percentage median instantaneous firing frequencies for all the 20nM, 100 nM, 
200 nM and 1000 nM where plotted against concentration figure 4.IOB), however 
there were too few points to accurately produce a dose response curve. There was no 
significant difference between the effects on the firing rate for the 4 different CART 
peptide concentrations. However I performed a product-moment correlation on the 4 
points which gave an r value of 0.9913 with 2 degree of freedom, this is a significant 
positive correlation (p<O.OI), and suggests that 20 nM CART is below the maximum 
effective concentration. 
4.2.7 - The CART peptide-mediated increase in firing rate is specific and is not an 
artefact 
Because there is currently no antagonist for CART peptide, the effects of CART 
peptide are subtle and there is little recovery following wash, it is possible that the 
observed effects of CART peptide are the result of a drift in the firing rate or 
flow/temperature artefacts. I have designed my experiments to eliminate any drift in 
the firing rate during the experiment by using relatively small samples of firing 
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Figure 4.10 - Summary of CART peptide effects on Purkinje cell firing frequency. A - Plot of percentage 
median instantaneous firing frequency of Purkinje cells in response to CART peptide under different 
conditions, from left to right: control , 20 nM CART/32°C, 100 nM CART/RT, 100 nM CART/32°C , 200 
nM/320C/10 IJM bicuculline/10 IJm CNQX, 200 nM CART/32°C/10 IJm bicuculline/5 mM kynurenic acid, 
1000 nM CART/32°C. B - Percentage median instantaneous firing frequency plotted against CART peptide 
concentration , each point is the average (n = 4-15) of all results for that concentration of CART peptide. 
Error bars are one SEM. * - p<O.05, ** - p<O.01 . 
directly before CART peptide application and in CART peptide. A temperature sensor 
was present in the bath and the temperature was continually monitored during 
recordings. There was no correlation between any small temperature changes and the 
actions of CART peptide. When CART peptide was bath applied, the perfusion was 
changed from a control syringe to a syringe containing CART peptide solution. It is 
possible that any differences in flow rate between the two syringes could produce the 
observed increase in firing frequency. To eliminate this possibility, the firing of 7 
Purkinje cells, at 32°C in lobe X were recorded using cell attached method, after a 
minimum of 10 minutes of control, a sham solution (identical to the control aCSF) 
was applied for 5 minutes with continuous recording. Changing from the control 
solution to the sham solution had no effect on the median instantaneous firing 
frequency (11.6 Hz vs 11.4 Hz). Thus a flow artefact does not underlie the observed 
increases in firing frequency. 
CART peptide positive fibres are only present in the vestibular cerebellum, therefore I 
hypothesised that Purkinje cells outside the vestibular cerebellum would not express 
CART peptide receptors and thus would not respond to CART peptide (this is of 
course unknown as the CART peptide receptor has yet to be identified). If the effects 
of CART peptide are specific, then I hypothesise that they should not be observed 
outside the vestibular cerebellum. To test this the firing of 5 Purkinje cells in lobe III 
to VII were recorded, after a minimum of 10 minutes of control, 100 nM CART 
peptide solution was bath applied for 5 minutes. The control median instantaneous 
firing frequency of these cells was 28.7 (20.0, 34.6) Hz; which is significantly 
(p<0.05) higher than the firing frequency of the Purkinje cells in the vestibular 
cerebellum. Application of CART peptide (100 nM) to these cells had no significant 
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affect on the firing rate (28.7 vs 31.4 Hz, figure 4.11 C). Thus it appears that the 
actions of CART peptide are specific to the vestibular cerebellum. 
4.2.8 - CART peptide increases the firing rate with no significant affect on firing 
pattern 
For the analysis of the effects of CART on firing of Purkinje cells, I have 
concentrated on the median instantaneous firing frequency because I believe it is the 
most appropriate measure of changes in firing caused by CART peptide; however 
there are other parameters which can be measured, such as the mean, coefficient of 
variance and other parametric statistical measurements. To examine these statistical 
measurements, I combined room temperature and 32°C 100 nM CART experiments 
(sections 4.2.2-3) as the control and CART peptide median instantaneous firing 
frequencies in these two groups were not significantly different. 
Table 4.6 shows the results of the other statistical tests, only the mean of the 
instantaneous firing frequencies are significantly different (p>0.05). The other 
statistical tests which measure the variability of the data (standard deviation, 
coefficient of variance, 90% interval and 50% interval) were not statistically different. 
Therefore I conclude that CART peptide increases the firing frequency without 
affecting variability and thus not changing the firing pattern (also see chapter 5) 
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Percentage 
Control CART change Significances 
Mean I Hz 11.14 ± 1.92 12.36 ± 2.06 110.9 ± 6.82 0.05 
Standard Deviation I Hz 7.44 ± 1.64 7.55 ± 1.80 110.8 ± 18.28 Not significant 
Coefficient of Variance I % 90.2 ± 21.7 67.6 ± 16.0 92.4 ± 11.8 Not significant 
90% interval I Hz 9.80 8.46 83.1 Not significant 
50% interval I Hz 2.78 3.23 97.6 Not significant 
Table 4.6 - Other statistic on the effects of 100 nM CART on Purkinje cell firing 
at room temperature and 32°C (data pooled). For mean, standard deviation and 
coefficient of variance, means and student t-tests were used. For 90% and 50% 
intervals, medians and wilcoxen t-tests were used. 
4.3 - CART peptide does not modulate basal climbing fibre-Purkinje cell synaptic 
transmission. 
My results demonstrate that CART peptide has a direct affect on the firing pattern of 
Purkinje cells and this effect is not via modulation of glutamatergic or GABAergic 
synaptic inputs. However in parasaggital slices both the climbing fibres and parallel 
fibres are cut, therefore the excitatory transmission to Purkinje cells is weak 
(kynurenic acid has no direct on the firing rate; chapter 5). Furthermore the climbing 
fibres are inactive in parasaggital slices and thus if CART peptide did modulate 
climbing fibre synaptic transmission this effect would probably not be detectable via a 
change in Purkinje cell firing rate. Thus I have directly stimulated climbing fibres 
and investigated whether CART peptide modulates the resultant excitatory 
postsynaptic currents (EPSCs) measured in Purkinje cells using whole cell voltage 
clamp. 
EPSCs were evoked using a stimulating electrode placed on the granule cell layer, 
adjacent to the Purkinje cell body that was being recorded from. To prevent any 
interference from inhibitory synapses, 10 !AM bicuculine was added to the aCSF to 
block GABAA receptors. In order to increase the signal to noise ratio, an internal 
pipette solution based on caesium chloride was used. The cells where held at -20 mY, 
in order to reduce EPSC amplitude and increase the quality of the voltage clamp. The 
climbing fibre EPSCs were identified by four criteria: 1) the EPSCs had a large 
amplitude (>-200 pA); 2) by using a pair pulse protocol (interval 100 ms), the 
amplitude of the second EPSC was smaller than that of the first EPSC (paired pulse 
depression; figure 4.128), which is characteristic of climbing fibre synapses 
(Hashimoto and Kano, 1998); 3) as there is only one climbing fibre innervating each 
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Figure 4.11 - The actions of CART peptide are not non-specific. Purkinje cell firing frequency is not 
significantly different following sham applications (n = 7; panels A and B). The firing frequency of 
Purkinje cells outside the vestibular cerebellum are not increased by CART peptide (n = 5; panels C 
and D). Red - control , Green (A,B) - sham, Green (C,D) -100nM CART peptide, blue - washout. 
Error bars are one SEM. Panels A and C show the absolute firing frequencies and panels Band D 
show frequencies normalised to control. 
Purkinje cell, the stimulus response curve was all or none (n = 2) (figure 4.12A); 4) 
the EPSCs were blocked by 10 ~M CNQX (n = 3) (figure 4.12B) confirming that they 
were glutamatergic. 
To investigate the effect of CART peptide on climbing fibre EPSCs, I used a protocol 
which alternatively stimulated the climbing fibre with a pair of stimuli (100 ms 
interval), and a single stimulus. These were delivered at 5 s intervals, giving 6 pairs 
and 6 single EPSCs per minute. In addition, once every minute a small depolarising 
pulse was applied to the Purkinje cell to check the quality of the seal. There was no 
significant change in the amplitude of this pulse for all of the cells included in the 
analysis. The pairs of EPSCs were used to measure the degree of paired pulse 
depression (the second EPSC always occurred after the first EPSC had completed 
decayed). The single EPSCs were used to measure EPSC decay kinetics. A typical 
pair of EPSCs is shown in figure 4.12C. Although the stimulus artefact has a large 
amplitude, the rise of the EPSC is not contaminated by the artefact (figure 4.12D). To 
calculate the amplitude and kinetics of the EPSCs, 5 minutes worth of EPSCs were 
averaged, the pairs and single EPSCs where averaged separately (figure 4.12E, single 
EPSC not show). Table 4.7 gives a typical set of statistics for 5 minutes of EPSCs. 
Recordings where made from 8 Purkinje cells in lobe X, with the bath application of 
200 nM CART peptide solution after a minimum of 10 minutes of control recording. 
Figure 4.13A-C shows a typical recording, in this example there was a slight decrease 
in EPSC amplitude following the application of CART peptide however the reverse 
was observed in other recordings (figure 4. 13D). If the compensation in voltage 
clamp was not perfect, or changes in seal resistance occurred during the recording 
then a slight hump was observed in the EPSC decay (figure 4.13D). If the humps were 
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1st EPSC 2nd EPSC PPR 
Peak amplitude I pA 765 644 84% 
10%-90% rise time I ms 0.45 0.51 n/a 
Tau11 ms 5.64 3.38 n/a 
A1/pA -275 -249 n/a 
Tau2/ ms 12.87 12.32 n/a 
A2/pA -414.33 -341.59 n/a 
Tau(weighted) / ms 9.99 8.55 n/a 
Table 4.7 - Statistic for a typical climbing fibre EPSC experiment 
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Figure 4.12 - Properties of evoked climbing fibre-excitatory post synaptic currents (EPSCs). A - Climbing 
fibre-EPSCs show an all or nothing response to increasing stimulus strength. B - Climbing fibre-EPSCs 
were blocked by 10 IJM CNQX.C - A single pair of climbing fibre-EPSCs illustrating paired pulse 
depression. 0 - EPSCs occur after the stimulus artefact. E - Average of 30 pairs of EPSCs, showing that 
the second EPSC occurs after the first EPSC has completely decayed (grey dotted line). 
Absolute value Control CART wash 
1 st EPSC peak amplitude / pA 581 ± 89 555 ± 99 565 ± 100 
2nd EPSC peak amplitude / pA 445 ±62 421 ± 69 424 ± 73 
Paired pulse ratio / % 78.2 ±2.9 83.0 ±5.3 75.6 ± 3.6 
1 st EPSC rise time / ms 0.479 ± 0.027 0.485 ± 0.028 0.514 ± 0.032 
2nd EPSC rise time / ms 0.768 ± 0.163 0.788 ± 0.166 0.672 ± 0.056 
1 st EPSC tau(w) / ms 12.85 ± 1.36 13.63 ± 1.32 12.08 ± 1.26 
2nd EPSC tau(w) / ms 11.01 ± 2.04 12.64 ± 2.16 11.31 ± 1.67 
Percentage change CART wash 
1 st EPSC peak amplitude 92.4 ± 4.0 102.5 ± 11.2 
2nd EPSC peak amplitude 98.0 ± 6.1 97.8 ±8.6 
Paired pulse ratio 105.9 ± 4.1 96.7 ±2.6 
1 st EPSC rise time 101.4 ± 1.6 107.1 ± 1.3 
2nd EPSC rise time 103.1 ± 1.6 98.7 ± 8.2 
1 st EPSC tau(w) 107.3 ± 2.8 98.4 ± 9.1 
2nd EPSC tau(w) 117.2 ± 8.9 111.3 ± 12.8 
Table 4.8 - Summary of the effects of 200 nM CART peptide on climbing 
fibre-EPSCs (n = 8). 
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Figure 4.13 - An example of the affects of 200 nM CART peptide on clim bing fibre-EPSCs from a single 
Purkinje cell (panel A-C). A - Plot of EPSC amplitudes against time for pairs of EPSCs. CART peptide 
did not effect the amplitude of the 1 Sl or 2nd EPSC. B - Plot of EPSC 10-90 % rise time and paired 
pulse ratio against time. CART peptide did not significantly effect the paired pulse ratio or 10-90 % rise 
time. C - The average EPSCs in control , during CART peptide application and following wash, 
superimposed. 0 - The average EPSCs in control , during CART peptide application and following wash, 
superimposed. There is a outward deflection above the baseline (grey dotted line) in the decay the 
EPSCs which may be due to a loss of clamp. 
A _ l " EPSC B l " EPSC 
2""EPSC 
120 
2""EPSC 
.60() ~100 
a. 
~ ~ 80 j400 ~ 2t 60 
~ ~ to 
~ I 40 to 2t .200 20 
0 0 
control CART wash control CART wash 
C Paired pulse ratio D 120 pa'redPu~ 
08 ~100 
3! 
~ 80 
0.6 I ~ e 
3! i 60 a. 0.4 ~ 'l5 40 [ .. 
02 ~ ~ 20 
2t 
0.0 0 
control CART wash control CART wash 
Figure 4.14 - CART peptide (200 nM) does not significantly change the amplitude (panels A and B) or 
paired pulse ratio (panels C and D) of climbing fibre-EPSCs. Error bars are one SEM. Panels A and C 
show the absolute values and panels Band 0 show values normalised to control. 
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Figure 4.15 - CART peptide (200 nM) does not significantly change the 10-90 % rise time (panels A 
and B) or weighted decay constant, tau(w) (panels C and D) of climbing fibre-EPSCs. Error bars are 
one SEM. Panels A and C show the absolute values and panels Band 0 show values normalised to 
control. 
consistent throughout the recording, then these recordings were used to calculate 
EPSC statistics and they were included in the final data set. 
The mean EPSC amplitude was -580 ± 89 pA in control, -535 ± 99 pA in CART 
peptide and -565 ± 100 pA following wash for the 1 sl EPSC, and -445 ± 62 pA in 
control, -421 ± 69 pA during CART peptide application and -424 ± 73 pA during 
wash for the 2nd EPSC (figures 4.14A). Expressed as a percentage of control 
amplitude the 1 S\ EPSC amplitude was 92.4 ± 4.0 % in CART peptide and 102.5 ± 
11.2 % during wash. For the 2nd EPSC the percentage of control amplitude during 
CART peptide applications was 98.0 ± 6.1 % and 97.8 ± 8.6 % during wash (figure 
4.14B). There was no significant difference in the amplitude of first EPSCs or second 
EPSCs between control, CART peptide application or wash. 
By dividing the amplitude of the second EPSC by the first this gives the paired pulse 
ratio (PPR) which gives a measure of release probability. There was no significant 
difference in PPR between control, CART peptide application or wash. In control the 
PPR was 78 ± 3 %, during CART peptide application it was 83 ± 5 % and during 
wash was 76 ± 4 % (figure 4.14C). 
There was also no significant difference in the 10-90 % rise time for first EPSC or 
second EPSC between control, CART peptide application or wash. The mean 10-90 
% rise time for the first EPSC was 0.48 ± 0.03 ms during control, 0.49 ± 0.03 ms 
during CART peptide application and 0.51 ± 0.03 ms during wash. The mean 10-90 
% rise time for the second EPSC was 0.77 ± 0.16 ms during control, 0.79 ± 0.17 ms 
during CART peptide application and 0.77 ± 0.06 ms during wash (figure 4.15A). 
The decay of the averaged EPSCs was fitted with a double exponentials and the 
weighted decay constant ('tw) was calculated to compare the kinetics of decay. There 
was no significant difference in the weighted decay constant for the first EPSC or 
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second EPSC between control, CART peptide application or wash. The average 
weighted decay constant for the first EPSC was 12.9 ± 1.4 ms in control, 13.6 ± 1.3 
ms in CART peptide and 12.1 ± 1.3 ms following wash. The average weighted decay 
constant for the second EPSC was 11.0 ± 2.0 ms in control, 12.6 ± 2.2 ms in CART 
peptide and 11.3 ± 1.7 ms following wash (figure 4.15C). 
These results suggest that CART peptide does not modulate basal synaptic 
transmission at the climbing fibre to Purkinje cell synapse, either post-synaptically or 
pre-synaptically. It is possible that CART peptide changes the threshold potential for 
transmitter release from climbing fibres, has effects during trains of EPSCs or has a 
very slow modulatory effect on the climbing fibre-Purkinje cell synapse, but using 
this method I was unable to investigate these possibilities. 
4.4 - CART peptide does not modulate basal parallel fibre-Purkinje cell transmission 
The expression of CART peptide at the climbing fibre-Purkinje cell synapse suggests 
that the climbing fibre synapse would be the most likely target of CART peptide 
modulation. However it is possible that CART peptide spills out from the climbing 
fibre synapse to act at other Purkinje cell synapses, for example parallel fibre 
synapses. To investigate the effects of CART peptide on parallel fibre-Purkinje cell 
synapses, I stimulated parallel fibres and investigated whether CART peptide 
modulates the excitatory postsynaptic currents measured using whole cell voltage 
clamp of Purkinje cells. 
EPSCs were evoked using a stimulating electrode placed on the molecular layer, close 
to the recorded Purkinje cell. To prevent any interference from inhibitory synapses, 
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10IlM bicuculine was added to the aCSF to block GABAA receptors. Parallel fibre 
EPSCs are smaller than climbing fibre EPSCs and therefore the cells where held at -
70 m V, in order to increase EPSC amplitude. The parallel fibre EPSCs were 
identified by four criteria: 1) the EPSCs had a small amplitude «-1000 pA, a 
climbing fibre EPSC recorded at -70 m V would be >3 nA); 2) by using a paired pulse 
protocol (interval 50 ms), the amplitude of the second EPSC was larger than that of 
the first EPSC (paired pulse facilitation), which is a characteristic of parallel fibre 
synapses (Perkel et al., 1990); 3) as multiple parallel fibres innervate Purkinje cells, 
increasing the stimulus strength recruited more fibres and thus the stimulus-response 
curve was linear (n = 4) (figure 4.16A); 4) EPSCs were blocked by IOIlM CNQX (n 
= 3) (figure 4.16B) confirming they were glutamatergic. 
To investigate the effect of CART peptide on parallel fibre EPSCs, I used a similar 
protocol as for climbing fibre EPSCs (section 4.3) only a shorter (50 ms) interval was 
used to measure paired pulse facilitation. The parallel fibre stimulation strength was 
chosen to give as large an EPSC as possible (for ease of measurement) without loss of 
clamp and these were delivered at 5 s intervals, giving 6 pairs and 6 single EPSCs per 
minute. As before, a small depolarising pulse was applied once per minute to check 
the quality of the seal and the same analysis methods were used as climbing fibre 
EPSCs (see above). 
Recordings where made from 9 Purkinje cells in lobe X, with the bath application of 
200 nM CART peptide solution after a minimum of 10 minutes of control recording. 
Figure 4.17 A-D shows a typical application of CART peptide. The mean EPSC 
amplitude (n = 9) was -200 ± 48 pA in control, -180 ± 37 pA during CART peptide 
application and -169 ± 38 pA following wash for the 1 sl EPSC, and -372 ± 85 pA in 
control, -394 ± 73 pA during CART peptide application and -360 ± 74 pA during 
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Figure 4.16 - Properties of evoked parallel fibre-excitatory post synaptic currents (EPSCs) from a 
single Purkinje cell . A - EPSCs show a linear relationship to increasing stimulus strength. B -
EPSCs are blocked by 10 IJM CNQX. C - Example of a single pair of parallel fibre-EPSCs illustrating 
paired pulse facilitation. 0 - EPSCs occur after the stimulus artefact. E - Average of 30 pairs of 
EPSCs, showing that the second EPSC occurs in the decay of the first EPSC. F - The average of 
the scaled single EPSC was substracted from the averaged paired EPSCs. Finally the stimulus 
artefacts were removed (arrows). 
A 
-600 
-500 
c{ 
~ -400 
! 1-3°O 
(.) 
~ -200 
w 
~.~ .~'-... ~ ;;IIfo~. ,OWJ :- -0 4ft •  0 •• , .0 .0. 0 • 
• 
-100 
5mln 
o 
c 200nM CART 
300 
250 
. .. . . . 
o 0 0-":" ... • 
• ale-=-- ••• ~ .. 
..... 0 'i ... .,:--... 0_ ~ 00 
-.. ... ....." -- .... ~ .. 
.,.. ......... ... -.. :.~ ... '" 
.. ~O .. : 0 ~o. 
o • o 
50 5mln 
B 3.0 
2.5 
fJ) 
~ 2.0 
Q) 
E 
~ 1.5 
." 
;F. 
~ 1.0 
a 
0.5 
0.0 
D 
o 
'/, 200nMCART • 1" EPSC 
o t" EPSC 
5 min 
T·~ (I;~ ~~CART 
f.! wash 
/;' '---'-'--------l 
/1 
'{ 
100 pA 
50ms 
Figure 4.17 - CART peptide (200 nM) had no effect on parallel fibre-EPSCs recorded in a single Purkinje 
cell. A - Plot of EPSC amplitudes against time for pairs of EPSCs. CART peptide did not affect the 
amplitude of the 1st or 2nd EPSC. B - Plot of EPSC 10-90 % rise time against time for pairs of EPSCs. 
CART peptide did not affect the 10-90 % rise times. C - Plot of EPSC paired pulse ratio against time_ 
CART peptide did not affect the pair pulse ratio. 0 - The average EPSCs in control , during CART peptide 
application and following wash, superimposed 
Absolute value Control CART wash 
1 st EPSC peak amplitude / pA 200 ±48 180 ± 37 169 ± 38 
2nd EPSC peak amplitude / pA 372 ± 85 393 ± 73 360 ± 74 
Paired pulse ratio / % 193 ± 12 229 ±20 224 ±23 
1 st EPSC rise time / ms 2.16 ± 0.31 2.21 ± 0.26 2.20 ± 0.30 
2nd EPSC rise time / ms 2.34 ± 0.28 2.75 ±0.28 2.56 ±0.38 
1st EPSC Tau(w) / ms 21.95 ± 1.89 24.40 ± 2.76 25.63 ± 2.48 
Percentage change CART wash 
1 st EPSC peak amplitude 94.4 ± 6.5 92.8 ± 15.4 
2nd EPSC peak amplitude 113 ± 12.7 106.2 ± 18.1 
Paired pulse ratio 120.2 ± 10.8 118.3 ± 13.7 
1 st EPSC rise time 105.9 ± 7.0 103.2 ± 5.5 
2nd EPSC rise time 122.6 ± 12.0 109.0 ± 5.3 
1 st EPSC Tau(w) 110.4 ± 5.6 118.7 ± 10.4 
Table 4.9 - Summary of the effects of 200 nM CART peptide on parallel 
fibre-EPSCs (n = 9). 
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Figure 4.18 - CART peptide (200 nM) did not significantly change the amplitude (panels A and B) or 
paired pulse ratio (panels C and D) of parallel fibre-EPSCs. Error bars are one SEM. Panels A and C 
show the absolute values and panels Band D show values normalised to control. 
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Figure 4.19 - CART peptide (200 nM) does not significantly change the 10-90 % rise time (panels A 
and B) or weighted decay constant, tau(w) (panels C and D) of parallel fibre-EPSCs. Error bars are 
one SEM. Panels A and C show the absolute values and panels Band 0 show values normalised to 
control. 
wash for the 2nd EPSC (figures 4.1SA). Expressed as a percentage of the control 
amplitude, the 151 EPSC amplitude was 94.4 ± 6.5 % during CART peptide 
application and 92.S ± 15.3% during wash. For the 2nd EPSC the percentage of 
control amplitude during CART peptide applications was 113.3 ± 12.7% and 106.2 ± 
lS.l % during wash (figure 4.18B). There was no significant difference in the first 
EPSC amplitude or second EPSC amplitude between control, CART peptide 
application or wash. As expected, there was also no significant difference in PPR 
between control (193 ± 12 %), CART peptide application (228 ± 20 %) or wash (224 
± 23 %, Figure 4.1SC). 
There was no significant difference in the 10-90 % rise time for first EPSC or second 
EPSC between control, CART peptide application or wash. The average 10-90 % rise 
time for the first EPSC was 2.16 ± 0.31 ms in control, 2.21 ± 0.26 ms during CART 
peptide application and 2.20 ± 0.30 ms following wash. The average 10-90 % rise 
time for the second EPSC was 2.34 ± 0.27 ms in control, 2.75 ± 0.28 ms during 
CART peptide application and 2.56 ± 0.38 ms following wash (figure 4.15A). There 
was also no significant difference in the weighted decay constant for the first EPSC or 
second EPSC between control, CART peptide application or wash. 
The average weighted decay constant for the first EPSC was 22.0 ± 1.9 ms in control, 
24.4 ± 2.8 ms during CART peptide application and 25.6 ± 2.5 ms following wash. 
These results suggest that CART peptide does not act to modulate basal synaptic 
transmission at the parallel fibre to Purkinje cell synapse, either post-synaptically or 
pre-synaptically. Because the parallel fibre EPSC measures the effect of transmitter 
released from multiple fibres it is unlikely that CART peptide changes the threshold 
potential for transmitter release as this would have changed the EPSC amplitude. 
However it is possible the CART peptide may have an effect during trains of EPSCs 
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or have a very slow modulatory affect on the parallel fibre-Purkinje cell synapse, but 
using my method I was unable to investigate these possibilities. 
4.5 - CART peptide does not modulate GABAergic miniature inhibitory postsynaptic 
currents (mIPSCs) 
CART peptide does not appear to modulate basal synaptic transmission at either 
climbing fibre or parallel fibre-Purkinje cell synapses. However Purkinje cells also 
receive synaptic connects from two other cells types in the cerebellum: the basket and 
stellate cells. These cells are both GABAergic and are often considered together as 
local interneurones. They have different morphology and make synaptic connections 
onto different areas of the Purkinje cell; the stellate cells make synapses onto the 
dendrites whereas the basket cells make their synaptic connections onto the cell body. 
As they both receive excitatory inputs from parallel and climbing fibres and inhibit 
Purkinje cells they may be considered as feed-forward inhibitory neurons. 
In parasaggital slices, these interneurones play a role in determining Purkinje cell 
firing rate, (unlike the parallel or climbing fibres), as demonstrated by the increase in 
Purkinje cell firing rate after the block of GABAA receptors (see above and chapter 5). 
Given that the effects of CART peptide were similar with or without GABAergic 
synaptic transmission, it seems unlikely that CART peptide modulates the synaptic 
transmission between intemeurones and Purkinje cells. However the effects of CART 
peptide on GABAergic may be subtle and not produce a marked change in Purkinje 
cell firing rate. Thus I investigated the actions of CART peptide on miniature 
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inhibitory post synaptic currents (mIPSCs) recorded from Purkinje cells using whole 
cell voltage clamp. 
Miniature inhibitory post synaptic currents were recorded in the presence of the 
sodium channel blocker TTX (1 ~M), and kynurenic acid (5 mM) to block glutamate 
receptors. Miniature IPSCs occured at a low frequency, had a small amplitude and 
resulted from the spontaneous exocytosis of GABA. They are useful because a 
change in mIPSC amplitude indicates post-synaptic modulation, whereas changes in 
mIPSC frequency indicates pre-synaptic modulation 
Miniature IPSCs where recorded from 6 Purkinje cells in lobe X using an internal 
patch clamp solution based on caesium chloride. Purkinje cells where held at -70 m V 
and under these conditions the mIPSCs were inward. A small depolarising pulse was 
applied once a minute to check the quality of the seal and there was no significant 
change in the amplitude of this pulse during the recordings. CART peptide was bath 
applied after a minimum of 10 minutes of control and statistics were calculated for 5 
minutes intervals: before CART peptide application (control), during CART peptide 
application (CART) and 5 minutes after washout of CART peptide. At the end of the 
recording, bicuculline was applied and all currents were abolished confirming they 
were GABAergic. Figure 4.20 shows a typical recording. 
For the 6 recordings, the mean mIPSC amplitude in control was -51.5 ± 11.5 pA with 
an average SD of 45.8 ± 9.1 pA, the mean mIPSC amplitude during CART peptide 
application was -43.6 ± 7.0 pA with an average SD of 32.8 ± 4.8 pA and the mean 
mIPSC amplitude after wash was -47.0 ± 7.4 pA with an average SD of 36.8 ± 4.8 pA 
(figure 4.21A). The average mIPSC frequency in control was 6.2 ± 2.8Hz with an 
average SD of 7.2 ± 1.5 Hz, the average mIPSC frequency during CART peptide 
application was 5.7 ± 2.8 Hz with an average SD of 6.3 ± 1.8 Hz and the average 
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Figure 4.20 - CART peptide (200 nM) has no effect on GABAergic mini IPSCs (mIPSCs) recorded in a 
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Figure 4.21 - CART peptide (200 nM) does not significantly change the amplitude (panels A and B) or 
instantaneous frequency (panels C and D) of mIPSCs. Error bars are one SEM. Panels A and C show the 
absolute values and panels Band 0 show values normalised to control. 
mIPSC frequency after wash was 504 ± 2.7 Hz with an average SO of 604 ± 1.5 Hz 
(figure 4.21 C). There was no significant difference in the mean or SO of either 
mIPSC amplitude or frequency between the 3 conditions. Thus CART peptide did not 
affect the miniature IPSCs recorded from Purkinje cellsA.6 - Mechanism of CART 
peptide-mediated increase in Purkinje cell firing rate. 
4.6.1- Whole cell recordings from Purkinje cells slowly depolarise. 
There are a number of possible mechanisms by which CART peptide could affect the 
firing rate of Purkinje cells. I can exclude the modulation of glutamatergic or 
GABAergic inputs onto the Purkinje cells and thus the most obvious mechanism is a 
direct effect on Purkinje cell, possibly via a ligand-gated ion channel or a G-protein 
coupled receptor, as described for other neuropeptides (see chapter 1). To investigate 
CART peptides mechanism action, I have made whole cell current clamp recordings 
from Purkinje cells. Using this method, the firing rate, membrane potential and input 
resistance can be recorded. By applying positive current steps it is also possible to 
measure the excitability of Purkinje cells. 
Using an intracellular patch solution based on potassium gluconate and containing 
ATP and GTP, I made whole cell current clamp recordings from 6 Purkinje cells in 
the vestibular cerebellum at 32°C. Of these 6 cells, 4 of them were spontaneously 
active at rest (figure 4.22A-B) but all fired action potentials in response to current 
injection. From current steps, I calculated the resting membrane potential and 
membrane resistance (figure 4.22C-O). The resting membrane potential and 
resistance were measured 5 minutes after establishing the whole cell recording, to 
allow equilibration. For all 6 cells, the mean membrane potential was -56.9 ± 3.1 mY, 
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Figure 4.22 - Examples of typical whole cell recordings from Purkinje cells . A - Recording from a 
constituently active cell. B - Recording from a silent cells. The square downward deflections in A and B 
are injection of negative current to measure membrane resistance . C - A typical Purkinje cell current 
voltage relationship (IV) (-450 pA-O pA in 50 pA steps). D - Plot of current against voltage (initial) for cell 
in C (average of 3 IV protocols) . The calculated resting membrane potential was -68.1 mV and the 
membrane resistance was 34.0 MO. 
the active Purkinje cells had a membrane potential of -53.0 ± 2.6 mY and the 
quiescent Purkinje cells had a membrane potential of -64.5 ± 4.1 mY. The mean 
membrane resistance was 26.0 ± 2.3 MO for all cells, for the active Purkinje cells 
26.3 ± 3 MO and for the quiescent cells was 27.1 ± 3.2 MO. To measure the stability 
of whole cell recordings, 30 minute recordings were made from all 6 cells and the 
electrical properties were compared at the beginning of the recording and at the end. 
At the beginning, the membrane potential was -56.7 ± 3.1 mY and the membrane 
resistance was 26.6 ± 2.3 MO. The resting membrane potential (-50.8 ± 2.81 mY) 
was significantly different after 30 minutes of recording (p>O.OI) but the membrane 
resistance (26.2 ± 3.0 MO) was not significantly different. For the active Purkinje 
cells, the median instantaneous firing frequency at the beginning of the recording was 
significantly (p<0.05) different from that at the end (10.8 vs 15.1). The drift in firing 
frequency and membrane potential during a recording means it would be very difficult 
to determine if any changes in the electrical properties of Purkinje cell were due to 
CART peptide or due to the drift in cell properties. To try and overcome this problem, 
I made whole cell recordings from Purkinje cells in the presence of synaptic blockers 
(kynurenic acid to block glutamate receptors and bicuculline to block GABAA 
receptors) and the sodium channel blocker TTX. I suspected that the drift maybe due 
to an accumulation/or loss of cellular factors that under normal conditions would be 
controlled by intracellular processes, but are disrupted by cell dialysis. By reducing 
the activity of Purkinje cells and the number of active conductances, this may stop 
cell dialysis having such a large effect on the electrical properties. 
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4.6.2 - CART peptide may change electrical properties of Purkinje cells with synaptic 
activity and action potentials blocked 
I used a protocol of negative currents steps to acquire current voltage relationships 
from Purkinje cells and from this calculated the resting membrane potential and 
membrane resistance of Purkinje cells and then investigated the effect of CART 
peptide 
I recorded current voltage relationships in whole cell current clamp from 6 Purkinje 
cells in lobe X at 32°C every 10 minutes for 30 minutes in the presence of 1 IlM TTX, 
10 IlM bicuculline and 5 roM kynurenic acid. The current voltage relationships were 
similar to those acquired in control but clearly no action potentials were observed and 
the membrane resistance was consistently higher (as a number of conductances were 
blocked). The mean resting membrane potential was initially -54.7 ± 1.4 mY, after 10 
minutes was -54.3 ± 1.4 mY, after 20 minutes was -55.2 ± 1.4 mV and after 30 
minutes was -55.2 ± 1.7 mV (figure 4.23A). The mean membrane resistance was 
initially 69.2 ± 3.4 MO, after 10 minutes was 70.0 ± 2.5 MO, after 20 minutes was 
70.7 ± 2.5 MO and after 30 minutes was 72.4 ± 2.7 MO (figure 4.23B). There was no 
significant difference in resting membrane potential or membrane resistance between 
any of the time intervals. 
Having established that the recording was stable over 30 minutes, I repeated the same 
protocol as above for 9 Purkinje cells to which 100 nM CART peptide was applied for 
5 minutes, 7 minutes into the recording. The current voltage relationships were 
similar to those acquired without CART peptide. The average resting membrane 
potential was initially -50.6 ± 1.9mV, during CART peptide application (10 minutes) 
was -50.1 ± 2.7 mY, after initial CART peptide wash (20 minutes) was -50.0 ± 3.1 
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Figure 4.23 - There is no obvious effect of CART peptide on Purkinje cell membrane properties. 
Recordings of current voltage relationships from Purkinje cells in the presence 1 IJM TTX, 10 IJM 
bicuculline and 5 mM kynurenic acid , with (in red; n = 9) and without (in black; n = 6) the application of 100 
nM CART peptide. The mean resting membrane potential (panels A and C) and the mean membrane 
resistance (panels B and D) was not significantly different at any of the time points. Panels A and B show 
absolute values and panels C and 0 show values normalised to control. 
mV and after 30 minutes was -50.5 ± 3.5 mY. The average membrane resistance was 
initially 69.4 ± 3.6 MO, during CART peptide application (10 minutes) was 69.2 ± 
4.1 MO, after initial CART peptide wash (20 minutes) was 68.3 ± 5.2 MO and after 
30 minutes was 67.6 ± 5.3 MO. There was no significant difference in resting 
membrane potential or membrane resistance between any of the time intervals. 
In addition there is no significant difference between the membrane potential or 
membrane resistance at each time interval between the control and in CART peptide. 
However, if the data after the application of CART peptide are collected together (10, 
20 and 30 minute intervals) and this is compared to the same intervals in the control 
experiment then the average resting membrane potential is significantly different (-
54.7 ± 1.4 mV in control experiment, -50.6 ± 1.9mV in CART peptide experiment, 
p>O.05). This maybe a false positive because of the difference in initial resting 
membrane potential between the two experiments, although it should be noted that 
there was not a significant difference between the initial resting membrane potentials 
in the two experiments, but the sample size for this group was a third of the size of the 
combined data from after the CART application. To investigate this further I made 
graphs of the percentage of initial resting membrane potential (figure 4.23C) and 
percentage of initial membrane resistance (figure 4.23D). Although these graphs 
cannot be used to make a statistical analysis, I believe they indicate that there is a 
difference in both resting membrane potential and the membrane resistance of the 
Purkinje cell, after the application of CART peptide as compared to the control. 
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4.6.3 - CART peptide reduces the membrane resistance of Purkinje cells with 
clamped membrane potential 
Purkinje cells have many ion channels in their membrane, and many of these channels 
are active at the resting potential of the Purkinje cell membrane, in addition some of 
these ion channels have the specific function of rectifying the membrane resistance 
(for example Ih current depolarises the membrane during hyperpolarisation and IA 
current hyperpolarises the membrane during depolarisation). A change in resting 
membrane potential, for example depolarisation, may active these channels which 
then act to oppose the change in membrane potential. If there is a large change in 
membrane resistance then the different effects of various rectifying currents may be 
small, but if there is a small change in membrane resistance then the rectification by 
the currents may mask the initial change. In the previous experiments there was 
significant variation in the resting membrane potential, if the CART peptide was 
having a small effect on membrane resistance then the variation in resting membrane 
potential may mask any CART peptide effect. One way of overcoming this problem 
is to fix the resting membrane potential by injecting current into the Purkinje cell via 
the patch electrode. By holding the Purkinje cell at a fixed membrane potential it is 
possible to investigate if CART peptide is altering the membrane resistance because 
the channels which oppose changes in the membrane potential will not be activated. 
I was also concerned that the electrical properties of Purkinje cell may be changing 
over time. To overcome this possible problem I made recording from Purkinje cells in 
lobe X and after 10 minutes of control applied either a 100 nM CART peptide 
solution (n = 16) or a control solution (n = 24). Purkinje cells were held at -75 m V 
and current voltage relationships where recorded using negative current steps (figure 
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4.24A), and also firing rate and excitability data was recorded using positive current 
steps. To reduce systematic error the solution (CART peptide or control) was chosen 
at random before the Purkinje cell had been patched. Two of the control recordings 
were rejected during analysis as there was evidence that the patch had sealed up. 
The mean control resting membrane potential (n = 22) was -75.8 ± 0.9 mV and the 
mean resting membrane potential (n = 16) in CART peptide was -75.4 ± 0.8 mV 
(figure 4.24B); as expected these where not significantly different as the cells were 
held at -75 mY. The mean current required to keep the cell at -75 mV in control was 
302 ± 35 pA and in CART peptide the mean current was 295 ± 34 pA (figure 4.24C); 
these currents are not significantly different. However, the mean membrane 
resistance in control (38.9 ± 9.0 MO) was significantly (p>O.Ol) higher than that 
measured in CART peptide (32.6 ± 4.7 MO, figure 4.24D). This reduction in input 
resistance suggests that CART may act by opening a conductance. 
One of the major rectifying currents in the Purkinje cell is the hyperpolarisation 
activated current, Ih, it is possible to calculate the size of Ih conductance and also the 
baseline Ih current from the current voltage relationship. The mean Ih conductance in 
control was 66.1 ± 15.1 nS and in CART peptide was 75.2 ± 19.7 nS (figure 4.25A); 
these were not significantly different. The average baseline Ih current in the control 
experiment was 21.7 ± 22.9 pA and in the CART experiment was 31.0 ± 50.2 pA 
(figure 4.25B); these are not significantly different. 
In addition to negative current steps in determine the current voltage relationship of 
the Purkinje cell; I also recorded the firing of the Purkinje cell at different positive 
current steps. Only one of the cells recorded from didn't firing action potentials (in 
the control group). The average threshold voltage for firing action potentials in the 
control experiment (n = 21) was -70.3 ± 1.6 mV and in the CART peptide experiment 
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(n = 16) was -70.S ± 1.5 mV (figure 4.25C); these are not significantly different. The 
average excitability of the Purkinje cell in the control experiment was 0.104 ± O.OOS 
Hz/pA or 2.S4 ± 0.27 Hz 1m V and in the CART experiment was 0.097 ± 0.007 Hz/pA 
or 3.04 ± 0.26 Hz/mV (figure 4.25D); these are not significantly different. 
In summary, CART peptide increases the conductance of the Purkinje cell membrane, 
presumably by opening an ion channel, or by modulating the properties of an ion 
channel already open at rest. The fact that neither the threshold for firing or the 
excitability changed during the application of CART peptide does not give any 
additional information to help identify the mechanism by which CART peptide has its 
effects. 
Finally it is worth noting that the CART peptide could have its effects out in the 
dendrites of the Purkinje cell. The geometry and distribution of ion channels in the 
Purkinje cell dendrite may mean that the effect observed at the soma is either much 
smaller or even completely different to that in the dendrites. 
4.7 -CART peptide does not modulate parallel fibre long term depression. 
Purkinje cells show various forms of synaptic plasticity, one of the most important is 
long term depression (LTD). With low frequency simultaneous stimulation of 
climbing fibres and parallel fibres, a prolonged reduction in the amplitude of events 
evoked by parallel fibre stimulation is observed. This form of plasticity may underlie 
motor learning in the cerebellum in a similar way that long term potentiation (LTP) is 
thought to underlie learning and memory in the hippocampus (for review see Ito 
2000). More recent evidence suggests that LTD may not be involved in learning and 
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memory but may be a neuro-protective mechanism when there is excess activity 
(Llinas et aI., 1997). Neuropeptides such as corticotropin-releasing factor (CRF) have 
been implicated in modulation of LTD in the cerebellum (Miyata et aI., 1999; 
Schmoleskyet aI., 2(07). Therefore it is possible that CART peptide may also have a 
role in modulating LTD in the vestibular cerebellum. To investigate this, I recorded 
parallel fibre EPSCs, then induced LTD (Kimura et aI., 2(05) either in control aCSF 
or in the presence of 100 nM CART peptide. To reduce systematic error, which 
solution to apply was chosen at random before the cell was patched. 
Whole cell voltage clamp recordings were made from 27 Purkinje cells in lobe X at 
room temperature (25°C). LTD was induced in 12 slices in control and in 15 slices in 
the presence of CART peptide. The parallel EPSCs were recorded by stimulation in 
the molecular layer (section 4.4) every 5 seconds. The LTD protocol consisted of 5 
minutes of stimulation of the parallel fibre at 1 Hz while the Purkinje cell was 
simultaneously depolarised to a membrane potential of 0 mV (Kimura et aI., 2(05). A 
small depolarising pulse was applied once a minute to check the membrane resistance. 
Out of 12 control experiments, 3 recordings were lost during the induction of LTD. 
Of the 15 recordings in CART peptide, 6 recordings were lost during LTD induction. 
The amplitude of the parallel fibre EPSCs before the LTD protocol was not 
significantly different between control and in the presence of CART peptide (table 
4.10), suggesting the quality of the recordings was similar and the average number of 
parallel fibres activated was equivalent. In addition there was no significant 
difference between the amplitude of EPSCs in experiments in which the recording 
was lost during LTD induction and in those which survived the protocol (figure 
4.26A). Thus it is not possible to identify cells which will survive or not survive the 
LTD protocol at the beginning of the experiment. Parallel fibre EPSCs were recorded 
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Amplitude / pA 
Control, cells lost during LTD protocol (n=3) 334 ± 96 
Control, survive LTD protocol (n=9) 408 ± 38 
CART peptide, cells lost during LTD protocol (n=6) 591 ± 73 
CART peptide, survive LTD protocol (n=9) 525 ± 42 
All control experiments (n=12) 527 ± 66 
All CART peptide experiments (n=15) 478 ± 32 
All cells lost during LTD protocol (n=9) 384 ± 39 
All survive LTD protocol (n=18) 558 ± 41 
All experiments (n=21) 500 ± 34 
Table 4.10 - Summary of parallel fibre-EPSC amplitudes 
before LTD. 
Control (n = 9) CART peptide (n = 9) 
Rise time before LTD I ms 2.41 ±0.19 2.43 ± 0.22 
Rise time, 5 min after LTD I ms 2.53± 0.28 2.39 ±0.24 
Rise time, 20 min after LTD I ms 2.77 ± 0.36 2.58 ± 0.28 
Decay constant before LTD I ms 21.6 ± 1.3 21.8 ± 1.6 
Decay constant, 5 min after LTD I ms 22.0 ± 1.0 24.5 ±2.2 
Decay constant, 20 min after LTD I ms 22.7 ± 1.5 26.5 ± 2.4 
Holding current before LTD I pA 380 ±55 391 ± 31 
Holding current, 5 min after LTD I pA 305 ±52 322 ±29 
Holding current, 20 min after LTD I pA 331 ± 54 304 ±28 
Membrane resistance before L TO I MO 52.9 ±6.7 53.9 ±5.0 
Membrane resistance, 5 min I MO 61.9 ±9.3 63.6 ±5.2 
Membrane resistance, 20 min I MO 65.1 ±7.2 74.2±5.4 
Table 4.11 - Summary of parallel fibre L TO experiments 
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Figure 4.26 - CART peptide (100 nM) did not effect long term depression (LTD) at the parallel fibre-
Purkinje synapse. A - There was no significant difference between the amplitudes of parallel fibre-EPSCs 
before the LTD protocol .8 - A typical recording from a single Purkinje cell with induction of LTD, the 
insert shows superimposed averages of 30 EPSCs before and after the LTD protocol. C-D - As expected 
the LTD protocol significantly reduced EPSC amplitudes, but the application of CART peptide during the 
LTD protocol did not significantly change EPSC amplitude. Panel C shows absolute values and panel D 
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Figure 4.27 - CART peptide has no effect of parallel fibre LTD. CART peptide did not significantly alter the 
effect of LTD on EPSC 10-90 % rise time (panel A), EPSC decay constants (panel B), the holding current 
requ ired to keep the cell at -70 mV (panel C) or the Purkinje cell membrane resistance (panel D) . 
same time interval. Thus CART peptide appears to have no effect on parallel fibre 
LTD in the vestibular cerebellum. 
4.8 - Summary of electrophysiology data 
The immunohistochemical distribution suggest that CART peptide is present pre-
synaptically in climbing fibre-Purkinje cell synapses in the vestibular cerebellum, 
therefore it is possible that CART peptide has a role in synaptic transmission, either 
directly as a neurotransmitter or as a modulator. My experiments examining the 
effect of CART peptide on the firing pattern of Purkinje cells demonstrate that CART 
peptide modulates Purkinje cell output. This effect of CART peptide persists in the 
presence of synaptic blockers and CART peptide doe not modulate basal GABAergic 
or glutamatergic synaptic transmission, suggesting that CART peptide does not 
produce this change in firing rate by modulating the release/action of other 
neurotransmitters. In addition CART peptide did not alter the induction of parallel 
fibre LTD. How CART peptide modulates the firing pattern of Purkinje cells remains 
unclear but may involve an ionic conductance since the input resistance of Purkinje 
cells is reduced. These results are consistent with the hypothesis that CART peptide is 
a climbing fibre neurotransmitter in the vestibular cerebellum. 
However, my experiments were not exhaustive, it is possible that CART peptide may 
modulate the response of other neurotransmitters present in the cerebellum, for 
example serotonin, norepinephrine, dopamine or acetylcholine. It is also possible that 
CART peptide be involved in synaptic or non-synaptic plasticity other than long term 
depression (see discussion). 
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Chapter 5: Determination of Purkinje cell firing patterns 
5.1 - Introduction. 
Purkinje cells are the sole output of the cerebellar cortex and both in vivo and in vitro 
are constituently active (firing action potentials without stimulation). I have already 
shown that CART peptide increases the firing frequency of Purkinje cells, but I was 
interested in what determines the different firing patterns of Purkinje cells (chapter I). 
In particular how Purkinje cell synaptic inputs affect the firing frequency and pattern. 
I have also observed that CNQX (a commonly used AMPA receptor antagonist) 
increases the firing frequency of Purkinje cells (chapter 4), which was unexpected as 
blocking glutamate receptors would be expected to decrease the firing frequency. 
Therefore I investigated whether this was a direct effect on the Purkinje cell or 
whether if could be explained by an indirect mechanism (for example a reduction in 
the excitation of inhibitory interneurones). 
5.2 - Classification of Purkinje cell firing patterns. 
It is clear, from examining the cell attached data, that Purkinje cells can produce 
distinct firing patterns. Superficially, there appears to be 4 firing patterns. The first of 
these patterns is characterised by large and irregular intervals between spikes (figure 
5.IA); this type of firing was often observed in control and also following increases in 
synaptic inhibition (e.g. with zolpidem). The second pattern is characterised by a high 
frequency of firing, either continuously or in bursts (figure 5.1 B); this type of firing 
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Figure 5.1 - From all Purkinje cells 4 different firing patters were observed. A - Slow irregular 
firing. B - High frequency tonic firing, sometimes in bursts . C - Trimodal firing . 0 - Short bursts 
of very high frequency firing, similar to the 2nd phase of trimodal firing. 
was by far the most commonly observed in control conditions, and is the most similar 
to that reported ill vivo. and in vitro (see chapter 1). The third firing pattern is similar 
to the reported trimodal pattern (Womack and Khodakhah, 2(02) (figure 5.1C); this 
type of firing is characterised by 3 distinct phases, initial continuous firing, followed 
by short fast bursts of firing, in which the interval between progressive spikes inside 
the burst gets less and less and finally followed by a short period of quiescence. This 
firing pattern was not often observed in control. The final observed firing pattern was 
the same as the trimodal but without the initial continuous firing phase (figure 5.1 D); 
this firing pattern was never seen in control and probably represents the most excited 
(depolarised) state of the Purkinje cell. In addition there is one more theoretical firing 
pattern: quiescence (or silence). However because the cell attached method was used 
to record the firing patterns, it was not possible to differentiate between cells which 
were silent because they were below threshold or were damaged. Thus recordings 
from silent cells were discarded. 
After analysing the firing patterns in more detail and constructing plots of 
instantaneous firing frequency against time, I propose that the 4 patterns outlined 
above are not sufficient to fully describe all the different firing patterns observed. In 
particular, the second firing pattern (high frequency continuous or bursts of firing) 
appears to consist of 4 distinct patterns. Thus I propose that there are 7 different 
firing patterns (lettered A-E Figure 5.2 A-G): 
A - Infrequent spikes, with a seemingly random distribution, low median firing 
frequency (figure 5.2 A,H). 
81 - Continuous firing with a narrow range of firing frequencies (figure 5.2 B,I). 
82 - The same as B 1 but firing in bursts (figure 5.2 C). 
CI - Continuous firing but with a larger range of firing frequencies (figure 5.2 D,J). 
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C2 - The same as C I but firing in bursts (figure 5.2 E). 
D - The trimodal firing pattern (figure 5.2F). 
E - The high frequency bursts, in which the interval between successive spikes in 
each burst gets shorter during the burst (figure 5.2G). 
In the majority of recordings, the firing pattern could easily be classified into one of 
the firing patterns detailed above simply by visual inspection of plots of log frequency 
against time combined with a number of rules. Firstly, the firing patterns were 
separated into bursting and tonic types, if there were any breaks in the firing of more 
than a second then the cell was classified as bursting (types A, B2, C2, D and E). The 
non-bursting types (B 1 and C 1) were separated on the variance of the firing rate 
(assessed from the log plots), if the plot did not have a very narrow range of 
instantaneous firing frequencies then it was assigned as C 1, all the other continues 
firing types were assigned as B 1. The firing pattern A was grouped with the bursting 
patterns, but was easily differentiated from the other bursting patterns because there 
was always a smooth gradient of instantaneous firing frequency from the high to low 
frequency. Firing patterns B2 and C2 were separated using the same procedure as B 1 
and C 1, leaving just patterns D and E. The distinguishing feature of both these firing 
patterns is short fast bursts. If only these short fast bursts were present and no longer 
slower bursts were present then the firing pattern was assigned as E, otherwise it was 
assigned as D. 
Because I plotted the instantaneous firing frequency of the different firing patterns on 
a log scale it maybe that the continuous patterns (A, Bland C 1) are all the same only 
shifted to different firing frequencies. To investigate this, I plotted out typical A, B 1 
and C 1 firing patterns on identical linear scales (figure 5.2H-J). Visually they look 
different on both linear and log scales, suggesting that they probably are different 
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Figure 5.2 - Classification of the observed firing patterns (continued from previous page). When 
the instantaneous firing frequencies (log scale) are plotted against time 7 different distinct firing 
patterns were observed (termed A, 81, 82, C1 , C2, 0 and E). A - Pattern A, infrequent events, 
with a seemingly random distribution and low median firing frequency. B - Pattern 81 ,continuous 
firing with a narrow range of firing frequencies . C - Pattern 82, the same as 81 but firing in bursts. 
0 - Pattern C1 , continuous firing but with a larger range of firing frequencies. E - Pattern C2, the 
same as C1 but firing in bursts . F - Pattern 0, the trimodal firing pattern (figure S.2F).G - Pattern 
E, high frequency bursts, in which the interval between successive events in each burst gets 
shorter during the burst. H-J - Plots of firing frequency (linear) against time for the same 
recordings as panel A, 8 and 0 , patterns A, 81 and C1 . 
firing patterns. Having characterised the different firing patterns of Purkinje cells, I 
was interested in their frequency of occurrence, and how the application of different 
drugs affected which firing patterns were observed. 
5.3 - How does blocking synaptic inputs affect the firing pattern of Purkinje Cells? 
The control firing patterns were categorised by examining plots of instantaneous 
firing frequency for all the cells before the application of any drug (n = 90) (of these 
cells 85 were in lobe X and 5 in lobes I-VIII). The number of cell with firing patterns 
in each group where: A - 9, Bl - 31, B2 - 19, Cl - 4, C2 - 23, D - 4 and E - O. 
Figure S.3A shows the percentages of each firing group observed. There are a 
number of interesting features in the distribution of firing patterns. Firstly, the most 
common firing pattern observed was continuous firing with small variation in the 
firing frequency (Bl). This is the pattern most commonly reported in the literature. 
Secondly, there were very few cells (4) which fired the trimodal pattern (D), 
suggesting that it is not a common firing pattern for the Purkinje cell at rest. Finally, 
although many cells fired in bursts both with high and variation in the firing 
frequency (B2 and C2), very few cells (4) fired continuously with a large variation in 
the firing frequency. 
To investigate whether these firing patterns were produced by synaptic inputs, I 
examined the firing patterns from cells to which I applied bicuculline (10 J.1M), 
blocking inhibitory (GABAergic) synapses, and then added kynurenic acid (5 mM), 
blocking excitatory (glutamatergic) and GABAergic synapses, (n = 13, figure 5.3B). 
In control the number of cells in each group was: A-I, B 1 - 6, B2 - 2, C 1 - 1, C2 -
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Figure 5.3 - Pie charts summarising the occurrence of different firing patterns. A - Plot of all the firing 
patterns observed in control (n = 90). B - The effect on firing pattern of the sequential appl ication of 10 IJM 
bicucull ine and 5 mM kynurenic acid (n = 13). Blocking GABAergic transmission has a large effect on 
firing patterns, but blocking glutamateric transmission does not. C - The distribution of different firing rates 
in control which gave firing rate B1 , 0 and E after synaptic currents were blocked. 
2, 0 - I and E - O. After blocking synaptic inhibition there was a striking change in 
the distribution of firing patterns with all cells showing only 3 firing patterns: B 1 - 5, 
o - 3 and E - 5. The shift to the DIE type firing pattern suggests that these firing 
patterns occur when the Purkinje cell is in an excited state and thus are rarely seen in 
control. Following the block of both synaptic inhibition and excitation, there was little 
further change in the distribution of firing patterns: B 1 - 6, 0 - 3 and E - 4. This 
suggests that blocking GABAergic synaptic transmission has a strong affect on the 
firing pattern of Purkinje cells. The observation that kynurenic acid has little effect 
on the distribution of firing patterns is not unexpected as there is little synaptic 
excitation in parasagittal slices, since most of the glutamatergic fibres are cut. Thus 
the firing patterns B 1,0 and E represent the inherent firing pattern of the synaptically 
isolated Purkinje cell. 
I was interested in how blocking the synaptic inputs changes the firing from one 
pattern to another. I investigated whether the control firing pattern determines the 
firing pattern produced when synaptic inputs were blocked. Cells which ended up 
firing the B I pattern, continuous firing with little variance were initially firing in 
patterns A-I cell, B 1 - 3 cells, B2 - 1 cells and C 1 - 1 cell. Those which ended up 
firing pattern 0 (trimodal) were initially firing in patterns B 1 - 1 cell, B2 - 1 cell and 
0- 1 cell. Those which were finally in group E (high frequency bursts) were initially 
firing in patterns B2 - 2 cells and C2 - 2 cells (figure 5.3C). There are some general 
trends in this data; only pattern B 1 in control produced all 3 of the different firing 
patterns observed after the synaptic inputs were blocked, suggesting that the synaptic 
inputs are able to covert all the different firing patterns back to the most commonly 
observed pattern. Also it is worth noting that the only cell firing the trimodal pattern 
remained firing in this pattern, and was not converted to pattern E, and that all of the 
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cells firing in mode C2 were converted to E. This suggests that E is not necessarily a 
progression from D (which it appears to be by visual investigation), but in fact the 
firing pattern resulting from removing inhibition from those cells firing in mode C2 
(bursting with large variance). 
5.4 - CART peptide does not affect the firing patterns of Purkinje cells. 
In chapter 4, I demonstrated that CART peptide had a small but significant effect on 
the median instantaneous firing frequency of Purkinje cells in the vestibular 
cerebellum~ I was interested to see if this change in firing rate was accompanied by a 
change in the firing pattern. I collected together all the CART peptide experiments 
which gave significant increases in median firing frequency (room temperature and 
32°C, 100 nM and 1000 nM CART peptide experiments) and quantified the firing 
patterns before and during CART peptide applications (n = 31) (figure 5.4). In 
control the firing patterns were: A - 3 cells, B 1 - 10 cells, B2 - 5 cells, C 1 - 1 cell, 
C2 - 11 cell, D - 1 cell and E - 0 cells. After the application of CART peptide the 
firing pattern distribution was almost exactly the same (A - 3, B 1 - 10, B2 - 5, C 1 - 1, 
C2 - 11, D - 1 and E - 0). This is expected as the small change in firing rate produced 
by CART peptide is unlikely to change the firing pattern. 
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Figure 5.4 - CART peptide (100-1000 nM) did not change the overall 
distribution of firing patterns (n = 31). 
5.5 - The relationship between firing pattern and median firing frequency 
In control conditions, Purkinje cells fire in one of 6 different firing patterns (pattern E 
was never seen in control). I was interested in whether the median instantaneous 
firing frequency was different for each of these firing patterns and could therefore be 
used to distinguish between the patterns. Taking the 90 control firing cells (S5 of 
these cells were in lobe X and 5 outside of lobe X); I averaged together the median 
firing frequencies for cells with the same firing pattern. The median firing 
frequencies for the 6 different firing patterns were (figure 5.5A): A - 4.7 (3.3, 5.7) Hz 
(n = 9), Bl - 13.1 (9.4,17.1) Hz (n = 31), B2 - 9.6 (S.O, 16.5) Hz (n = 19), CI- 21.4 
(17.9,23.2) Hz (n = 4), C2 - 11.9 (6.4, 21.5) Hz (n = 23) and D - 27.S (23.S, 31.5) Hz 
(n = 4). 
I then performed a Krustal-WaIlis test on the firing rates (figure 5.5B). The median 
firing frequencies of cells in group A was significantly different from all the other 
groups. None of the median firing frequencies of cells in groups B 1, B2, C 1, C2 and 
D were significantly different from each other. I believe that group D must be 
considered different from the other patterns. Therefore I combined groups B 1, B2, C 1 
and C2, thus giving 3 different groups of firing patterns based on firing frequency 
(figure 5.5C). The median firing frequencies of cells in each group were: A -4.7 (3.3, 
4.7) Hz (n = 9), B/C -11.9 (S.2, 20.3) Hz (n = 77) and D - 27.S (23.S, 31.5) Hz (n = 
4). These groups were all significantly different from each other (A vs B/C -
p>o.OOO I, A vs D - p>o.O 1 and B/C vs D - p>0.05). 
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Figure 5.5 - The median instantaneous firing frequencies for Purkinje cells with different firing 
patterns (n = 90). A - Plot of average median instantaneous firing frequency for all the different 
firing patterns. B - Table summarising the results of t-tests between median firing frequencies of 
different firing patterns . ... - p<O.05, ... * - p<O.01 and .... * - p<0.001 .There was no significant 
differences between the firing frequencies in groups B1 , B2, C1 and C2, therefore they were 
combined into one group, B/C. C- Plot of average median instantaneous firing frequency for the 3 
different firing pattern groups, A, BIC and D. 
5.6 - Effect of synaptic blockers on instantaneous firing rate 
I mentioned in section 4.2.5 that the application of the glutamate receptor antagonist, 
CNQX unexpectedly increased the firing rate of Purkinje cells. To investigate this 
observation further, I have conducted experiments to examine how blocking synaptic 
transmission affects the firing rate of Purkinje cells and demonstrated that the 
observed increase in firing rate by CNQX was a direct effect on the Purkinje cell. 
And finally I looked at the effect of the benzodiazepine-like drug, zolpidem, on the 
firing rate of Purkinje cells. All experiments were carried out on cells in lobe X of the 
cerebellum. 
5.6.1 - Effects of bicuculline, CNQX and kynurenic acid on firing rate. 
When I first noticed that CNQX had the unexpected effect of increasing the firing rate 
of Purkinje cells, I suspected this was due to the block of glutamatergic transmission 
onto the inhibitory interneurons, reducing the level of inhibition experienced by the 
Purkinje cell. This hypothesis has some circumstantial evidence to support it; there 
are approximately 10 inhibitory intemeurones to every Purkinje cell and unlike 
granule cells, they only synapse onto Purkinje cells near to their cell bodies. This 
means a larger proportion of the inhibitory synapses will be present in the parasaggital 
slices compared to excitatory synapses. In addition there is evidence that it is the 
intemeurons that are responsible for setting the firing rate of Purkinje cells (Hausser 
and Clark, 1997) and decreases in the strength of the parallel fibre inputs results in an 
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increase in Purkinje cell firing rate as decreased inhibition has a greater effect than a 
reduction in direct excitation (Mittmann and Hausser, 2(07). 
My first experiment was to sequentially bath apply CNQX and bicuculline. The firing 
of 9 Purkinje cells, at 32°C, in lobe X, were recorded with a minimum of 5 minutes in 
control. then a solution containing 10 !J.M CNQX was bath applied for 10 minutes and 
then a solution containing both 10 !J.M CNQX and 10 !J.M bicuculline was bath 
applied for a further 10 minutes. The median instantaneous firing frequency in 
control was 13.6 (5.9, 24.4) Hz, in CNQX was 18.1 (11.4, 30.4) Hz and in both 
CNQX and bicuculline was 35.0 (28.4, 48.2) Hz (figure 5.6A). Expressed as a 
percentage of control median instantaneous firing frequency the firing rate in CNQX 
was 123.5 (117.1.137.6) % and in CNQX and bicuculline was 215.8 (189.4,430.1) % 
(figure 5.68). The firing rate in the presence of CNQX was significantly higher than 
in control (p<O.OI), the firing rate in CNQX and bicuculline was significantly greater 
than control (p<O.Ol) and significantly higher than in the presence of CNQX alone 
(p<O.OI). One might expect this result if CNQX is acting to reduce inhibition: a 
reduction in inhibition (via loss of interneurone excitation) would be expected to 
produce a smaller increase in Purkinje cell firing rate compared to a complete 
abolition of inhibition. 
If the increase in Purkinje cell firing rate only resulted from a decrease in the 
excitation of intemeurones. then blocking synaptic inhibition (with bicuculline) 
followed by blocking synaptic excitation (with bicuculline and CNQX) should 
initially give a large increase in the firing rate followed by either no change or a small 
decrease in firing rate. The firing of 6 Purkinje cells, at 32°C. in lobe X, were 
recorded with a minimum of 5 minutes in control, then 10 !J.M bicuculline was bath 
applied for 10 minutes and then 10 !J.M bicuculline and 10 !J.M CNQX were bath 
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Figure 5.6 - Blocking synaptic inputs to Purkinje cells increases their median instantaneous firing 
frequency. A-B - Application of 1 0 ~M CNQX significantly increased the firing frequency, addition 
of 1 0 ~M blcuculline further increased the firing frequency (n = 9). C-D - Application of 1 0 ~M 
bicuculline Significantly increased the firing frequency, addition of 1 0 ~M CNQX further increased 
the fi ring frequency (n = 6) . .... - p<O.01 , *** - p<O.001 . Panels A and C show absolute values and 
panels B and 0 show values normalised to control values . 
applied for a further 10 minutes. The median instantaneous firing frequency in 
control was 18.2 (10.2, 24.2) Hz, in bicuculline was 38.4 (28.8, 41.8) Hz and in 
bicuculline and CNQX was 45.3 (38.6, 51.4) Hz (figure 5.6C). Expressed as a 
percentage of control, the firing rate in bicuculline was 219.4 (176.9, 272.1) % and in 
bicuculline and CNQX was 301.0 (213.4, 319.0) % (figure 5.6D). The firing rate in 
the presence of both CNQX and bicuculline was significantly greater than in 
bicuculline (p>O.OI). The increase in firing rate produced by CNQX when synaptic 
inhibition was blocked suggests it maybe having a direct effect on Purkinje cells, as 
blocking the synaptic excitation to Purkinje cells would be expected to produce a 
reduction in the median firing frequency of Purkinje cells. CNQX has been reported 
to have a direct excitatory effect on other GABAergic neurons (McBain et aI., 1992) 
(Brickley et aI., 2001) (Maccaferri and Dingledine, 2002) (Hashimoto et aI., 2004). 
To investigate this I used another glutamatergic receptor antagonist kynurenic acid 
and compared its effects on the firing of Purkinje cells to that of CNQX. The firing of 
9 Purkinje cells, at 32°C, in lobe X, were recorded with a minimum of 5 minutes in 
control, then a solution containing 10 lAM bicuculline was bath applied for 10 minutes 
and then a solution containing both 10 lAM bicuculline and 5 mM kynurenic acid was 
bath applied for a further 10 minutes. The median instantaneous firing frequency in 
control was 17.9 (14.0, 26.7) Hz, in bicuculline was 23.3 (21.3, 32.3) Hz and in both 
bicuculline and kynurenic acid was 26.8 (20.1, 36.1) Hz (figure 5.7 A). Expressed as a 
percentage of control median instantaneous firing frequency the firing rate in 
bicuculline was 151.1 (129.2, 209.7) % and in bicuculline and kynurenic acid was 
154.2 (121.0, 207.7) % (figure 5.7B). As expected the firing rate in the presence of 
bicuculline was significantly higher than in control (p<O.OOI) and the firing rate in 
both bicuculline and kynurenic acid was significantly higher than control (p<O.OI). 
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increased the firing frequency by 113 % (n = 6) . * - p<O.05. Panels A and C show absolute values 
and panels Band 0 show values normalised to control values. 
However the firing rate in both bicuculline and kynurenic acid was not significantly 
different from that just in bicuculline. Thus kynurenic acid is acting as expected for a 
glutamate receptor antagonist, once the GABAergic transmission onto the Purkinje 
cells has been blocked, blocking the excitatory input onto these cells has little affect 
on the Purkinje cell firing. 
As a further experiment, I investigated whether the effects of CNQX persisted when 
glutamate receptors where pre-blocked by kynurenic acid. To 6 cells, which both 
bicuculline and kynurenic acid had been applied, 10 !Jm CNQX was added and the 
firing recorded. The firing rate in the presence of bicuculline and kynurenic acid was 
28.6 (19.1, 55.1) Hz and after the addition of CNQX the firing rate was significantly 
(P<0.05) increased to 27.8 (23.7, 60.7) Hz (figure 5.7C) (113.0 (101.5, 119.0) % of 
that in bicucullinelkynurenic acid; figure 5.7D). This result strongly suggests that 
CNQX is having a direct effect on the firing rate of Purkinje cells which is not via 
glutamate receptors. 
5.6.2 - Effect of zolpidem of Purkinje cell firing. 
The GABAA receptor has a binding site which increases the receptors affinity of 
GABA, the so called benzodiazepine (BDZ) binding site (Barker and Barasi, 2003). 
It has been demonstrated that zolpidem both increases the amplitude and decay time 
of inhibitory post synaptic currents recorded in Purkinje cells (Wall, 2005). I was 
interested in how this modulation of synaptic inhibition onto Purkinje cells would 
affect the firing pattern. 
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To investigate this I recorded the firing of 7 Purkinje cells, in lobe X, at 32°C. After a 
minimum of 5 minutes control, 500 nM zolpidem was applied for 5 minutes then 
following a 10 minute wash, 10 IlM bicuculline was applied. The median 
instantaneous firing frequencies were: in control 9.9 (7.8, 12.3) Hz, in zolpidem 4.5 
(3.3, 5.9) Hz, following wash 6.4 (5.0, 10.7) Hz and in bicuculline 21.3 (16.3, 29.9) 
(figure 5.8A). Expressed as percentages of control the firing rates were: in zolpidem 
36.3 (31.9, 58.1) %, following wash 69.5 (54.5, 89.7) % and in bicuculline 203.2 
(157.8,230.3) % (figure 5.8B). The firing rate was significantly lower in the presence 
of zoplidem (p>0.05) and significantly higher in the presence of bicuculline (p>0.05), 
compared to control. There was no significant difference between the firing rate in 
control and following wash. 
It is clear that zolpidem has a significant effect on the firing properties of Purkinje 
cells, but what is more interesting is the relationship between the firing rate in the 
presence of bicuculline and in the presence of zolpidem (figure 5.8C). You might 
expect that if the GABAergic inhibition was setting the firing rate of Purkinje cells, 
then variations in inhibitory transmission would underlie variations in the Purkinje 
cell firing pattern. Thus in the presence of bicuculline the firing rates would all be 
similar, however this is not what I observed. The amount of variation was higher in 
the presences of bicuculline (inter quartile range of 13.7 Hz, 64.3 % of the median) 
than in control (inter quartile range of 4.4 Hz, 44.3 % of the median), suggesting that 
rather than GABAergic inhibition setting the frequency of the Purkinje cell, it is in 
fact modulating the intrinsic firing frequency to give a narrower range of frequencies. 
The effect on variance of zolpidem was to decrease the inter quartile range (from 4.4 
to 2.6 Hz), but because the median frequency also decreased there was an overall 
increase in the variance (44.3 % to 58.1 %). This increase in variance seems to add 
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weight to the hypothesis that the intemeurones are acting to reduce the variability of 
Purkinje cell firing. 
5.7 - Whole cell current clamp investigation into the effect of CNQX. 
The glutamate receptor antagonist CNQX is used by many investigators to block 
excitatory events~ however I have demonstrated that CNQX has a direct effect on the 
firing properties of Purkinje cells not via glutamatergic synapses. To investigate the 
mechanism of CNQX action, I made whole cell recordings from Purkinje cells in the 
presence of the glutamate receptor antagonist, kynurenic acid, the GABAA receptor 
antagonist. bicuculline and the sodium channel blocker, TTX, then applied CNQX 
and examined the changes in membrane properties. 
The current voltage relationships of 10 Purkinje cells in lobe X, at 32°C, were 
recorded in the presence of 10 11M bicuculline, 5 mM kynurenic acid and 1 11M TTX. 
The cells were allowed to rest for 5 minutes before the first set of current pulses were 
applied, then after the application of 10 11M CNQX, another set of current steps was 
applied. CNQX significantly (P<O.05) depolarised the membrane potential (from -
68.4 ± 1.8 to -66.9 ± 1.9 mY, figure 5.9A) but had little affect on the membrane 
resistance (63.2 ± 4.4 Vs 66.9 ± 1.9 Mil; figure 5.9B). By plotting out the average 
membrane potential against injected current for both the control and the CNQX data a 
visual representation of the current voltage relationship can be obtained (figure 5.8C). 
The point where these two lines cross gives an estimate of the reversal potential for 
the ionic current which is affected by CNQX. Extrapolating the lines back gives an 
approximate reversal potential of - -135 m V, the closest calculated reversal potential 
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Figure 5.9 - CNQX (10 ~M) has a direct effect on the membrane properties of Purkinje cells (n = 
10. All record ings where made in the presence of 1 ~M TTX, 1 0 ~M bicuculline and 5 mM 
kynurenuc acid. A - Application of CNQX does not significantly alter the membrane resistance. B -
Applicat ion of CNQX significantly increases the resting membrane potential. C - Plotting out the 
average current voltage relationships before and CNQX application. * - p<0.05. 
to this is that for K+ ions (-100 mY), so the CNQX effect may be mediated by closing 
or blocking a potassium channel. The differences between the reversal potentials may 
reflect inaccuracy due to the insignificant change in membrane resistance. 
5.8 - Whole cell current clamp investigation into effect of blocking synaptic 
inhibition 
Both CART peptide and CNQX produced changes in the firing properties of Purkinje 
cells but produced little affect on the membrane properties of Purkinje cells recorded 
in whole cell. Therefore as a positive control, I investigated the actions of the GABAA 
receptor antagonist bicuculline on the membrane properties of Purkinje cells. 
Bicuculline has marked affects on firing frequency and thus it would be predicted to 
produce measurable changes in membrane properties. To make a direct comparison to 
the results obtained for CART peptide then identical protocol was used as in section 
4.6.3. From the cell attached experiments (section 5.4.1) I would predict that 
bicuculline would depolarise the Purkinje cell membrane, but in the protocol used the 
membrane potential is held at -75 mY. Simplistically, if the bicuculline was to 
depolarise the Purkinje cell membrane then you might expect that a larger holding 
current would be required to keep the cell at -75 mY, however if the depolarisation is 
limited to the dendrites then the amount of current required to hold the soma down at 
-75 m V may not change significantly. A similar case maybe be true of the membrane 
resistance, blocking the GABAA receptor may increase the membrane resistance if 
enough channels on the soma are open under control conditions, but if only a few 
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channels are open on the soma, or the channels that are open are in the distal dendrites 
then there may not be a significant change in the measured membrane resistance. 
It is equally hard to predict what effect bicuculline will have on the excitability and 
firing threshold of the Purkinje cell. 
The current voltage relationships of 9 Purkinje cells in lobe X at 32°C were recorded 
using a protocol identical to that used in section 4.6.3 with the application of 10 IJ.M 
bicuculline and the results were compared to the control data acquired in section 4.6.3 
(n = 24). The resting membrane potential was -76.1 ± 0.3 mV in bicuculline 
compared to -75.8 ± 0.2 mV in control (figure 5. lOB), the holding current was -247.5 
± 33.5 pA in bicuculline compared to -333.8 ± 33.2 pA in control (figure 5.lOC) and 
the membrane resistance was 35.8 ± 1.2 M!l in bicuculline compared to 38.8 ± 1.8 
M!l in control (figure 5.90); none of these values were significantly different. 
There was a clear difference in the firing rate of the Purkinje cells in bicuculline 
compared to control (figure 5.11A). The excitability in bicuculline was 3.9 ± 0.6 
Hz/mY compared to 2.8 ± 0.3 Hz/mY in control (figure 5.llB) and the firing 
threshold in bicuculline was -76.5 ± 1.9 mV as compared to -70.3 ± 1.6 mV in control 
(figure 5.11 C). It is possible to extrapolate back the plots of firing rate against 
injected current, and the point at which they cross should be the reversal potential of 
the ion producing the bicuculline effect. The reversal potential estimated from the 
plots of firing against injected current was - 90 mY, which given the large variation 
in firing rate is in good agreement to the calculated cr reversal potential. 
It appears from these results that bicuculline is having it affect on firing by changing 
the properties of the dendrites, the decrease in inhibition is causing an increase, 
presumably, in the calcium type action potentials and/or an increase depolarisation, 
this translates into an increase in firing at the soma, without significant changes in the 
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membrane resistance. It is likely that this increase in firing at the soma will also be 
accompanied by a depolarisation, however because this depolarisation is being cause 
directly by the effect on bicuculline on ion channel present in the cell membrane of 
the soma, in my experiment on significant change in the holding current was observed 
(change in holding current would imply change in resting membrane potential if the 
cells had not been held at a constant membrane potential). Finally it is worth nothing 
that the number of cells which bicuculline was applied to was much fewer than the 
number in control, if could be possible that the excitability and/or membrane 
resistance would become significantly different if a larger sample of cells had been 
used. 
5.9 - Summary 
In this chapter I have tried to address a number of different questions. My method of 
recording firing of Purkinje cells gives agreement with the types of firing most 
commonly observed. In control conditions the majority of cells (86 %) fired tonically 
either continuously or with interspersed periods of quiescence. In the presence of 
synaptic blockers the majority of cells fired continuously without quiescence (46 %), 
but also showed trimodal behaviour (23 %) and sometimes fired high frequency bursts 
(type E, 31 %). These results are a little different from other investigators who report 
either all cells firing in the tonic or the trimodal firing modes. It is possible that other 
investigators do not report the type E pattern as they only distinguish patterns by 
measuring events per second. Using this measure, pattern E and patterns B/C cannot 
be distinguished. I have also shown that CART peptide does not change the type of 
firing pattern only the median firing frequency. 
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The observation that CNQX has a direct affect on, not only the firing, but the resting 
membrane potential is not a new observation for CNQX, but it is the first time it has 
been reported for Purkinje cells. Given that CNQX is commonly used to block 
AMP Alkainate receptors in the cerebellum, the additional direct effect of CNQX on 
Purkinje cells may complicate the interpretation of results. This is especially true in 
experiments where the firing rate is being measured, and under these conditions 
CNQX may not be an appropriate antagonist to use. It is still unclear how CNQX is 
having its effect, although my results are consistent with the closure of a potassium 
channel, thereby depolarising the cell and increasing the firing rate. The only way to 
confirm how the CNQX is affecting the firing of Purkinje cells is to block possible 
targets until the effect of CNQX is abolished. 
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Chapter 6 - Discussion 
6.1 - Implications of location of CART peptide in cerebellum. 
I have shown that CART peptide is expressed in a subset of climbing fibres 
innervating Purkinje cells in the vestibular cerebellum (lobes IX and X of the vermis 
and the paraflocculus). This observation leads to some obvious questions: What is the 
function of CART peptide in the vestibular cerebellum? And why is it only expressed 
in a subset of fibres? It is possible that CART peptide is associated with all areas of 
the vestibular system; in the same way that CART peptide is found at all levels of the 
HPA axis (Dun et al., 2006). However, to my knowledge, no-one has specifically 
examined the vestibular nuclei (in the brainstem) or the organs of the ear, for the 
presence of CART mRNA or CART peptide expression. If CART peptide is 
associated with all regions of the vestibular system, then why is the distribution not 
uniform across the vestibular cerebellum? Thus it seems unlikely that CART peptide 
is generally associated with the vestibular system, but instead serves a specific role in 
the vestibular cerebellum. 
The banding of gene activity and peptide expression in zones across the cerebellum 
has been shown for many different genes and peptides (Oberdick et aI., 1998), some 
of these have been implicated in cerebellar development for example: wingless-type 
MMTV integration site family genes (wnt) and engrailed (en) ((Millen et aI., 1995). It 
may be that CART peptide is also involved in development, for example CART 
peptide may have a role in guiding climbing fibres to specific targets (Purkinje cells) 
and its presence in the adult cerebellum may serve to consolidate these connections. 
If this was the case then the direct electrophysiological effects I observed, may 
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represent only a minor action of CART peptide, the primary effect being 
synaptogenesis. 
It is possible that the major role of CART peptide in the vestibular cerebellum is 
electrophysiological. If this was the case, why is there a banded distribution of CART 
peptide expression across the nodulus? It may be that the climbing fibres not 
expressing CART peptide express another, as of yet, unidentified neuropeptide, which 
serves a similar role to CART peptide. It is also possible that CART peptide plays a 
signalling role in climbing fibres that are part of specific pathways within the 
vestibular cerebellum. 
There is another neuropeptide that is expressed in climbing fibres; corticotrophin 
releasing factor (CRF) (van den Dungen et aI., 1988). CRF is expressed in the 
vestibular cerebellum and also has a banded distribution (Cummings, 1989). Thus it is 
possible that CRF and CART have similar roles in the vestibular cerebellum. 
However, CRF is also found in climbing fibres allover the cerebellum as well as in 
mossy fibres (Primus et al., 1997; Chen et al., 2000). I have been interested in 
whether CART and CRF are co-localised in the same climbing fibres or whether they 
represent different and distinct groups of climbing fibres. However the CRF 
antibodies were not very effective and did not label cerebellar slices. 
The CART peptide knockout mouse does not show a phenotype typical of cerebella 
dysfunction and thus CART peptide signalling may play only a minor role in 
cerebellar function (Moffett et al., 2006). However there are no reports of locomotor 
tests such as the rotarod being carried out with the knockout mice and thus subtle 
defects in motor control may have been missed. It would be interesting to make 
electrophysiological recordings from the Purkinje cells in the vestibular cerebellum of 
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the CART knockout mice to see if there were any significant differences in their 
properties. 
Future work 
There are a number of experiments which could be carried out to further investigate 
the expression of CART peptide. For example single vestibular Purkinje cells could 
be filled (using a patch pipette) with either a fluorescent dye or with biocytin, and 
then examined for CART peptide and VGluT2 expression. This would provide 
elegant confinnation of my observation, that all the connections from a single 
climbing fibre contain CART peptide. It would also be interesting to fill the Purkinje 
cells from which the whole-cell recordings were made and then identify whether or 
not the cells were all innervated by CART peptide containing climbing fibres. My 
experiments suggest that not all Purkinje cells are innervated within the vestibular 
cerebellum and yet all respond to CART peptide. It maybe that some of the cells I 
included into my results did not respond to CART peptide, but it is not possible to 
separate responding cell and none responding cells. If I had been able to remove the 
cell which did not respond to CART peptide my observed effects may have been 
larger. I did add biocytin to my internal pipette solution, and then fixed and labelled 
the slices, but the biocytin filled Purkinje cells were not visible, presumably because 
the cells had died when the patch pipette was removed. Although filling Purkinje 
cells is usually a straight forward procedure, the long recording time (> 30 minutes) 
may have contributed to the loss of filled cells. 
It would also be interesting to investigate how CART peptide containing fibres are 
localised with other structures in the cerebellum, for example with interneurones 
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(using antibody against GAD). Climbing fibres make contacts onto basket cells, so it 
may be that CART peptide is associated with these synapses. It is possible that 
CART peptide may modulates cholinergic or catecholaminergic synaptic transmission, 
in my experiments looking at firing rate I did not block either of these inputs. To 
investigate this one could look for association between acetylcholine containing fibres 
(using antibody against ChAT) or noreadrenaline/dopamine containing fibres (using 
antibody against tyrosine hydroxylase) and CART peptide containing climbing fibres. 
Further work, which would have been difficult for me to perform, but would be of 
considerable interest, is to examine CART peptide localisation using electron 
microscopy (gold particle immunolabelling). In particular, to confirm that CART 
peptide is present in LDCVs in climbing fibre terminals together with SSVs 
containing glutamate. 
6.2 - A possible signalling role of CART peptide? 
My experiments have shown that CART peptide has a small but significant effect on 
the firing rate of Purkinje cells in the vestibular cerebellum, probably by increasing a 
membrane conductance. CART peptide does not appear to modulate either the 
excitatory (glutamatergic) or inhibitory (GABAergic) inputs to Purkinje cells or 
modulate the induction of LTD. If CART peptide is released from climbing fibres it 
could modulate the output of the cerebellum (DCN cell firing) in two ways: Firstly, 
the increase in Purkinje cell simple spike firing leads to the increased inhibition of 
DCN neurones (as Purkinje cells release GABA). This would be interesting, as the 
general effect of climbing fibre discharge is to reduce the Purkinje cell-mediated 
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inhibition of neurones in the DCN because the AHP following a complex spike 
prevents simple spiking (McKay et aI., 2(07). If CART peptide release is produced 
by the high frequency stimulation of climbing fibres (as some other neuropeptides are 
(Stjarne, 1989» then CART peptide could maintain simple spike firing which would 
counter the disinhibition of DCN neurones. 
Sercondly, the extended AHP of the complex spikes is caused by the large 
depolarisation of the Purkinje cell dendrite; if CART peptide increased this 
depolarisation then it could increase the length of the complex spike AHP and 
therefore decrease the inhibition of DCN neurones. Functionally this could be 
important because both simple spikes and complex spikes are indistinguishable by the 
time they reach the Purkinje cell synapses in the DCN (Khaliq and Raman, 2(05). If 
CART peptide is released under high frequency stimulation then it might act to 
further reduce the firing of simple spikes, compensating for the increase in complex 
spike frequency. Of course these hypothesises both rely on the assumption that 
CART peptide is released during high frequency activation of climbing fibres, and 
although this may be a reasonable assumption there is no direct evidence for it from 
the data. Work in our lab has been done to try and detect CART peptide release 
(using western blots from slice supernatant), but following trains of stimuli to 
vestibular climbing fibres no CART peptide could be detected (Wall, personal 
communication. 
If CART peptide modulates cerebellar output what effect could this have on 
behaviour? How the Purkinje cells regulate balance is not fully understood, but I 
hypothesise that to correct posture, in order to maintain balance, would require the 
neurones of the DCN to fire action potentials to inform the motor centres to contract 
or relax particular muscles, and to inform higher brain areas of the expected change in 
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body position (Bear et al., 2(07). To induce activity in the neurones of the DCN 
would require a reduction in the activity of Purkinje cells innervating them. Because 
CART peptide could either increase or decrease the simple spike firing rate of 
Purkinje cells, it is unclear that effect it has on balance. It would seem likely that its 
role is to somehow to compensate the output of the vestibular system in such a way to 
improve balance. 
Future work 
In my experiments, I examined the most obvious targets for CART peptide, but of 
course there are many things I did not investigate; these include the effect of CART 
peptide on LTP at the parallel fibre-Purkinje cell synapse (Hartell, 2002), the effect on 
DSUDSE (Llano et al., 1991a; Kreitzer and Regehr, 2(01), effects of CART peptide 
on intracellular signalling molecules, for example; calcium (Bird and Putney Jr., 
2006), ERKlMAPK (Lakatos et al., 2005) or cAMP (Jones and Kuhar, 2(05). 
6.3 - Mechanism of CART peptides action. 
The increase in firing rate observed after the application of CART peptide seems to be 
explained by the opening of a conductance, which depolarises the Purkinje cell. 
CART peptide has been shown to modulate ion channels, for example it inhibits L-
type calcium channels in hippocampal neurones (Yermolaieva et al., 200 1). However 
because Purkinje cells possess many different conductances active around the resting 
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membrane potential, it is not possible to say for definite which type of ion channel is 
modulated by CART peptide. 
The work done by Wall and Spanswick (2004) suggests that CART peptide can 
directly depolarise or hyperpolarise sympathetic preganglionic neurones without 
affecting their membrane resistance. I propose that this effect is not a direct effect, 
but rather that CART peptide is modulating inhibitory interneruones and this is 
explained by the fact the effect of CART which they observe is blocked by the 
GABAA receptor antagonist bicuculline. 
Future work 
To further investigate which channels CART peptide modulates, I would like to 
repeat the whole-cell voltage clamp experiments looking at the current voltage 
relationships with the membrane potential fixed at -75 mY. In particular, I would 
investigate whether the effect of CART peptide persists in the presence of TTX, 
bicuculline and kynurenic acid (to block synaptic transmission). Although using this 
method, I would be unable to measure the reversal potential (because the two current 
voltage relationship plots would cross at -75 m V), there would be no run up during 
the recording. I would also repeat the experiment in the presence of cadmium to block 
calcium channels; this would tell us whether CART peptide modulates calcium 
channels (Lansman et al., 1986). Furthermore, it would be interesting to see if the 
effect of CART peptide was blocked by the Guo inhibitor pertussis toxin, since CART 
peptide has been shown to signal via Gi/o activation (Lakatos et al., 2005). The effects 
of CART peptide on Purkinje cells are small and thus finding the mechanism of action 
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is difficult. Therefore a better approach may be to identify the element on Purkinje 
cells that CART peptide binds to. 
Identifying the CART peptide receptor 
So far only one protein has been show to have a high affinity interaction with CART 
peptide, the SDHB mitochondrial protein (Mao et al., 2(07), and further studies with 
this protein may identify the CART peptide binding domain and help identify 
possible binding motifs in GPCRs or other membrane bound proteins which may 
interact with CART peptide. 
To investigate whether CART peptide binds to an extracellular receptor, a number of 
approaches could be taken. It may be possible to tag CART peptide (iodination or 
fluorescence), and then apply the fluorescent CART peptide construct to the 
cerebellum. Stimulation of neuropeptide receptors causes their internalisation, and 
thus if CART peptide binds to specific receptors, then the CART peptide will be taken 
up into cells together with the receptors and the cells will fluoresce. A similar 
mechanism has been described for substance P (Larsen et al., 1989). Because we 
know that CART peptide is only expressed in climbing fibres innervating Purkinje 
cells in the vestibular cerebellum, the other areas of the cerebellum could be used as a 
perfect negative control. 
If CART peptide is not be internalised then another approach would be to use a ligand 
binding assay, competing radiolabelled CART with increasing concentrations of 
unlabelled CART peptide. Such an experiment would demonstrate that CART peptide 
specifically binds to a receptor-like element in the vestibular cerebellum and give 
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values for parameters such as Bmax and I«J and this has been shows for CART peptide 
in dissociated hypothalamic neurons (Vicentic et al., 2(05). 
Whether CART peptide is internalised or not if might be useful to use the membrane-
extract from the vestibular cerebellum and look for binding using 
immunoprecipitation (Playfair and Chain, 2(05) with CART peptide and CART 
antibody (either in solution or fixed to a column), followed by some form of protein 
sequencing (Steen and Mann, 2004). This might succeed in identifying a receptor 
where other techniques have failed because of the smaller area of the brain reducing 
non-specific interactions. It could be that CART peptide binds to a membrane protein 
which could internalise the peptide and undergo a conformational change in which it 
no longer binds it. If this was the case then it might not be possible to find the protein 
by any binding studies, however if it was shown that CART peptide has such an 
interaction then a modified CART peptide in which internalisation was prohibited 
could be designed and the protein to which is binds could be identified. 
It is possible that CART peptide does not have its effect by binding to a membrane 
protein, but rather by passing across the cell membrane and acting directly on an 
intracellular protein. Although this would represent a novel mechanism, there is some 
circumstantial evidence that this could occur: CART peptide passes freely across the 
blood-brain barrier and its rate of transfer is not self limiting suggesting it passes 
across by diffusion and not via an active transporter (Kastin and Akerstrom, 1999). 
CART peptide is predicted to have both positively and negatively charged areas on its 
surface, but this is was with only the core of the peptide and the free floating N-
terminus could fold in such a way promote diffusion across a membrane (Ludvigsen 
et al., 2(01). 
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The only identified protein to interact with CART is an intracellular protein associated 
with ATP generation in the mitochondrial (Mao et al., 2(07); there are ion channels 
(examples ATP sensitive potassium channel; KATP) that respond to intracellular ATP 
and this could produce the observed increase in firing rate and decrease in membrane 
potential. KATP channels are found in Purkinje cells (Zhou et al., 1999b) and 
increalies in A TP levels result in reduction of conductance of these channels, this has 
the effect of depolarising the cell. This does not fit with the observed decrease in 
membrane resistance after CART peptide application. Finally because the intracellular 
concentration of CART peptide required to effect SDHB was a hundred times lower 
than was used in my experiments only a small fraction of the CART peptide present 
would need to pass across the cell membrane to have its effects. 
6.4 - General properties of Purkinje cells in the vestibular cerebellum 
I observed that the Purkinje cells in lobe X (part of the vestibular cerebellum) had a 
median firing frequency of - 14 Hz and exhibited a number of different firing patterns. 
The firing frequency I observed is at the low end of the range that has been reported 
in literature (1-150 Hz) (Llinas and Sugimori, 1980a; Hausser and Clark, 1997; 
Womack and Khodakhah, 2002; Smith and Otis, 2003; Cerminara and Rawson, 2004; 
Loewenstein et al., 2005) and the different patterns I observed have also been reported 
for slice preparation, although none report observing the 7 patterns I outline in chapter 
5. 
It maybe that the firing rate/patterns in the vestibular cerebellum are slightly different 
from the rest of the cerebellum, and there is an indication of this from some 
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preliminary data. The median firing frequency outside lobe X was - 26 Hz which is 
significantly higher than in lobe X (14 Hz). This raises a number of interesting 
questions: Are the intrinsic properties of the Purkinje cells different in lobe X? Is 
there more synaptic inhibition in lobe X? What is the functional significance of the 
lower firing frequency? The first question could be addressed by recording the firing 
rates inside and outside of the lobe X in the presence of bicuculline to block 
GABAergic synapses. 
The differences I observed between lobe X and the rest of the cerebellum maybe 
representative of the vestibular cerebellum in general, or may be particular to lobe X. 
It is difficult to make recordings from the other major part of the vestibular 
cerebellum, the paraflocculus, because its position makes it hard to remove without 
damaging and when removed the it is almost impossible to cut it in such as way as to 
not cut through the Purkinje cell dendrites. 
My system of identifying firing patterns of Purkinje cells and grouping them into 7 
different types (A, B 1, B2, C 1, C2, D and E) I think is the most comprehensive study 
of Purkinje cell firing patterns. Other investigators have used changes in firing 
patterns to show changes in Purkinje cell properties; a good example of this the ducky 
mutant (Barclay et al., 2001; Donato et al., 2006). Donato et al showed that a single 
or double copy of the mutant gene (an a282 calcium channel subunit; is a model for 
absence epilepsy with spike-wave seizures and cerebellar ataxia) result in a decrease 
in the proportion of cells which show tonic firing, with no change in the proportion 
firing in bursts and an increase in the proportion of silent cells. They used 3 different 
classifications, including silent cells, but they do not look at the relative firing rates in 
the different firing patterns. I did occasionally have a silent Purkinje cell, and have 
tried to simulate them into firing by applying high potassium, but was never able to 
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stimulate them into firing. I believe that my classification system for firing rate is 
useful and that it is another tool to investigate how drugs or stimuli affect the firing of 
Purkinje cells. It is clear that different drugs can change the firing patterns as well as 
the firing rates. I believe that a single Purkinje cell cannot fire in all of the different 
firing patterns, meaning that the firing pattern do no just represent different degrees of 
depolarisation. However I did not do enough experiments to show how patterns are 
related to each other by increases or decreases in resting membrane potential. One 
way to investigate this would be to look at how the firing rate and firing pattern 
change using different concentration of extracellular potassium, some less than 
normal aSCF (hyperpolarising the membrane potential) and some higher (depolarising 
the membrane potential). This might be complicated by changes in synaptic input as 
well as direct changes to the Purkinje cell, but the experiment could be done in the 
presence and absence of synaptic blockers. 
6.5 - Synaptic integration in the cerebellum. 
The effect of blocking GABAergic transmission on the firing properties of the 
Purkinje cells is very pronounced, much more than blocking the glutamatergic inputs. 
This is not unexpected as the majority of the parallel fibres and all of the climbing 
fibres are cut in the parassagital slices. I believe that the large effect of the 
GABAergic interneurones on firing rate is more than just an artefact of the slice 
preparation, but suggest that it is the interneurones which relay the information from 
the granules cells to the Purkinje cells. In my experiments, I showed that decreasing 
the level of inhibition, using bicuculline, resulted in a large increase in the variance of 
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the firing rate of Purkinje cells, this is evidence that it is the activity of 
internereurones that sets the Purkinje cell firing rate within a narrow range. 
Increasing the level of inhibition, with zolpidem, did not result in a large change in 
the variance of firing rate, but significantly reduced the Purkinje cell firing rate. 
There are many more basket cells and stellate cells in the cerebellum than Purkinje 
cells, and they receive similar levels of synaptic inputs from the passing parallel fibres. 
If the interneurones respond to a similar degree to stimulation as the Purkinje cells do 
then activation of granules cells might be expected to create a net inhibition of 
Purkinje cells, this is not what is observed in vivo (Dunbar et al., 2004). However in 
order to see the typical beams of activation of parallel fibres a large stimulus has to be 
used and this may overcome the inhibition by interneurones. Also the in vivo 
experiments use calcium imaging (Dunbar et al., 2004) to visualise the activated 
Purkinje cells, however the calcium dyes only show changes in activity and this does 
not necessary have to come from parallel fibre-Purkinje cell activation, but could 
come from parallel fibre-interneurone activity. 
This is of course just speculation, but the information coming into the cerebella cortex 
via the mossy fibres comes from very disparate nuclei in the eNS and is likely to 
result in a broad mild stimulation of parallel fibres rather than a focal stimulation. If 
Purkinje cells are both inhibited and excited by parallel fibres then when a single 
parallel fibre or group of parallel fibres are activated then they may not be a 
significantly net change in the level of Purkinje cell output along the axes of these 
parallel fibres. However the interneurones spread there axons and dendrites across 
several row and columns of Purkinje cells, so activation of multiple different parallel 
fibres could serves as way of addressing specific Purkinje cells by summing indirect 
inhibition from different parallel fibres. In addition if the normal function of the . 
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Purkinje cell is to inhibit the neurones of the DCN then if mossy fibres provide an 
inhibitory rather than excitatory drive to Purkinje cells, this would result in a 
reduction of inhibition of neurones of the DCN, this is more in keeping with the idea 
that the cerebellum adjusts the motor movements to give a smooth and correct 
execution. 
This is a difficult problem to address experimentally, but I believe that is can be 
investigated with some of the techniques I have used to investigate firing frequency. 
A key experiment which I did not have time to do was to look at the effect on firing 
by first blocking glutamate receptors with kynurenic acid, then block GABA receptors 
with bicuculline. This would give a measure of the relative importance of excitation 
of intemeurones relative to the very low levels of direct excitation of Purkinje cells. I 
suspect that on its own kynurenic acid would have a small effect on the firing rate of 
Purkinje cells, much lower that effect of blocking inhibition, suggesting that the levels 
of parallel fibre activity are low and that the interneurone connection is a stronger 
connection. This could be further investigated by recording cell attached Purkinje cell 
activity with stimulation of granules cells to increase the baseline activity of parallel 
fibres, and then repeating the same drug application to see if during granule cell 
activation the relative importance of the direct excitation and indirect inhibition is the 
same. It would also be interesting to see record from Purkinje cells in vivo with the 
drug applications. 
In investigating the effect of bicuculline as a positive control for my whole cell 
current clamp experiment investigating the current voltage relationship of Purkinje 
cells holding the membrane down at -75 mY, I believe I have found a new way of 
identifying the current carrying a change in neuronal behaviour using the firing rate 
against injected current. To my knowledge no-one else has used this method to look 
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for the reversal potential of the current causing a change in the firing properties, and 
certainly not in Purkinje cells where current clamp current voltage relationships are 
often difficult to interpret because of the multiple different channels open at the 
typical resting membrane potential of a Purkinje cell. If I had had time I would have 
liked to see if this technique could be used to identify the ions channels being affected 
by other drugs with known targets, such as zolpidem (chloride), ro-conotoxin (N-type 
calcium channels), ZD 7288 (lh current block) and oubain (a sodium/potassium pump 
inhibitor). 
6.5 - Importance of observations on CNQX. 
CNQX has been used by many investigators to selectively block the AMP A receptors 
in the cerebellum. However, if experiments are done using current clamp, cell 
attached or field recording methods, the excitatory effects of CNQX on Purkinje cells 
could interfere with the interpretation of the experimental data. I was a little surprised 
that no-one has previously reported that CNQX has direct effects on Purkinje cells. 
Given that CNQX has been shown, in a number different areas of the brain, to directly 
excite cells (McBain et al., 1992; Brickley et al., 2001; Maccaferri and Dingledine, 
2002; Hashimoto et aI., 2004) if would seem that other blockers of glutamate receptor 
maybe more appropriate. If seems to me that for voltage clamp experiments, looking 
for example at EPSCs recorded in Purkinje cells, then CNQX is probably still an 
appropriate drug to use to show these events are glutamatergic. In experiments 
looking at intrinsic properties of Purkinje cells, CNQX is no longer an appropriate 
drug to use as it directly excites the Purkinje cell. If would be interesting to see if the 
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increase in Purkinje cell firing was also observed with other members of the CNQX 
family of drugs: 6,7-Dinitroquinoxaline-2,3-dione (DNQX) and 2,3-dihydroxy-6-
nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX). When trying to identify 
which channel CNQX is affecting I would have liked to have used the same method 
as I used to show the direct effect of CART peptide, only of course I would need first 
to block the glutamate receptors with kynurenic acid. 
McBain et al (1992) showed that CNQX increases the spontaneous firing of CA3 
hippocampal interneurones. The calculated the current voltage relationship of this 
current and showed that it had a reversal near to 0 mV, suggesting that the CNQX 
effect is caused by a mixed cation conductance. They also showed that both DNQX 
and NBQX that similar effects, but kynurenic acid did not have any effect. The 
concentrations of CNQX they used to show effects were an order of magnitude higher 
than I used, suggesting that I might have been applying the CNQX below its maximal 
effective concentration. It would be interesting to produce a concentration-response 
curve for CNQX on Purkinje cell firing rate. 
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Appendix 1- Worked example of Wilcoxen t-test 
Data taken from section 4.2.3; change of median instantaneous firing frequency with 
application of 100 nM CART peptide at room temperature. 
control CART 
32.47 35.21 
4.13 4.71 
6.79 7.43 
4.90 4.69 
13.89 19.08 
3.43 3.75 
7.58 8.91 
3.35 2.73 
2.52 3.06 
13.51 15.15 
25% 3.61 3.99 
median 5.85 6.07 
75% 12.03 13.59 
A B B-A R(+) R(-) 
3.349 2.734 -0.614 5 
4.902 4.690 -0.212 1 
3.429 3.751 0.322 2 
2.519 3.063 0.544 3 
4.132 4.706 0.574 4 
6.793 7.429 0.636 6 
7.576 8.909 1.333 7 
13.514 15.152 1.638 8 
32.468 35.211 2.744 9 
13.889 19.084 5.195 10 
sum= 49 6 
n= 10 
5% significance level 8 
Z= 2.1915 
The smallest sum of ranks was 6 which is less than the 5 % confidence level, 
therefore the null hypothesis (groups A and B are the same) is rejected. Alternatively 
using the z value; the 5 % confidence level is z>1.960, 1 % confidence level is 
z>2.576, therefore p<o.05 that groups A and B are the same. 
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